B Cell Receptor Signaling Pathway%WikiPathways_20191210%WP23%Homo sapiens 5.63 5.95 6.01 6.63 5.72 5.98 5.97 6.16 5.78 5.91 6.19 5.51 5.74 5.91 6.17 5.9 5.7 6.07 5.89 6.14 6.45 5.77 5.96 5.94 6.4 5.91 6.39 6.42 5.63 5.73 6.12 6.13 5.88 6.15 6.33 6.24 6.05 6.28 5.63
Trans-sulfuration pathway%WikiPathways_20191210%WP2333%Homo sapiens 5.86 6.04 6.1 6.96 6.01 6.49 6.31 5.95 6.72 6.45 6.06 6.56 6.16 7.25 6.24 6.35 6.04 6.24 5.77 6.27 6.39 6.16 6.03 6.46 6.13 6.76 6.46 6.26 6.33 6.45 6.53 5.93 6.57 7.2 6.41 6.59 6.57 6.43 5.89
Nanoparticle triggered autophagic cell death%WikiPathways_20191210%WP2509%Homo sapiens 6.19 6.21 5.98 6.74 6.31 6.12 6.12 6.01 5.99 6.2 5.86 6 6.08 5.75 5.89 6.1 5.97 6.22 5.94 5.87 6.22 6.37 6.04 5.83 6.14 6.1 5.79 6.44 5.89 5.89 6.41 6.2 5.98 6.26 5.75 5.92 6.07 6.14 6.11
Mammary gland development pathway - Embryonic development (Stage 1 of 4)%WikiPathways_20191210%WP2813%Homo sapiens 5.28 5.43 5.43 6.45 5.27 5.63 5.51 5.28 5.31 5.54 5.67 5.46 5.52 5.53 5.6 5.49 5.23 5.29 5.48 5.35 6.44 5.53 5.58 5.58 5.18 5.39 5.71 5.77 5.24 5.17 6.35 5.87 5.18 5.8 5.95 5.63 5.41 5.7 5.6
Codeine and Morphine Metabolism%WikiPathways_20191210%WP1604%Homo sapiens 3.5 3.72 3.86 3.43 3.58 3.62 4.2 3.82 3.7 3.75 4.05 3.84 4.25 3.64 3.74 3.68 3.38 3.49 3.83 3.73 3.25 3.58 3.73 3.97 3.74 3.71 3.67 4.03 3.93 4.02 3.88 3.73 3.48 3.59 3.63 3.69 3.41 3.39 3.45
Calcium Regulation in the Cardiac Cell%WikiPathways_20191210%WP536%Homo sapiens 5.72 5.99 6.15 6.33 6.09 6 5.66 5.66 5.46 5.71 5.55 5.8 5.49 5.86 5.57 5.84 5.69 5.92 5.9 5.69 6.04 5.89 5.89 5.82 5.74 5.76 5.91 5.66 5.88 5.35 6.08 5.87 5.77 5.55 5.83 5.88 5.97 5.82 5.9
Alanine and aspartate metabolism%WikiPathways_20191210%WP106%Homo sapiens 7.34 7.11 6.97 6.54 7.09 7.26 6.37 6.71 8.06 7.06 6.79 6.68 5.74 7.67 6.56 6.74 7.57 7.27 7.9 7.12 7.25 7.12 7.09 7.62 7.51 8.18 7.09 7.11 7.14 6.72 7.91 7.14 7.98 7.19 5.93 6.22 7.6 7.12 6.77
White fat cell differentiation%WikiPathways_20191210%WP4149%Homo sapiens 5.61 5.6 5.73 5.78 5.55 5.54 5.65 5.49 5.47 5.5 5.56 5.78 5.49 5.37 5.6 5.55 5.49 5.52 5.85 5.62 5.39 5.47 5.48 5.91 5.63 5.96 5.41 5.31 5.52 5.58 5.24 5.85 5.74 5.61 5.87 5.8 5.62 5.38 5.44
EGF/EGFR Signaling Pathway%WikiPathways_20191210%WP437%Homo sapiens 6.34 6.35 6.62 6.83 6.71 6.72 6.69 6.52 6.57 6.58 6.51 6.38 6.32 6.65 6.65 6.44 6.27 6.67 6.43 6.69 6.77 6.6 6.6 6.84 6.62 6.64 6.77 6.73 6.43 6.43 6.72 6.58 6.46 6.68 6.8 6.71 6.66 6.81 6.28
DNA Replication%WikiPathways_20191210%WP466%Homo sapiens 4.13 4.31 4.54 4.91 4.25 4.61 4.5 4.57 4.56 4.21 4.51 4.48 4.32 4.05 4.28 4.32 4.21 4.27 4.3 4.3 4.78 4.39 4.51 4.24 4.43 4.35 4.22 4.35 4.37 4.21 4.36 4.37 4.18 4.33 4.6 4.24 4.17 4.27 4.42
Pyrimidine metabolism%WikiPathways_20191210%WP4022%Homo sapiens 5.17 5.19 5.33 5.62 5.32 5.62 5.23 5.32 5.04 5.23 5.08 5.3 5.23 5.02 5.31 5.33 5.12 5.5 5.4 5.18 5.34 5.38 5.27 5.43 5.48 5.37 5.4 5.26 5 5.24 5.32 5.32 5.2 5.23 5.49 5.18 5.26 5.32 5.26
Vitamin B12 Metabolism%WikiPathways_20191210%WP1533%Homo sapiens 4.03 4.18 4.35 4.34 4.06 4.16 4.33 4.45 4.03 4.53 4.38 4.35 4.26 4.38 4.46 3.9 3.89 4.4 4.25 4.42 4.05 4.19 4.2 4.25 4.47 4.13 4.38 4.21 4.22 4.26 4.43 4.36 4.19 4.36 4.18 4.18 4.1 4.28 4.12
Angiopoietin Like Protein 8 Regulatory Pathway%WikiPathways_20191210%WP3915%Homo sapiens 5.94 5.88 5.89 6.1 5.96 6.1 5.87 5.55 5.86 5.87 5.59 5.72 5.67 5.58 5.94 5.85 5.91 5.94 5.88 5.97 6.06 5.93 6 5.71 5.9 5.69 6.07 5.76 5.76 5.64 5.89 6 5.94 5.94 5.9 5.98 5.85 5.84 5.84
DNA Damage Response%WikiPathways_20191210%WP707%Homo sapiens 5.15 5.21 5.28 5.71 5.08 4.87 5.33 5.27 5.09 5.4 5.48 5.17 5.22 5.34 5.26 5.19 5.16 5.11 5.26 5.31 5.37 5.25 5.22 5.27 5.13 5.02 5.55 5.49 5.25 5.33 5.37 5.27 4.99 5.29 5.37 5.28 5.11 5.4 4.98
Oxidative Damage%WikiPathways_20191210%WP3941%Homo sapiens 5.84 6.13 6.51 6.45 6.04 6.69 5.14 6.22 5.94 6.29 6.18 5.96 5.08 6.63 6.42 5.65 5.67 6.41 5.79 6.37 6.35 6.11 5.9 5.97 6.55 5.9 6.46 5.99 5.67 5.67 6.47 6.07 6.17 6.54 6.44 6.51 6.44 6.39 5.14
Spinal Cord Injury%WikiPathways_20191210%WP2431%Homo sapiens 5.29 5.41 5.48 5.79 5.98 6.1 5.12 5.39 4.98 5.81 5.3 5.24 5.16 5.78 5.87 5.43 5.47 5.61 5.73 5.64 6.14 6.02 5.62 5.44 5.29 5.41 5.93 5.29 5.16 5.11 5.69 5.51 5.19 5.77 6 5.88 5.62 5.91 5.18
Nicotine Activity on Dopaminergic Neurons%WikiPathways_20191210%WP1602%Homo sapiens 7.11 6.79 6.56 5.63 7.23 6.41 4.11 4.71 3.72 5.67 5.18 3.96 4.01 4.92 5.99 6.73 6.5 7.11 6.33 5.87 6.13 6.9 6.43 5.03 5.63 5.42 5.53 5.15 5.59 4.02 5.64 5.77 6.81 4.96 5.85 5.53 5.72 5.21 6.67
PI3K/AKT/mTOR - VitD3 Signalling%WikiPathways_20191210%WP4141%Homo sapiens 4.92 4.86 4.6 4.93 4.88 4.81 4.85 4.58 4.82 4.63 4.69 4.64 4.38 4.36 4.22 4.55 4.85 4.67 4.67 4.55 4.95 5.07 4.75 4.71 4.64 4.78 4.89 4.63 4.8 4.56 4.47 4.75 5.13 4.6 4.83 4.74 4.93 4.65 4.82
IL-1 signaling pathway%WikiPathways_20191210%WP195%Homo sapiens 5.92 5.79 6.03 6.81 6 6.22 6 6.13 6.03 5.92 5.8 5.63 5.95 6.45 6.09 5.82 5.92 5.91 5.82 5.89 6.36 5.98 5.96 5.95 6.27 6.02 6.42 5.84 5.94 5.82 6.13 6.1 6.04 6.67 6.07 6.09 6.07 6.32 5.9
Gastric Cancer Network 1%WikiPathways_20191210%WP2361%Homo sapiens 4.01 4.07 4.06 3.88 3.63 3.75 4.33 4.09 3.92 3.52 4.03 3.92 3.97 3.89 3.93 3.91 4.09 3.89 3.93 4.14 3.93 3.88 4.34 3.8 4 3.55 3.85 4.18 3.9 3.88 3.85 3.93 3.95 3.7 4.05 3.91 3.85 3.92 3.89
Copper homeostasis%WikiPathways_20191210%WP3286%Homo sapiens 5.91 6.05 6.25 7.25 6.59 7.18 5.97 6.61 6.21 6.89 6.39 6.07 6.21 6.51 6.83 6.45 6.25 6.32 6.83 6.73 7.16 6.83 6.45 6.92 6.59 6.2 6.93 6.65 5.93 6.21 6.72 6.6 6.59 6.67 7.04 6.65 6.74 7.25 6.25
Kit receptor signaling pathway%WikiPathways_20191210%WP304%Homo sapiens 6.22 6.39 6.35 6.47 6.62 6.64 6.58 6.44 6.27 6.67 6.4 6.38 5.93 6.69 6.49 6.3 6.11 6.36 6.16 6.46 6.78 6.59 6.08 6.41 6.45 6.34 6.5 6.56 6.23 6.38 6.49 6.5 6.42 6.58 6.57 6.64 6.49 6.87 6
TGF-beta Receptor Signaling%WikiPathways_20191210%WP560%Homo sapiens 4.79 4.9 5.01 5.87 5.14 5.41 5.07 5.52 4.81 5.24 5.45 5.02 5.04 5.5 5.4 5.3 4.69 5.18 4.84 4.71 5.72 5.43 4.91 5.09 5.51 5.23 5.53 5.09 4.69 5.05 5.32 5.19 5.33 6.17 5.77 5.75 5.65 5.63 4.49
Vitamin D Metabolism%WikiPathways_20191210%WP1531%Homo sapiens 3.67 3.87 3.97 3.5 3.67 3.12 4.32 3.83 3.72 3.81 4.16 4.09 4.14 3.74 3.78 3.72 3.48 3.62 3.85 3.97 3.32 3.56 3.84 4 3.86 3.75 3.71 3.85 3.81 3.95 3.98 3.83 3.58 3.61 3.69 3.63 3.68 3.49 3.61
miRNAs involvement in the immune response in sepsis%WikiPathways_20191210%WP4329%Homo sapiens 4.26 4.03 4.05 4.92 4.31 4.3 4.17 4.94 4.23 4.38 4.19 4.17 4.44 4.31 4.68 4.26 4.31 4.37 4.24 4.33 4.43 4.31 4.2 4.23 4.57 4.07 4.41 4.74 4.15 4.08 4.38 4.43 4.08 4.54 4.56 4.37 4.1 4.37 4.01
Prostaglandin Synthesis and Regulation%WikiPathways_20191210%WP98%Homo sapiens 4.57 5.38 5.31 6.21 4.61 5.4 5.27 5.25 5.09 5.2 5.34 5.24 5.17 4.94 5.01 5.01 5.02 5.15 5.1 5.62 5.52 4.67 4.87 5.24 5.37 5.2 5.38 5.48 4.93 4.79 5.23 5.06 4.73 4.74 4.93 5.26 5.12 5.37 4.64
Amyotrophic lateral sclerosis (ALS)%WikiPathways_20191210%WP2447%Homo sapiens 6.35 6.45 6.51 6.6 6.59 6.88 6.68 6.52 6.63 6.53 6.43 6.42 6.39 6.84 6.53 6.42 6.18 6.65 6.47 6.47 6.33 6.65 6.46 6.31 6.89 6.42 6.69 6.34 6.4 6.6 6.66 6.51 6.47 7 6.56 6.34 6.41 6.54 6.36
Serotonin Receptor 4/6/7 and NR3C Signaling%WikiPathways_20191210%WP734%Homo sapiens 6.52 6.23 6.55 6.66 6.56 5.86 6.16 6.19 6.49 6.5 6.73 6.33 6.03 5.95 6.45 6.54 6.81 6.65 6.38 6.54 6.72 6.78 6.35 6.81 5.68 6.33 6.67 6.42 6.55 6.28 6.01 6.59 6.45 6.14 6.38 7.21 6.79 6.53 6.29
ID signaling pathway%WikiPathways_20191210%WP53%Homo sapiens 5.78 6.6 6.89 6.67 6.29 6.01 6.28 6.2 6.18 6.65 6.84 6.52 6.62 6.59 6.82 6.66 6 6.62 6.49 6.86 6.84 6.35 6.61 6.71 6.17 6.34 6.67 6.78 6.53 6.11 6.91 6.9 6.63 6.63 7 6.9 6.78 6.3 5.63
Integrated Breast Cancer Pathway%WikiPathways_20191210%WP1984%Homo sapiens 5.48 5.41 5.53 6.03 5.56 5.7 5.51 5.64 5.67 5.64 5.61 5.46 5.63 5.49 5.72 5.49 5.42 5.76 5.55 5.44 5.92 5.57 5.62 5.65 5.59 5.52 5.68 5.64 5.58 5.47 5.66 5.38 5.68 5.59 5.54 5.7 5.77 5.97 5.46
Glycerolipids and Glycerophospholipids%WikiPathways_20191210%WP4722%Homo sapiens 5.51 5.3 5.19 5.13 5.61 5.97 5.99 5.24 5.48 5.48 5.11 5.28 5.17 5.23 5.09 5.55 5.2 5.48 5.45 5.08 5.27 5.46 5.39 5.56 5.23 5.43 5.44 5.36 5.31 5.45 5.46 5.3 5.36 5.61 5.15 5.1 5.23 5.36 5.57
Type II interferon signaling (IFNG)%WikiPathways_20191210%WP619%Homo sapiens 4.52 5.17 5.02 5.74 5 4.8 4.6 5.28 4.65 5.34 6.12 4.57 4.37 4.67 5.36 4.91 4.93 5.78 4.87 4.97 5.76 4.79 4.77 4.86 5.04 4.8 5.31 6.03 4.56 4.31 4.94 4.99 4.72 4.9 5.57 5.14 4.62 5.24 4.6
Development and heterogeneity of the ILC family%WikiPathways_20191210%WP3893%Homo sapiens 3.25 3.43 3.47 3.35 3.25 3.35 3.69 3.55 3.36 3.62 3.65 3.46 3.7 3.49 3.51 3.2 3.25 3.24 3.48 3.43 3.16 3.36 3.41 3.54 3.48 3.37 3.49 3.57 3.48 3.67 3.48 3.38 3.09 3.32 3.38 3.4 3.19 3.33 3.14
Mitochondrial LC-Fatty Acid Beta-Oxidation%WikiPathways_20191210%WP368%Homo sapiens 6.4 6.1 5.64 6.49 6.05 6.7 6.18 6.13 6.42 6.93 5.51 6.57 6.86 6.44 6.44 5.97 6.12 5.86 5.66 5.92 5.85 6.24 5.91 5.98 6.2 5.99 6.2 5.78 6.39 6.37 6.63 5.94 6.51 6.13 6.16 5.97 6.09 5.87 6.02
Hematopoietic Stem Cell Differentiation%WikiPathways_20191210%WP2849%Homo sapiens 3.74 3.67 3.86 4.12 3.82 3.73 4.08 4.13 3.87 4.07 4 3.92 4.22 3.95 4.1 3.8 3.87 3.85 3.97 3.78 4.03 4.06 3.79 4.1 3.92 3.9 3.94 4.16 3.89 4.16 3.95 4.04 3.75 3.86 4.17 4.04 3.9 3.78 3.73
Methionine De Novo and Salvage Pathway%WikiPathways_20191210%WP3580%Homo sapiens 7.74 7.66 7.41 7.57 7.67 8.19 7.19 7.32 7.55 6.88 6.63 7.26 7.58 7.7 7.03 7.44 7.61 7.7 7.37 7.49 6.96 7.88 7.63 6.79 7.89 7.69 7.16 7.2 7.19 7.98 7.29 7.44 7.5 7.78 7.19 7.51 7.32 7.62 7.1
TP53 Network%WikiPathways_20191210%WP1742%Homo sapiens 5.14 5.35 5.46 5.74 5.29 5.33 5.39 5.51 5.2 4.95 5.62 5.42 5.32 5.34 5.59 5.25 5.18 4.97 5.43 5.42 5.35 5.41 5.41 5.07 5.49 5.2 5.48 5.49 5.13 4.96 5.47 5.47 5 5.26 5.4 5.6 5.17 5.34 4.98
GABA receptor Signaling%WikiPathways_20191210%WP4159%Homo sapiens 5.44 4.77 4.2 4.01 5.08 4.52 4.3 4.54 5.08 4.28 4.23 4.63 3.4 4.32 4.5 4.92 5.24 4.65 4.48 4.15 4.65 4.96 4.39 4.69 4.65 5.4 4.37 4.75 4.94 4.29 4.1 4.39 5.92 3.69 4.25 4.6 5.57 4.59 5.34
TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition%WikiPathways_20191210%WP3859%Homo sapiens 5.9 6 6.42 6.97 6.06 6.21 5.8 5.97 5.47 6.55 5.9 5.74 6.15 6.23 6.28 6.03 6.09 6.23 6.56 6.3 7.07 6.17 6.36 5.95 6.17 5.73 6.62 6.12 5.77 5.99 6.29 6.56 6.01 6.76 6.28 6.54 6.2 6.4 5.91
Valproic acid pathway%WikiPathways_20191210%WP3871%Homo sapiens 5.62 5.5 5.74 5.47 5.64 5.68 5.57 5.53 5.47 5.77 5.58 5.89 5.7 5.47 5.36 5.6 5.64 5.67 5.51 5.56 5.49 5.75 5.57 5.42 5.56 5.49 5.63 5.5 6.03 5.71 5.16 6.16 5.47 5.39 5.5 5.44 5.44 5.58 5.41
Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways%WikiPathways_20191210%WP706%Homo sapiens 5.42 5.35 5.5 5.33 5.73 5.66 5.04 5.26 4.88 5.38 4.86 5.06 4.74 4.96 5.34 5.35 5.32 5.36 5.58 5.36 5.69 5.68 5.49 5.19 5.33 5.52 5.35 5.23 5.16 5.21 5.28 5.29 5.74 4.91 5.51 5.37 5.38 5.38 5.25
Histone Modifications%WikiPathways_20191210%WP2369%Homo sapiens 5.35 5.38 5.74 5.18 5.04 5.4 5.5 5.39 5.46 5.2 5.47 5.76 5.14 5.6 5.04 5.19 5.29 5.43 5.41 5.41 5.16 5.27 5.49 5.54 5.03 5.44 5.29 5.2 5.2 5.14 5.53 5.7 5.62 5.62 5.37 5.29 5.73 5.49 5.26
Pathways in clear cell renal cell carcinoma%WikiPathways_20191210%WP4018%Homo sapiens 6.72 6.97 7.03 7.06 7.03 7.29 6.99 6.94 7.11 7.36 6.89 6.91 7.21 7.54 7.13 6.86 6.56 6.9 6.86 6.96 7.04 6.85 7.14 7.27 7.09 7.26 7.57 6.88 7.01 7.08 7.3 7.07 7.15 7.35 7.19 7.57 7.41 7.13 6.76
miRNAs involved in DNA damage response%WikiPathways_20191210%WP1545%Homo sapiens 5.08 5 4.71 5.48 4.93 4.82 5.42 5.51 4.89 5.24 5.58 4.78 5.21 5.31 5.19 4.96 4.79 4.85 5.14 4.85 5.34 5.15 4.97 4.87 4.46 5.13 5.51 5.72 4.94 4.73 5.42 5.32 4.87 4.99 5.2 5.51 4.97 5.59 4.62
Zinc homeostasis%WikiPathways_20191210%WP3529%Homo sapiens 6.43 6.78 6.62 7.84 6.41 6.54 6.61 6.51 6.55 7.2 6.77 6.55 6.74 7.27 7.78 6.43 6.49 6.9 6.37 6.83 7.62 6.58 7.04 6.55 6.53 6.53 7.04 6.37 6.61 6.48 7.33 6.67 6.54 7.07 7.53 6.99 6.77 7.38 6.26
BMP2-WNT4-FOXO1 Pathway in Human Primary Endometrial Stromal Cell Differentiation%WikiPathways_20191210%WP3876%Homo sapiens 3.85 4.06 4.13 3.71 3.91 3.99 4.68 4.05 3.94 4.24 4.36 4.02 4.62 3.92 4.19 3.81 3.85 3.81 4.23 4.1 3.7 3.86 4.02 4.58 4.23 4.11 4.18 4.59 4.19 4.18 4.29 4.18 3.71 3.68 3.87 3.96 4.26 4.32 3.76
Alzheimers Disease%WikiPathways_20191210%WP2059%Homo sapiens 5.81 5.81 5.97 5.89 6.22 5.96 5.38 5.54 5.64 5.67 5.48 5.68 5.77 5.88 5.94 5.84 5.8 5.96 5.74 5.52 6.1 6.09 5.71 5.49 5.74 5.82 5.61 5.48 5.85 5.43 5.75 5.71 6.31 6.02 6.12 5.76 6 5.99 5.65
Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway%WikiPathways_20191210%WP2203%Homo sapiens 4.87 5.22 4.98 6.42 5.21 5.4 5.16 5.6 5.28 5.43 5.53 5.15 5.07 5.3 5.82 5.07 5.13 5.38 4.96 5.03 5.82 5.34 5.15 5.04 5.84 5.39 6 5.81 5.02 5.35 5.35 5.25 5.14 5.42 5.68 5.59 5.31 6.02 5.27
Imatinib and Chronic Myeloid Leukemia%WikiPathways_20191210%WP3640%Homo sapiens 6.28 6.66 7.29 7.31 6.72 7.33 6.66 7.06 6.89 6.7 6.56 6.78 6.83 6.89 6.95 6.67 6.47 6.75 6.98 7.05 7.01 6.59 6.53 6.86 7.05 6.59 7.08 6.68 6.6 6.81 6.65 7.01 6.89 6.95 6.86 7.08 7.03 7.14 6.49
Eicosanoid Synthesis%WikiPathways_20191210%WP167%Homo sapiens 3.52 3.73 3.86 4.43 3.55 3.93 3.86 3.9 3.66 3.95 3.93 3.76 3.73 3.6 3.74 3.67 3.58 3.58 4.07 3.74 4.37 3.56 3.73 3.59 3.92 3.77 3.7 3.79 3.69 3.66 4.03 4.06 3.43 3.63 3.82 3.65 3.6 3.57 3.46
Signaling of Hepatocyte Growth Factor Receptor%WikiPathways_20191210%WP313%Homo sapiens 6.87 6.8 6.8 7.12 7.1 6.8 6.45 6.7 6.94 6.99 6.62 6.89 6.99 7.03 7.17 6.85 6.89 6.85 6.91 6.9 7.42 6.94 6.96 7 6.76 6.75 7.33 6.73 6.9 7.01 7.02 6.74 7.02 6.95 7.31 7.28 7.27 7.36 6.94
Signal Transduction of S1P Receptor%WikiPathways_20191210%WP26%Homo sapiens 6.16 6.01 6.25 6.92 6.91 6.85 6.16 6.5 6.15 6.49 5.79 6.53 6.03 6.42 6.3 6.43 6.64 6.32 6.04 6.14 6.96 6.8 6.04 6.76 6.63 6.48 6.72 6.33 6.6 6.1 6.99 6.12 6.48 6.63 6.39 6.52 6.34 6.52 6.13
Selenium Micronutrient Network%WikiPathways_20191210%WP15%Homo sapiens 4.44 4.38 4.51 4.93 4.5 4.42 4.55 4.47 4.39 4.54 4.5 4.55 4.39 4.5 4.48 4.4 4.33 4.45 4.57 4.44 4.42 4.64 4.67 4.54 4.5 4.42 4.44 4.44 4.44 4.37 4.64 4.66 4.32 4.63 4.56 4.49 4.4 4.36 4.26
Eukaryotic Transcription Initiation%WikiPathways_20191210%WP405%Homo sapiens 6 5.88 6.11 6.21 5.84 6.41 5.89 6.34 6.21 6.3 5.83 5.86 6.59 6.18 6.11 5.83 5.75 5.97 5.8 5.87 5.89 5.99 5.91 6.11 6.13 5.76 6.28 6.03 6.17 6.07 6.13 5.99 5.85 5.89 6.03 5.83 6.1 6.06 6.01
Wnt Signaling Pathway and Pluripotency%WikiPathways_20191210%WP399%Homo sapiens 5.17 5.41 5.53 5.89 5.47 5.49 5.56 5.72 5.34 5.55 5.47 5.42 5.51 5.46 5.59 5.51 5.32 5.56 5.55 5.49 5.49 5.47 5.49 5.61 5.35 5.51 5.52 5.49 5.43 5.38 5.57 5.71 5.32 5.53 5.59 5.66 5.6 5.51 5.18
Glutathione metabolism%WikiPathways_20191210%WP100%Homo sapiens 6 5.8 5.89 5.81 5.83 6.01 5.7 4.78 5.81 5.34 5.25 5.61 5.32 5.86 6.06 5.86 5.95 5.63 5.79 5.54 6.11 5.85 5.89 5.08 5.13 5.87 5.84 5.47 6.02 5.69 5.65 5.11 6.02 5.99 6.08 5.87 4.9 5.58 5.26
NOTCH1 regulation of human endothelial cell calcification%WikiPathways_20191210%WP3413%Homo sapiens 5.98 5.79 6.66 6.78 6.33 7.49 6.4 6.7 6.33 6.68 6.34 6.42 6.41 6.68 6.52 6.15 6.23 5.86 6.93 7.2 6.91 6.3 6.73 6.45 7.04 6.43 6.69 6.77 6.54 6.25 6.83 6.8 6.13 6.73 6.85 6.91 6.48 6.69 5.6
Role of Osx and miRNAs in tooth development%WikiPathways_20191210%WP3971%Homo sapiens 4.76 5.47 5.97 5.65 5.73 5.92 6.03 5.67 5.26 5 5.49 5.7 5.66 5.63 5.83 4.6 4.69 5.2 5.99 6.23 5.52 5.92 5.13 5.91 6.2 5.43 5.01 5.42 5.31 5.36 5.74 6.74 5.81 5.18 6.06 6.07 5.26 4.97 4.82
Deregulation of Rab and Rab Effector Genes in Bladder Cancer%WikiPathways_20191210%WP2291%Homo sapiens 4.39 4.72 4.92 4.66 4.59 4.59 4.86 4.35 4.52 4.76 4.99 4.55 4.43 4.51 5.12 4.51 4.58 4.68 4.75 5.03 4.92 4.59 4.71 4.6 4.63 4.5 4.64 4.91 4.63 4.83 4.89 4.7 4.79 4.25 5.24 4.96 4.62 4.73 4.53
IL-5 Signaling Pathway%WikiPathways_20191210%WP127%Homo sapiens 6.26 6.66 6.92 6.77 6.78 6.85 6.45 6.61 6.49 6.74 6.51 6.62 6.69 6.96 6.9 6.62 6.32 6.8 6.86 6.82 6.94 6.7 7.07 6.81 6.62 6.52 7.3 6.66 6.44 6.88 6.89 6.71 6.93 6.94 7.24 7.17 7.08 7.02 6.11
Sterol Regulatory Element-Binding Proteins (SREBP) signalling%WikiPathways_20191210%WP1982%Homo sapiens 6.79 6.72 6.93 6.83 6.93 6.84 6.44 6.37 6.75 6.31 6.19 6.69 6.06 6.29 6.38 6.6 6.76 6.65 6.39 6.39 6.96 6.85 6.75 6.39 6.36 6.64 6.34 6.46 6.61 6.33 6.28 6.03 6.69 5.97 6.32 6.44 6.7 6.65 6.74
GPCRs, Class A Rhodopsin-like%WikiPathways_20191210%WP455%Homo sapiens 2.9 2.91 2.99 2.75 2.77 2.82 3.09 2.98 2.85 2.96 3.09 2.94 3.08 2.86 2.93 2.78 2.83 2.79 2.99 2.95 2.67 2.82 2.94 2.93 2.93 2.86 2.77 2.96 2.95 3.02 2.92 2.94 2.8 2.79 2.91 2.85 2.8 2.75 2.81
Allograft Rejection%WikiPathways_20191210%WP2328%Homo sapiens 3.68 3.84 3.88 3.77 3.66 3.87 4.06 3.89 3.51 3.85 4.23 3.74 3.96 3.72 3.98 3.78 3.7 4.1 3.87 4.2 4.05 3.72 3.78 3.84 3.94 3.69 3.7 3.93 3.8 3.84 3.79 3.77 3.65 4 3.98 3.78 3.63 3.88 3.56
IL1 and megakaryocytes in obesity%WikiPathways_20191210%WP2865%Homo sapiens 4.29 4.83 4.52 6.09 4.88 5.17 4.61 5.16 4.62 5.18 4.97 4.62 4.36 4.55 5.39 4.53 4.18 5.04 4.67 4.51 5.72 4.86 4.62 4.67 4.94 4.65 5.58 5.05 4.69 4.44 4.97 4.63 4.52 4.69 5.53 5.32 4.53 5.5 4.15
Chemokine signaling pathway%WikiPathways_20191210%WP3929%Homo sapiens 5.04 5.26 5.39 5.82 5.23 5.59 4.91 5.4 5.01 5.41 5.19 5.06 5.07 5.15 5.56 5.31 5.06 5.65 5.19 5.3 5.52 5.3 5.33 5.09 5.76 5.03 5.61 5.19 5.12 5.14 5.31 5.29 5.34 5.48 5.57 5.5 5.27 5.59 4.97
MECP2 and Associated Rett Syndrome%WikiPathways_20191210%WP3584%Homo sapiens 5.81 5.88 5.54 5.98 6.22 6.26 5.82 5.83 5.98 5.64 5.53 5.71 5.28 5.83 5.82 5.84 5.94 5.98 5.89 5.77 6.19 6.18 5.63 5.9 6.26 5.89 5.84 5.96 6.11 5.77 5.76 5.73 5.97 5.73 5.78 5.71 5.92 6.25 5.66
Focal Adhesion%WikiPathways_20191210%WP306%Homo sapiens 5.64 5.64 6.08 6.19 5.93 6.3 5.71 5.9 5.77 6.13 5.65 5.65 5.76 5.99 6.22 6.07 5.85 5.91 5.95 6.25 6.12 5.89 6.02 5.92 6.2 5.9 6.21 5.92 5.85 5.8 5.99 6.17 5.9 6.2 6.2 6.27 6.14 6.21 5.55
miRs in Muscle Cell Differentiation%WikiPathways_20191210%WP2012%Homo sapiens 4.94 5.4 5.64 6.35 5.52 5.75 5.63 6.06 5.64 5.81 5.92 5.28 5.27 5.45 5.89 5.65 5.04 5.68 5.96 5.7 6.09 5.8 5.7 5.9 5.75 5.87 5.84 6.16 5.43 5.31 5.95 5.8 5.69 5.73 6.06 5.93 5.91 6.06 4.99
Primary Focal Segmental Glomerulosclerosis FSGS%WikiPathways_20191210%WP2572%Homo sapiens 5.92 5.92 6.3 6.39 6.09 6.5 6.23 6.15 6 6.22 6.14 6.19 6.21 6.36 6.27 6.06 5.99 6.03 6.08 6.39 6.59 6.03 6.05 6.34 6.38 6.13 6.45 6.41 6.12 6.25 6.22 6.3 6.11 6.58 6.25 6.58 6.4 6.09 5.81
Glucuronidation%WikiPathways_20191210%WP698%Homo sapiens 3.29 3.55 3.63 3.31 3.44 3.89 3.69 3.89 3.46 3.66 3.63 3.57 4.01 3.45 3.56 3.47 3.44 3.46 3.6 3.54 3.39 3.44 3.49 3.62 3.59 3.52 3.5 4.16 3.81 3.76 3.98 3.59 3.41 3.45 3.37 3.45 3.24 3.42 3.44
Genes targeted by miRNAs in adipocytes%WikiPathways_20191210%WP1992%Homo sapiens 3.56 3.81 3.92 4.8 3.63 4.25 4.31 3.86 4.36 3.83 3.87 3.67 4.08 3.74 4.33 3.45 3.83 3.72 3.94 4.41 3.66 3.53 3.61 3.87 4.45 4.44 4.09 4.53 3.96 3.86 4.98 4.12 3.94 4.2 3.81 3.79 4.21 4.12 3.78
mRNA Processing%WikiPathways_20191210%WP411%Homo sapiens 7.42 7.37 7.58 7.65 7.54 7.92 7.6 7.75 7.77 7.56 7.51 7.42 7.82 7.65 7.68 7.51 7.37 7.35 7.33 7.55 7.72 7.43 7.5 7.81 7.53 7.61 7.75 7.76 7.55 7.58 7.76 7.54 7.52 7.87 7.47 7.46 7.6 7.9 7.46
Wnt/beta-catenin Signaling Pathway in Leukemia%WikiPathways_20191210%WP3658%Homo sapiens 4.91 5.24 5.65 5.52 4.97 5.53 5.6 5.25 4.86 5.56 5.37 5.24 5.11 5.31 5.38 5.04 4.96 4.93 5.56 5.68 5.25 5.16 5.26 5.29 5.11 5.13 5.29 5.31 5.08 5.27 5.1 5.54 5.06 5.22 5.43 5.28 5.43 5.4 5.13
RalA downstream regulated genes%WikiPathways_20191210%WP2290%Homo sapiens 6.26 7.46 7.88 7.85 7.33 7.74 6.94 7.08 6.9 7.48 6.79 6.83 7.23 7.19 7.43 6.68 6.28 7.64 7.63 7.4 7.76 7.42 7.44 7.4 6.99 7.58 7.49 7.16 7.56 6.88 7.87 6.71 7.65 6.92 7.62 7.58 7.75 7.36 5.97
EBV LMP1 signaling%WikiPathways_20191210%WP262%Homo sapiens 4.87 5 5.01 4.91 4.9 5.18 5.23 5.18 4.91 5.07 5.42 5.12 5.22 4.93 5.33 5.01 4.87 5.14 4.99 5.14 4.83 4.91 4.93 5 5.32 4.92 5.44 5.19 5.03 5.12 5.08 5.19 4.79 5.46 5.34 5.12 5.04 4.84 4.73
Farnesoid X Receptor  Pathway%WikiPathways_20191210%WP2879%Homo sapiens 3.5 3.97 3.79 3.3 3.7 4.36 3.88 4.46 4.4 4.06 3.76 4.37 4.18 3.74 4.24 3.5 3.26 3.84 3.54 3.96 3.51 3.58 3.96 4.3 3.82 4.43 3.95 4.38 4.39 4.22 3.61 3.87 4.07 3.64 3.89 4.13 4.08 4.08 3.37
Hepatitis C and Hepatocellular Carcinoma%WikiPathways_20191210%WP3646%Homo sapiens 5.03 5.19 5.48 6.28 5.23 5.49 5.3 5.88 5.26 5.44 5.48 5.33 5.39 5.71 5.59 5.3 5.18 5.36 5.25 5.42 5.7 5.47 5.05 5.35 5.55 5.38 5.53 5.49 5.17 5.21 5.42 5.37 5.38 6.17 5.54 5.5 5.65 5.91 4.87
Transcription factor regulation in adipogenesis%WikiPathways_20191210%WP3599%Homo sapiens 5.79 5.71 5.62 5.9 5.6 5.84 5.53 5.51 5.51 5.88 5.68 5.49 5.13 5.47 5.27 5.47 5.69 5.96 5.56 5.4 5.92 5.47 5.43 5.9 5.45 6.15 5.76 5.67 5.82 5.53 5.45 5.28 5.95 4.95 5.23 5.95 5.89 5.87 5.57
Electron Transport Chain (OXPHOS system in mitochondria)%WikiPathways_20191210%WP111%Homo sapiens 9.7 9.6 9.04 9.45 9.31 9.22 8.8 9.24 9.69 9.35 8.74 9.36 9.45 9.07 9.15 9.24 9.25 9.68 9.24 8.65 9.25 9.18 9.08 8.96 9.18 9.29 8.99 8.74 9.24 9.14 9.07 8.7 9.29 9.02 8.95 8.59 9.09 9.34 9.72
Melatonin metabolism and effects%WikiPathways_20191210%WP3298%Homo sapiens 5.4 5.6 5.96 6.02 5.91 6.14 5.47 6.12 5.67 5.81 5.62 5.55 5.63 5.6 5.86 5.81 5.87 5.42 5.84 5.66 6.07 5.72 6.21 5.99 5.61 5.58 6.04 5.6 5.79 5.5 5.99 5.84 5.58 5.56 5.97 5.88 5.94 6.34 5.75
AGE/RAGE pathway%WikiPathways_20191210%WP2324%Homo sapiens 5.94 6.05 6.33 6.81 6.42 6.53 6.16 6.39 6.6 6.52 6.4 6.36 6.57 6.66 6.44 6.32 6.18 6.18 6.36 6.56 6.6 6.53 6.59 6.62 6.59 6.52 6.59 6.44 6.37 6.52 6.56 6.55 6.31 6.91 6.69 6.84 6.58 6.55 6.03
miR-509-3p alteration of YAP1/ECM axis%WikiPathways_20191210%WP3967%Homo sapiens 3.97 3.98 4.38 4.51 3.84 3.94 4.17 4.2 4.06 4.37 4.14 3.87 4.46 4.33 4.09 3.76 4.16 3.97 4.27 4.39 4.8 3.89 4.33 4.05 4.08 4 4.17 4.08 4.06 4.44 4.23 4.48 3.67 4.6 4.34 3.86 4 4.46 3.85
Nucleotide GPCRs%WikiPathways_20191210%WP80%Homo sapiens 3.47 3.71 3.8 4.38 3.42 4.36 4.53 3.97 4.38 3.77 4.01 4.57 4.57 4.4 3.77 3.45 3.47 3.58 4.28 4.5 3.38 3.69 4.16 3.9 4.51 4.48 3.66 3.97 3.82 3.93 4.76 3.96 3.35 4.4 3.5 3.54 4.33 3.47 3.61
Translation Factors%WikiPathways_20191210%WP107%Homo sapiens 8.25 8.4 8.25 8.59 8.23 8.66 8.33 8.5 8.6 8.39 8.01 8.28 8.42 8.28 8.37 8.35 8.29 8.48 8.09 8.14 8.51 8.28 8.26 8.31 8.35 8.53 8.47 8.35 8.29 8.13 8.29 8.31 8.33 8.39 8.27 8.16 8.4 8.62 8.4
Estrogen metabolism%WikiPathways_20191210%WP697%Homo sapiens 4.76 4.9 5.53 5.13 4.87 5.47 4.43 5.75 4.87 5.52 5.15 4.39 4.66 4.61 5.51 4.48 5.34 4.35 5.79 5.85 5.08 5.25 6.1 4.4 5.49 4.4 5.64 4.38 4.68 4.53 5.46 4.89 4.42 4.54 5.8 5.34 4.57 5.33 4.35
miRNA regulation of p53 pathway in prostate cancer%WikiPathways_20191210%WP3982%Homo sapiens 3.96 4.22 4.28 4.17 3.87 4.05 4.65 4.22 4.08 4.82 4.44 3.89 4.41 3.92 4.23 4.13 4.28 4.1 4.31 4.16 4.56 3.85 4.18 4.3 4.28 4.18 4.58 4.83 4.37 4.15 4.59 4.13 4.05 3.85 4.03 4.33 4.45 4.64 4.12
G Protein Signaling Pathways%WikiPathways_20191210%WP35%Homo sapiens 6.89 6.66 6.95 6.91 6.93 7.05 6.33 6.57 6.61 6.5 6.2 6.65 6.25 6.35 6.64 6.76 6.66 6.89 6.67 6.55 6.73 6.79 6.67 6.47 6.63 6.62 6.4 6.56 6.66 6.37 6.64 6.53 6.97 6.54 6.61 6.57 6.74 6.59 6.95
Differentiation Pathway%WikiPathways_20191210%WP2848%Homo sapiens 3.57 3.68 3.68 3.61 3.32 3.57 3.77 3.67 3.6 3.81 3.76 3.7 3.74 3.65 3.73 3.38 3.42 3.54 3.83 3.69 3.56 3.53 3.69 3.69 3.7 3.67 3.67 3.95 3.69 3.91 3.97 4.02 3.46 3.61 3.64 3.63 3.63 3.73 3.45
Nuclear Receptors Meta-Pathway%WikiPathways_20191210%WP2882%Homo sapiens 4.98 5.07 5.25 5.62 5.25 5.42 5.23 5.31 4.98 5.55 5.15 5.13 5.15 5.19 5.42 5.1 5.04 5.14 5.22 5.29 5.55 5.44 5.37 5.13 5.2 5.24 5.39 5.25 5.19 5.14 5.16 5.27 5.23 5.1 5.44 5.37 5.3 5.35 4.89
T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection%WikiPathways_20191210%WP3863%Homo sapiens 4.76 5.25 5.14 5.64 5.17 5.32 5.17 5.26 5.07 5.2 5.22 4.54 4.75 4.81 5.67 5.06 4.92 5.25 5 4.84 5.65 5.22 5.22 5.25 5.33 5.38 5.46 5.64 5.11 4.63 5.27 5.08 5.09 5.44 5.66 5.65 5.22 5.58 4.78
Overview of leukocyte-intrinsic Hippo pathway functions%WikiPathways_20191210%WP4542%Homo sapiens 5.47 5.69 5.48 5.52 5.57 5.72 5.81 5.79 5.48 5.72 5.66 5.65 6.23 5.82 5.87 5.5 5.57 5.42 5.61 5.86 5.6 5.6 5.45 5.76 6.14 5.77 5.99 5.75 5.7 6.34 5.7 5.96 5.62 6.1 5.79 5.87 5.9 5.78 5.36
TGF-beta Signaling Pathway%WikiPathways_20191210%WP366%Homo sapiens 5.91 5.83 6.25 6.68 6.14 6.29 5.94 6.18 5.83 6.24 5.9 5.89 5.93 6.11 6.28 6.11 5.83 6.09 6.03 6.12 6.6 6.18 6.11 6.1 6.09 5.87 6.39 6.1 5.85 5.81 5.98 6.17 5.92 6.34 6.23 6.29 6.08 6.45 5.74
ATM Signaling Pathway%WikiPathways_20191210%WP2516%Homo sapiens 5.14 4.8 5.22 5.31 4.57 4.79 4.9 5.27 5.07 5.02 5.29 4.97 5.22 5.17 5.13 5.04 4.89 5.01 5.1 4.9 5.29 4.74 5.02 5.22 5.13 4.91 5.15 5.19 5.23 5.07 5.14 5.22 4.88 5 4.94 5.2 4.86 5.13 4.76
Toll-like Receptor Signaling Pathway%WikiPathways_20191210%WP75%Homo sapiens 4.2 4.51 4.38 5.21 4.18 4.4 4.53 4.87 4.46 4.76 4.68 4.17 4.44 4.56 4.92 4.28 4.31 4.6 4.49 4.38 4.79 4.4 4.48 4.63 4.89 4.45 4.88 4.76 4.22 4.25 4.62 4.43 4.4 4.6 4.79 4.56 4.43 4.73 4.01
Interferon type I signaling pathways%WikiPathways_20191210%WP585%Homo sapiens 5.92 6 6.09 6.55 5.76 6.05 6.01 5.74 5.93 6.1 6.25 5.73 5.68 5.93 6.26 5.89 5.76 6.01 5.89 6.08 6.35 5.63 5.97 6.04 6.33 5.93 6.06 6.07 5.74 5.89 5.99 6.19 5.93 5.85 6.3 6.24 6.05 6.1 5.67
Oxidative phosphorylation%WikiPathways_20191210%WP623%Homo sapiens 9.3 9.28 8.89 8.85 9.15 9.03 8.55 8.83 9.37 8.86 8.43 9.3 8.91 8.96 8.53 9.01 9.13 9.04 8.74 8.47 8.93 9.05 8.8 8.54 8.93 9.09 8.66 8.49 8.96 8.83 8.7 8.5 8.9 8.68 8.48 8.35 8.68 8.81 9.49
Photodynamic therapy-induced AP-1 survival signaling.%WikiPathways_20191210%WP3611%Homo sapiens 5.45 4.94 5.07 5.35 5.38 5.33 5.08 4.94 4.94 4.97 5.02 4.96 5.04 5.28 5.15 5.4 5.11 5.11 5.08 5.33 5.33 5.41 5.42 4.94 5.03 5.2 5.15 4.83 4.88 4.96 5.1 5.07 4.79 5.21 5.21 5.25 4.87 5.34 4.98
NAD metabolism, sirtuins and aging%WikiPathways_20191210%WP3630%Homo sapiens 5.93 6.14 6.91 6.83 7.05 6.9 6.49 6.94 6.93 7.27 6.66 6.45 6.12 6.56 6.91 6.03 6.06 6.74 6.83 7.29 6.84 7.07 7.09 6.98 6.77 6.93 7.15 7.01 6.66 5.44 7.22 6.16 6.76 7.07 7.02 7.3 6.6 6.85 6.04
Fatty Acid Biosynthesis%WikiPathways_20191210%WP357%Homo sapiens 7.69 7.75 7.52 7.22 7.82 8.01 7.17 7.59 7.98 7.4 7.4 7.92 7.84 7.81 7.16 7.81 7.48 7.66 6.81 7.17 7.75 7.62 7.14 7.77 7.52 7.61 7.68 6.88 7.82 7.59 7.82 7.51 7.61 7.93 7.76 7.43 7.8 7.13 6.96
Corticotropin-releasing hormone signaling pathway%WikiPathways_20191210%WP2355%Homo sapiens 5.91 5.99 5.87 6.46 6.21 5.97 6.16 6.05 6.13 5.78 6.05 5.9 5.74 6.04 5.99 5.96 6 6.06 5.93 6.12 6.25 6.24 5.91 6.03 6.19 5.97 6.04 6.42 5.96 5.83 6.1 6.24 6.11 6.33 6.19 6.23 6.19 6.17 5.95
GPCRs, Class C Metabotropic glutamate, pheromone%WikiPathways_20191210%WP501%Homo sapiens 4.33 4.52 4.25 4.07 4.19 4.09 4.43 4.14 4.18 4.21 4.03 4.8 4.03 4.33 4.39 4.2 4.19 4.15 5.4 4.1 4.08 4.18 4.54 4.59 3.98 4.72 4.16 4.18 4.76 4.27 4.73 4.28 4.09 3.78 4.54 4.2 4.41 4.08 4.67
Amplification and Expansion of Oncogenic Pathways as Metastatic Traits%WikiPathways_20191210%WP3678%Homo sapiens 5.4 5.47 5.97 6.37 5.73 6.7 5.03 6.34 5.12 6.35 4.94 5.29 5.97 6.22 5.8 5.76 5.52 5.65 5.99 6.23 5.94 5.88 5.61 5.61 5.63 4.87 6.44 5.48 5.61 5.75 5.59 6.4 5.5 6.28 6.06 6.55 5.62 5.9 5.23
Exercise-induced Circadian Regulation%WikiPathways_20191210%WP410%Homo sapiens 8.17 8.15 7.96 8.78 8.24 8.54 7.96 8.4 8.42 8.16 7.81 8.24 8.18 7.58 7.99 7.93 7.99 8.24 8.14 7.69 8.37 8.32 8.17 8.18 8.43 8.28 8.12 8.19 8.39 7.96 8.21 7.77 8.29 7.87 7.87 8.43 8.2 8.54 8.02
PI3K-AKT-mTOR signaling pathway and therapeutic opportunities%WikiPathways_20191210%WP3844%Homo sapiens 5.98 6 6.2 6.81 6.54 6.73 6.54 6.39 6.67 6.79 6.3 6.42 6.25 6.64 6.47 6.19 6.05 6.49 5.92 6.48 6.51 6.67 6 6.77 7.08 6.58 6.59 6.32 6.49 6.47 6.53 6.38 6.46 6.69 6.47 6.51 6.5 6.46 6.01
Neural Crest Differentiation%WikiPathways_20191210%WP2064%Homo sapiens 5.09 5.24 5.48 5.36 5.29 5.41 5.51 5.38 5.34 5.63 5.15 5.42 5.49 5.53 5.59 5.48 5.05 5.22 5.55 5.54 5.49 5.47 5.54 5.61 5.57 5.4 5.48 5.18 5.35 5.64 5.62 5.7 5.19 5.69 5.6 5.5 5.36 5.38 5.06
Apoptosis Modulation by HSP70%WikiPathways_20191210%WP384%Homo sapiens 4.38 4.68 4.68 5.51 4.42 4.64 4.72 4.66 4.64 4.95 4.53 4.29 4.73 4.76 4.61 4.65 4.4 4.68 4.67 4.63 5.33 4.4 4.43 4.66 4.85 4.47 4.7 4.7 4.46 4.64 4.59 4.54 4.05 4.75 4.68 4.6 4.5 4.94 4.56
Serotonin Transporter Activity%WikiPathways_20191210%WP1455%Homo sapiens 4.18 4.46 4.65 6.06 4.6 5.07 4.79 4.69 4.65 5.13 4.61 4.59 4.71 4.51 4.75 4.4 4.23 4.42 4.58 5.13 5.38 4.82 4.6 4.55 5.16 4.51 4.93 4.67 4.47 4.71 4.76 4.75 3.97 4.91 5.22 4.43 4.36 5.62 4.2
TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway%WikiPathways_20191210%WP2036%Homo sapiens 4.87 5 5.22 6.13 5.14 5.18 5.31 5.22 5.26 5.48 5.26 5.06 5.22 5.7 5.34 4.99 4.92 5.14 5.23 5.3 5.42 5.15 5.07 5.12 5.4 4.99 5.25 5.27 5.05 5.12 5.25 5.19 5.08 5.86 5.52 5.26 5.17 5.13 4.73
NRF2 pathway%WikiPathways_20191210%WP2884%Homo sapiens 5.14 5.48 5.31 5.68 5.46 5.43 5.15 5.2 5.03 5.25 5.13 5.17 5.04 5.71 5.4 5.37 5.2 5.44 5.24 5.19 5.67 5.58 5.48 5.21 5.37 5.22 5.33 5.24 5.36 5.02 5.16 5.36 5.55 5.24 5.58 5.36 5.31 5.14 4.98
Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4)%WikiPathways_20191210%WP2817%Homo sapiens 5.41 5.27 5.38 5.19 5.44 5.64 5.27 5.23 5.14 5.61 4.98 5.06 5.23 5.52 5.69 5.35 5.51 5.28 5.52 5.42 5.77 5.67 5.39 5.37 5.03 5.39 5.55 5.19 5.05 4.98 5.26 5.26 5.13 5.11 5.72 5.62 5.33 5.82 5.34
RAC1/PAK1/p38/MMP2 Pathway%WikiPathways_20191210%WP3303%Homo sapiens 5.57 5.59 5.93 6.38 5.76 5.86 5.78 5.65 5.74 5.84 5.78 5.6 5.82 5.96 5.99 5.69 5.76 5.72 5.7 6.04 6.02 5.74 5.83 5.74 6.2 5.64 6.04 5.66 5.65 5.83 5.93 6 5.93 6.19 6.11 5.98 5.78 6.02 5.5
Synaptic Vesicle Pathway%WikiPathways_20191210%WP2267%Homo sapiens 7.85 7.74 7.17 6.75 7.48 6.93 6.61 6.24 7.29 6.68 6.33 6.61 5.52 6.58 6.93 7.33 7.45 7.94 7.09 6.94 7.77 7.14 6.72 6.61 6.71 6.61 6.9 6.64 6.85 6.14 6.58 6.97 7.72 6.55 7.19 6.69 7.11 6.8 8.06
Ovarian Infertility Genes%WikiPathways_20191210%WP34%Homo sapiens 4.18 3.98 4.15 3.7 3.87 3.42 4.34 4.09 3.9 4.03 4.65 4 4.26 3.95 4 3.98 3.77 3.84 4.04 4.17 3.62 3.86 4.07 4.1 4.01 3.97 4.01 4.04 3.92 4.16 4.16 4.06 3.83 3.9 4.12 3.8 3.85 3.6 3.81
TCA Cycle (aka Krebs or citric acid cycle)%WikiPathways_20191210%WP78%Homo sapiens 8.82 8.44 8.04 8.14 8.37 8.31 7.69 7.78 8.55 8.02 7.5 8.58 7.81 7.96 7.97 8.32 8.33 8.53 8 7.57 8.38 8.41 8.3 7.94 8 8.36 7.78 7.64 8.1 7.69 8.03 7.69 8.3 7.85 7.6 7.67 7.93 7.94 8.85
Parkinsons Disease Pathway%WikiPathways_20191210%WP2371%Homo sapiens 7.4 6.91 6.53 6.8 7.25 6.53 6.08 6.21 6.18 6.52 6.22 6.35 6.36 6.2 6.48 7.01 6.87 6.98 6.57 6.58 7.13 7.15 6.87 6.41 6.5 6.33 6.63 6.39 6.56 6.25 6.63 6.52 7.22 6.59 6.73 6.45 6.65 6.27 6.98
Arrhythmogenic Right Ventricular Cardiomyopathy%WikiPathways_20191210%WP2118%Homo sapiens 4.4 4.44 4.47 4.29 4.33 4.66 4.56 4.53 4.59 4.58 4.69 4.45 4.82 4.43 4.34 4.51 4.34 4.33 4.71 4.74 4.28 4.44 4.74 4.46 4.46 4.4 4.4 4.86 4.44 4.56 4.73 4.72 4.37 4.5 4.46 4.47 4.38 4.31 4.36
MFAP5-mediated ovarian cancer cell motility and invasiveness%WikiPathways_20191210%WP3301%Homo sapiens 5.78 5.74 5.35 6.07 5.85 5.07 6.02 6.13 5.98 5.64 6.05 5.66 5.65 5.45 5.43 5.85 6 5.65 5.76 5.7 5.67 5.8 5.7 6.25 5.75 5.9 6.04 5.96 5.93 5.58 5.81 6.04 5.95 5.42 5.52 5.87 6.19 6.17 5.97
Hair Follicle Development: Cytodifferentiation (Part 3 of 3)%WikiPathways_20191210%WP2840%Homo sapiens 3.7 4.1 4.21 4.44 4.22 4.33 4.54 4.17 4.28 4.46 4.36 3.94 4.4 4.23 4.28 4.23 4.29 4.3 4.11 4.35 4.37 4.31 4.21 4.4 4.42 4.33 4.42 4.37 3.97 4.25 4.37 4.13 4.24 4.29 4.25 4.46 4.36 4.25 3.92
Globo Sphingolipid Metabolism%WikiPathways_20191210%WP1424%Homo sapiens 4.85 4.19 4.26 3.93 4.52 4.18 4.17 4.11 4.32 4.13 4.17 4.51 4.06 3.94 4.19 4.44 4.89 4.89 5 4.35 4.22 4.76 5.08 4.05 4.08 4.25 4.04 3.98 4.56 4.22 4.16 3.88 4.53 4.13 4.43 4.12 4.22 4.39 4.74
Urea cycle and metabolism of amino groups%WikiPathways_20191210%WP497%Homo sapiens 6.51 6.56 6.32 5.9 6.79 6.68 6.33 6.52 6.37 6.16 6.35 6.52 6 6.46 6.44 6.57 6.65 6.56 6.09 6.14 6.22 6.77 6.03 6.19 7.05 6.52 5.95 6.32 6.53 6.57 6.51 6.77 6.25 6.63 6.46 6.08 6.09 6.52 6.5
Non-homologous end joining%WikiPathways_20191210%WP438%Homo sapiens 4.73 4.7 5.04 4.78 4.7 4.6 5.05 4.81 4.93 4.76 4.99 5.05 5.09 4.93 4.97 4.7 4.61 4.65 4.83 4.73 4.46 4.7 4.79 4.84 4.79 4.9 4.67 5.09 4.96 4.9 4.93 4.7 4.38 4.61 4.67 4.68 4.67 4.58 4.87
One Carbon Metabolism%WikiPathways_20191210%WP241%Homo sapiens 5.61 6.09 6.02 6.67 5.87 6.15 5.87 6.04 6.24 5.92 6.04 6 6.16 6.03 6.14 6.02 5.77 5.85 6.01 6.14 6.42 6.13 5.74 6.12 6.15 5.98 5.95 6.08 5.94 6.03 5.89 6.23 6 6.25 5.97 5.96 6.01 6.23 5.75
H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity%WikiPathways_20191210%WP3969%Homo sapiens 5.54 5.45 5.84 6.78 5.89 6.21 5.96 6.15 5.52 6.2 5.56 5.5 5.67 5.93 6.15 5.91 5.83 5.96 5.83 5.91 6.36 5.8 5.94 5.94 5.18 5.51 6.18 6.06 5.23 5.69 5.97 5.89 5.33 6.01 5.96 5.88 5.82 6.39 5.77
Overview of nanoparticle effects%WikiPathways_20191210%WP3287%Homo sapiens 4.56 4.9 5.02 5.34 4.62 4.56 4.71 4.79 4.76 4.84 4.94 4.58 4.87 5.07 5.12 4.8 4.44 4.84 4.91 4.89 5.29 4.75 4.83 4.93 4.86 4.79 5.06 5.04 4.71 4.75 5.09 5.09 4.83 5.12 5.31 4.98 4.92 4.79 4.41
Glycolysis and Gluconeogenesis%WikiPathways_20191210%WP534%Homo sapiens 8.14 8.02 8.05 7.59 7.86 7.95 7.47 7.56 8.28 7.84 7.52 8.41 7.8 8.06 7.85 7.89 7.78 8.06 7.86 7.6 7.89 7.76 8.08 7.92 7.82 8.11 7.77 7.47 7.92 7.46 7.91 7.57 7.98 7.94 7.84 7.82 7.99 7.77 8.2
Myometrial Relaxation and Contraction Pathways%WikiPathways_20191210%WP289%Homo sapiens 5.8 6.18 6.22 6.52 6.23 6.42 5.9 6.14 5.96 6.08 5.87 5.94 5.73 6.09 5.9 5.94 5.96 6.06 6.12 6.17 6.43 6.3 5.94 6.06 6.21 6.18 6.09 5.95 5.95 5.65 6.12 6.03 6.05 6.12 6.14 6.07 6.21 6.51 5.94
Constitutive Androstane Receptor Pathway%WikiPathways_20191210%WP2875%Homo sapiens 4.95 5.17 5.33 4.88 5.14 5.18 5.45 5.39 5.11 5.61 5.18 5.38 5.51 5.32 5.05 5.14 5.07 5.12 5.37 5.31 4.9 5.15 5.33 5.33 5.19 5.26 5.5 5.37 5.52 5.28 5.27 5.4 5.16 4.85 4.98 5.29 5.32 5.22 5.08
Lung fibrosis%WikiPathways_20191210%WP3624%Homo sapiens 4.12 4.12 4.37 4.68 4.35 4.2 4.44 4.55 4.35 4.53 4.59 4.18 4.44 4.49 4.68 4.28 4.3 4.16 4.35 4.39 4.24 4.59 4.53 4.36 4.57 4.23 4.51 4.57 4.23 4.33 4.49 4.64 4.23 4.53 4.61 4.46 4.12 4.34 4.07
Simplified Depiction of MYD88 Distinct Input-Output Pathway%WikiPathways_20191210%WP3877%Homo sapiens 3.55 4.29 3.83 6.58 3.48 4.59 4.34 5.58 3.9 4.63 4.63 3.57 4.24 4.18 4.61 4.14 3.61 4.57 4.1 4.2 5.27 3.88 4.21 4.27 5.58 3.95 5.48 5.35 3.94 3.75 5.03 4.19 4.29 4.26 5.13 4.5 4.39 5.34 3.37
Nanomaterial induced apoptosis%WikiPathways_20191210%WP2507%Homo sapiens 4.49 4.71 4.9 5.65 4.46 4.71 4.83 4.75 5 5.18 4.6 4.72 4.74 4.81 4.74 4.82 4.54 4.8 4.78 4.65 5.23 4.65 4.57 4.75 4.88 4.7 4.94 4.7 4.62 4.7 4.79 4.61 4.65 5.06 4.84 4.74 4.64 4.97 4.71
Blood Clotting Cascade%WikiPathways_20191210%WP272%Homo sapiens 2.98 2.99 3 2.86 2.87 2.91 3.12 2.89 2.94 3.03 3.07 3.03 3.11 2.98 2.97 2.94 2.87 2.89 3.06 2.99 2.7 2.87 2.99 3.03 2.82 2.97 2.74 3.02 2.99 3.15 3.04 3.05 2.84 2.95 2.97 2.98 2.93 2.78 2.84
Ethanol metabolism resulting in production of ROS by CYP2E1%WikiPathways_20191210%WP4269%Homo sapiens 5.24 6.05 5.86 6.17 5.96 5.81 6.26 6.39 5.95 6.18 5.69 5.79 5.85 6.35 6.01 5.37 5.5 5.83 5.37 5.92 5.97 6.21 6.04 6.09 5.76 5.88 5.88 5.9 5.74 5.74 5.66 5.85 5.88 6.5 5.92 6.2 5.91 6.08 5.49
Insulin Signaling%WikiPathways_20191210%WP481%Homo sapiens 6.14 6.03 6.24 6.62 6.31 6.34 6.18 6.22 6.24 6.27 6.27 6 6.02 6.29 6.34 6.05 6.11 6.21 6.14 6.25 6.48 6.31 6.01 6.33 6.29 6.18 6.33 6.42 6.03 5.96 6.32 6.22 6.37 6.28 6.38 6.36 6.31 6.25 6.04
Sulfation Biotransformation Reaction%WikiPathways_20191210%WP692%Homo sapiens 4.9 4.91 5.34 4.89 4.66 4.95 5.27 5.15 5.2 5.2 5.35 5.19 4.35 5.01 5.13 4.87 4.8 4.66 5.14 5.12 4.91 4.81 5.11 5.17 5.11 5.15 5.05 4.86 4.75 5.02 5.1 5.36 5.05 4.85 5.19 5.08 4.98 4.86 4.69
Interactome of polycomb repressive complex 2 (PRC2) %WikiPathways_20191210%WP2916%Homo sapiens 6.29 6.14 6.34 6.59 6.24 6.86 6.15 6.6 6.22 6.31 6.72 6.09 6.93 6.25 6.17 5.96 6.14 6.48 6.53 6.16 6.53 6.17 6.09 6.42 6.07 6.22 6.72 6.72 6.35 6.38 6.32 6.02 6.4 6.46 6.23 6.25 6.37 6.79 6.1
Serotonin Receptor 2 and ELK-SRF/GATA4 signaling%WikiPathways_20191210%WP732%Homo sapiens 7.29 7.19 6.99 6.83 7.1 6.8 6.19 6.33 6.86 7.01 6.62 6.74 6.63 6.58 7.02 6.85 6.89 7.09 7.03 6.9 7.11 7.07 7.19 6.88 6.26 6.62 7.08 6.58 6.78 6.39 7.02 6.65 7.6 6.73 7.19 7.48 7.47 6.7 7.02
Nanoparticle triggered regulated necrosis%WikiPathways_20191210%WP2513%Homo sapiens 4.4 4.71 4.94 5.51 4.43 4.6 4.92 4.66 4.91 4.95 4.7 4.66 4.73 4.93 5.12 4.65 4.4 4.65 4.7 4.63 5.23 4.4 4.43 4.66 4.57 4.64 4.88 4.72 4.4 4.67 4.8 4.39 4.64 4.89 4.68 4.56 4.7 4.84 4.56
Nuclear Receptors in Lipid Metabolism and Toxicity%WikiPathways_20191210%WP299%Homo sapiens 3.24 3.35 3.42 3.22 3.13 3.11 3.59 3.43 3.3 3.37 3.57 3.4 3.54 3.31 3.37 3.24 3.15 3.21 3.43 3.58 3.15 3.17 3.44 3.52 3.39 3.35 3.3 3.46 3.38 3.44 3.49 3.31 3.18 3.41 3.24 3.33 3.18 3.23 3.09
TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc)%WikiPathways_20191210%WP2453%Homo sapiens 7.77 7.66 7.71 7.93 7.83 7.98 7.09 7.55 7.71 7.58 7.05 7.86 7.6 7.61 7.71 7.58 7.68 7.82 7.6 7.3 7.77 7.69 7.81 7.23 7.33 7.89 7.49 7.32 7.7 7.44 7.54 7.35 7.67 7.32 7.46 7.58 7.72 7.45 8
DNA IR-damage and cellular response via ATR%WikiPathways_20191210%WP4016%Homo sapiens 5.14 5.06 5.24 5.47 4.99 4.94 5.25 5.3 5.1 5.14 5.14 5.01 5.22 4.99 5.18 5.04 4.89 5.01 5.03 4.92 5.25 4.97 5.13 4.99 5.13 4.98 4.9 5.17 5.09 5.07 5.23 5.05 5.01 5.25 5.04 5.07 4.86 5.26 4.69
Leptin signaling pathway%WikiPathways_20191210%WP2034%Homo sapiens 5.91 5.95 6.21 6.64 6 6.16 5.97 6.13 5.98 6.09 6.04 5.74 5.83 6.29 6.26 5.9 5.94 6.08 5.95 6.28 6.37 5.88 6 6.21 6.43 6.18 6.42 6.13 6.03 5.83 6.49 6.43 6.09 6.33 6.37 6.24 6.19 6.39 5.74
DNA Damage Response (only ATM dependent)%WikiPathways_20191210%WP710%Homo sapiens 5.57 5.63 5.61 6.43 5.61 5.77 5.56 5.88 5.43 5.8 5.67 5.49 5.6 5.71 5.77 5.61 5.54 5.64 5.67 5.8 5.93 5.59 5.69 5.64 5.6 5.59 5.83 5.82 5.6 5.65 5.73 5.86 5.6 6.12 6.05 6.1 5.65 5.94 5.4
Cytoplasmic Ribosomal Proteins%WikiPathways_20191210%WP477%Homo sapiens 11.4 11.69 11.67 12.29 11.64 12.21 12.16 12.22 11.98 12.15 12.19 11.76 12.18 11.63 12 11.7 11.71 11.9 11.76 11.8 11.89 11.7 11.72 12.02 12.54 11.91 12.04 12.35 11.79 12.03 12.03 11.75 11.69 11.99 11.96 11.73 11.87 12.2 11.39
Estrogen Receptor Pathway%WikiPathways_20191210%WP2881%Homo sapiens 4.44 4.01 4.5 3.66 4.23 4.89 4.43 5.21 4.53 4.88 4.46 4.35 4.84 4.41 4.75 4.25 4 4.19 4.21 4.61 3.82 4.08 4.77 4.94 5 4.22 4.6 4.64 4.17 4.44 4.56 4.04 4.1 4.05 4.25 5.05 4.53 4.75 3.49
Gastric Cancer Network 2%WikiPathways_20191210%WP2363%Homo sapiens 5.07 5.02 4.86 5.84 5.11 5.19 5.19 4.89 5.15 5.38 4.89 4.77 4.69 5.22 5.5 4.89 4.68 4.86 4.84 5.05 5.67 4.71 5 4.82 4.27 5.23 5.3 4.76 4.52 5.18 5.24 4.86 5.09 4.95 5.56 5.13 4.86 5.45 4.91
Phytochemical activity on NRF2 transcriptional activation%WikiPathways_20191210%WP3%Homo sapiens 7.34 7.03 7.14 8.01 7.22 7.34 6.54 6.94 7.26 7.64 6.82 7.16 7.83 7.59 7.03 7.27 7.37 7.3 6.96 7.12 7.8 7.12 7.27 6.75 7.05 7.13 7.63 6.37 7.2 7.49 7.21 7.11 7.2 7.5 6.81 7.49 7.43 7.2 7.17
IL-7 Signaling Pathway%WikiPathways_20191210%WP205%Homo sapiens 6.37 6.28 6.48 6.58 6.78 6.8 6.16 6.44 6.54 6.78 6.13 6.38 5.93 6.81 6.44 6.45 6.4 6.63 6.52 6.45 6.8 6.83 6.4 6.62 6.92 6.52 6.66 6.29 6.44 6.52 6.72 6.59 6.48 6.88 6.67 6.32 6.49 6.39 6.44
Tryptophan metabolism%WikiPathways_20191210%WP465%Homo sapiens 5.22 5.17 5.71 5.13 5.34 5.63 4.8 5.8 4.87 5.52 4.5 4.5 4.82 4.61 5.51 5.41 5.7 5.12 5.83 5.79 5.47 5.27 5.93 4.47 5.49 4.56 5.54 4.96 4.43 4.52 5.46 4.79 5.2 4.54 5.8 5.34 4.79 5.33 5.18
Sphingolipid pathway%WikiPathways_20191210%WP1422%Homo sapiens 7.31 6.59 6.69 7.07 7.44 6.8 6.91 6.81 7.01 6.98 6.58 6.84 6.68 6.78 6.72 7.14 7.4 6.97 6.54 6.57 7.04 7.25 6.7 6.79 6.68 6.8 7.05 6.66 6.94 6.78 7.28 6.32 7.26 6.88 6.8 6.82 7.2 6.87 7.71
Complement Activation%WikiPathways_20191210%WP545%Homo sapiens 3.91 4.05 4.01 4.67 3.93 4.12 4.23 4.05 3.98 4.48 4.26 4.01 3.99 4.46 4.26 4.16 4.01 4.28 4.16 4.26 4.05 4.13 3.99 4.05 4.76 3.93 4.43 4.35 4.06 4.28 4.48 4.46 3.89 4.73 4.29 4.08 3.86 4.13 3.85
Alpha 6 Beta 4 signaling pathway%WikiPathways_20191210%WP244%Homo sapiens 5.72 5.76 5.89 6.46 5.65 6.1 5.71 5.81 5.83 5.9 5.61 5.68 6.17 6.53 6.3 5.72 5.64 5.94 5.9 6.14 6.63 5.72 6 5.99 6.13 5.85 6.33 5.91 6.02 5.96 5.89 5.97 5.74 6.67 5.82 6.24 5.81 6.1 5.78
Sleep regulation%WikiPathways_20191210%WP3591%Homo sapiens 3.47 3.37 3.54 4.44 3.78 4.03 3.76 3.66 3.58 4.03 3.7 3.57 3.79 4.21 3.57 3.56 3.61 3.73 3.68 3.57 3.9 3.8 3.57 3.9 4.37 4.24 3.67 3.68 3.56 3.58 4.25 3.82 3.63 4.36 3.64 3.7 4.2 3.77 3.49
Adipogenesis%WikiPathways_20191210%WP236%Homo sapiens 5.36 5.4 5.38 5.36 5.2 5.41 5.44 5.31 5.34 5.45 5.48 5.36 5.4 5.33 5.35 5.41 5.15 5.47 5.51 5.37 5.36 5.4 5.42 5.3 5.23 5.5 5.39 5.46 5.38 5.46 5.31 5.61 5.58 5.31 5.18 5.41 5.59 5.37 5.05
Neovascularisation processes%WikiPathways_20191210%WP4331%Homo sapiens 5.37 5.27 5.82 6.09 5.65 5.59 5.31 5.86 5.44 5.65 5.71 5.41 5.47 5.83 5.79 5.83 5.48 5.39 5.95 5.87 5.97 5.64 5.55 5.84 5.99 5.79 6.05 5.88 5.38 5.82 5.7 5.94 5.48 6.24 5.92 6.15 5.87 5.54 5.03
TYROBP Causal Network%WikiPathways_20191210%WP3945%Homo sapiens 4.44 5.13 5.19 6.43 4.61 5.59 5.06 5.74 4.8 5.21 6.21 4.73 4.72 4.76 5.32 5.06 4.5 5.62 5.17 5.48 5.93 4.87 5.14 5.06 6.4 5.01 5.68 6.48 4.92 4.67 5.66 5.67 4.88 5.41 5.79 5.64 4.96 5.55 4.28
Serotonin and anxiety%WikiPathways_20191210%WP3947%Homo sapiens 5.17 4.62 4.19 4.28 5.14 4.79 4.63 3.98 4.67 4.32 4.2 4.47 4.37 4.36 4.59 4.09 5.2 4.97 4.91 4.09 4.53 5.2 4.56 4.65 4.29 5.23 4.02 4.23 4.6 4.16 4.42 4.23 5.16 4.39 4.44 4.24 5.33 4.45 4.22
ncRNAs involved in STAT3 signaling in hepatocellular carcinoma%WikiPathways_20191210%WP4337%Homo sapiens 4.72 4.59 4.43 4.92 4.55 4.49 4.85 5.54 4.45 4.5 4.67 4.59 4.63 4.66 5.03 4.56 4.54 4.51 4.59 4.71 4.07 5.15 4.54 4.61 4.6 4.57 4.49 4.6 4.46 5.21 4.58 4.81 4.52 4.73 4.57 5.28 4.55 4.45 4.54
Statin Pathway%WikiPathways_20191210%WP430%Homo sapiens 3.94 4.09 4.5 5.42 4.18 4.76 4.69 4.43 4.44 4.52 4.55 4.47 4.19 4.59 4.56 3.69 3.92 4.21 4.29 4.58 4.82 4.21 4.34 4.57 4.63 4.45 4.64 4.54 4.3 4.07 4.62 4.25 4.21 4.97 4.78 4.36 4.44 4.65 3.85
Extracellular vesicle-mediated signaling in recipient cells%WikiPathways_20191210%WP2870%Homo sapiens 5.48 5.55 6.22 5.94 5.65 5.78 5.39 5.88 5.5 5.89 5.45 5.44 5.93 6.05 5.74 5.99 5.31 5.63 5.69 5.92 6.04 5.49 5.69 5.88 5.46 5.63 6.17 5.46 5.33 5.81 5.75 6.17 5.6 6.33 6.05 6.28 5.65 6.16 5.06
Leptin Insulin Overlap%WikiPathways_20191210%WP3935%Homo sapiens 5.91 5.63 5.74 5.72 5.65 5.92 5.29 5.57 5.41 5.97 5.48 5.07 5.35 5.19 5.62 5.3 5.88 5.88 5.91 5.66 5.83 5.56 5.94 5.98 5.86 5.47 6.02 5.98 5.64 5.44 5.66 5.77 5.85 5.02 5.32 6.1 5.83 5.76 5.6
ATM Signaling Network in Development and Disease %WikiPathways_20191210%WP3878%Homo sapiens 5.87 5.63 5.49 5.97 5.77 5.65 5.42 5.73 5.99 5.61 5.59 5.62 5.43 5.53 5.82 5.65 5.67 5.68 5.59 5.46 5.77 5.71 5.53 5.6 5.84 5.73 5.59 5.63 5.61 5.37 5.73 5.52 5.72 5.74 5.58 5.59 5.51 5.52 5.66
Bone Morphogenic Protein (BMP) Signalling and Regulation%WikiPathways_20191210%WP1425%Homo sapiens 4.79 4.44 4.46 6.02 4.97 4.76 5.07 5.26 5.38 4.84 5.01 5.02 5.33 5.15 5.13 4.99 5.21 5.18 4.11 4.52 5.93 5.08 4.9 5.09 5.46 5.23 5.53 5.09 4.69 5.05 5.38 4.16 5.42 5.62 5.28 5.26 5.65 5.94 4.99
Regulation of Actin Cytoskeleton%WikiPathways_20191210%WP51%Homo sapiens 6.08 6.39 6.42 6.58 6.18 6.5 5.87 6.21 6.06 6.28 6.11 5.93 6.12 6.3 6.45 6.21 6.18 6.38 6.32 6.47 6.59 6.07 6.48 6.22 6.53 6.19 6.62 6.15 6.2 6.04 6.39 6.31 6.18 6.34 6.52 6.5 6.3 6.5 6.1
Initiation of transcription and translation elongation at the HIV-1 LTR%WikiPathways_20191210%WP3414%Homo sapiens 6.32 6.32 6.13 6.32 6.03 6.07 6.23 6 6.09 5.95 6.08 6.46 5.91 6.18 5.85 6.3 6.13 6.17 5.83 5.96 5.95 6.29 5.59 6.24 6.51 6.22 6.07 5.89 6.11 6.18 6.11 6.01 6.37 6.22 5.84 5.93 6.04 5.8 6.14
Tumor suppressor activity of SMARCB1%WikiPathways_20191210%WP4204%Homo sapiens 6.18 6.24 6.57 6.56 6.07 6.76 6.23 6.43 6.36 6.29 6.39 6.18 6.29 6.12 6.12 6.03 6.18 5.87 6.26 6.19 6.23 6.36 6.14 5.97 5.73 6.12 6.05 6.21 6.25 6.13 6.43 5.87 6.39 6.33 6.41 6.21 6.43 6.65 6.16
Bladder Cancer%WikiPathways_20191210%WP2828%Homo sapiens 5.38 5.32 5.5 5.25 5.38 5.33 5.24 5.15 5.19 5.43 5.05 5.33 5.47 5.35 5.28 5.28 5.26 5.24 5.42 5.4 5.35 5.5 5.44 5.34 4.96 5.39 5.07 5.14 5.13 5.34 5.29 5.43 5.13 5.22 5.33 5.31 5.32 5.53 5.12
miRNA Regulation of DNA Damage Response%WikiPathways_20191210%WP1530%Homo sapiens 5.19 5.27 5.29 5.74 5.11 4.94 5.39 5.3 5.15 5.41 5.55 5.23 5.32 5.36 5.28 5.25 5.18 5.26 5.28 5.32 5.38 5.25 5.27 5.3 5.25 5.25 5.55 5.59 5.3 5.42 5.4 5.36 5.06 5.55 5.4 5.29 5.17 5.59 5.12
Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds%WikiPathways_20191210%WP3664%Homo sapiens 4.99 5.23 5.7 5.86 5.24 6.01 6.06 5.96 5.35 5.62 5.33 5.44 5.56 5.6 5.47 5.51 5.15 5.36 5.4 6.17 5.2 5.45 5.46 5.7 5.61 5.42 5.42 5.63 5.32 5.79 5.83 5.79 5.22 6.24 5.55 5.51 5.4 5.18 4.81
GPR40 Pathway%WikiPathways_20191210%WP3958%Homo sapiens 6.02 5.97 6.04 6.46 5.74 6.22 6.52 6.42 6.14 6 6.14 6.25 6.36 6.34 6.21 6.12 5.9 6.35 6.17 6.42 6.24 5.76 5.92 6.31 6.87 6.31 6.42 6.13 6.37 6.3 6.24 6.31 6.07 6.43 6.01 6.53 6.38 6.2 5.99
Development of pulmonary dendritic cells and macrophage subsets%WikiPathways_20191210%WP3892%Homo sapiens 4.15 4.19 4.39 4.89 4.13 4.07 4.6 4.24 3.88 4.21 4.65 4.3 4.29 4.19 4.28 4.15 4.07 3.95 4.21 4.19 4.26 3.96 4.21 4.23 4.31 4.2 4.16 4.22 4.22 4.33 4.96 4.3 4.19 4.07 4.86 4.17 4.05 4.5 3.85
Cell Differentiation - Index%WikiPathways_20191210%WP2029%Homo sapiens 2.97 3.56 3.12 2.93 2.93 2.82 3.21 3.05 3.01 3.01 3.14 3.06 3.25 3 3.36 2.99 2.95 2.95 3.09 3.08 2.86 2.98 3.04 3.09 2.98 3.02 2.99 3.03 2.96 3.17 3.05 3.04 2.91 2.95 3.01 3.31 2.98 2.88 2.98
Photodynamic therapy-induced NF-kB survival signaling%WikiPathways_20191210%WP3617%Homo sapiens 3.41 3.88 3.95 4.61 3.8 3.8 4.02 4.12 3.48 4.03 3.98 3.8 3.93 3.85 4.06 3.6 3.58 3.77 3.71 3.89 4.01 3.86 3.77 3.81 3.94 3.73 4.25 3.84 3.79 3.66 4.11 3.89 3.64 4.12 4.28 4.18 3.51 3.88 3.52
ESC Pluripotency Pathways%WikiPathways_20191210%WP3931%Homo sapiens 4.65 4.5 4.46 4.84 4.6 4.29 4.69 4.37 4.27 4.48 4.37 4.35 4.62 4.5 4.56 4.51 4.5 4.69 4.77 4.49 4.83 4.5 4.69 4.73 4.5 4.53 4.8 4.54 4.23 4.54 4.63 4.4 4.7 4.81 4.68 4.59 4.63 4.75 4.51
NO/cGMP/PKG mediated Neuroprotection%WikiPathways_20191210%WP4008%Homo sapiens 4.61 4.53 4.45 4.56 4.89 4.76 4.56 4.44 4.16 4.71 4.38 4.75 4.48 4.53 4.76 4.57 4.69 4.43 4.56 4.71 4.92 4.98 4.85 4.62 4.23 4.74 4.5 4.42 4.53 4.8 4.71 4.75 4.75 4.34 4.96 4.62 5.09 4.71 4.73
BDNF-TrkB Signaling%WikiPathways_20191210%WP3676%Homo sapiens 5.92 5.68 5.83 6.07 6.03 5.73 5.92 5.65 5.98 5.83 5.63 5.8 5.83 5.73 5.75 5.78 5.91 5.76 5.83 5.62 5.93 5.84 5.61 6 5.62 6.09 6 5.83 5.77 5.69 5.73 5.63 5.84 5.62 5.79 5.77 6.04 6.1 5.9
Regulation of Apoptosis by Parathyroid Hormone-related Protein%WikiPathways_20191210%WP3872%Homo sapiens 5.03 5.41 5.48 6.33 5.29 5.49 5.56 5.51 5.34 5.81 5.48 5.42 5.41 5.34 6.26 5.25 5.18 4.97 5.43 5.42 6.31 5.59 5.41 5.07 5.74 5.4 5.48 5.49 5.43 5.55 6.11 5.37 5.19 5.26 6.5 5.37 5.17 6.08 5.18
Mammary gland development pathway - Involution (Stage 4 of 4)%WikiPathways_20191210%WP2815%Homo sapiens 4.88 5.08 5.16 5.18 4.99 5.08 5.27 5.15 5.04 5.32 5.23 5.1 5.14 5.05 5.2 5.22 4.93 4.83 5.23 5.09 5.08 5.32 5.1 4.94 5.13 5.08 5.1 5.16 5.05 5.26 5.24 5.21 4.95 4.96 5.07 5.1 5.02 5.2 4.94
IL-2 Signaling Pathway%WikiPathways_20191210%WP49%Homo sapiens 6.06 6.3 7.06 6.85 6.73 7.03 6.09 6.62 6.52 6.76 6.43 6.5 6.68 6.89 6.9 6.59 6.3 6.65 6.79 6.84 6.94 6.64 6.83 6.85 6.61 6.61 7.33 6.66 6.4 6.8 6.65 6.6 6.78 7.04 7.15 7.04 6.8 7.24 6.23
Steroid Biosynthesis%WikiPathways_20191210%WP496%Homo sapiens 2.62 2.71 2.71 2.55 2.61 2.6 2.85 2.69 2.66 2.71 2.86 2.72 2.89 2.65 2.72 2.79 2.61 2.6 2.75 2.77 2.51 2.75 2.69 2.77 2.73 2.67 2.64 2.76 2.75 2.79 2.73 2.77 2.55 2.58 2.72 2.67 2.58 2.57 2.58
Leptin and adiponectin%WikiPathways_20191210%WP3934%Homo sapiens 6.42 6.37 6.79 6.48 6.25 6.81 5.94 6.7 6.23 5.96 6.39 6.32 6.29 6.05 6.45 6.1 6.8 6.54 7.24 6.38 6.69 6.43 6.6 6.29 6.49 6.27 6.71 6.39 6.12 6.07 6.04 6.25 6.62 6.16 6.13 6.39 6.38 6.66 6.52
Notch Signaling Pathway Netpath%WikiPathways_20191210%WP61%Homo sapiens 6.3 6.19 6.69 6.86 6.59 6.78 6.62 6.67 6.44 6.67 6.22 6.38 6.58 6.6 6.54 6.45 6.31 6.26 6.45 6.73 6.94 6.57 6.45 6.68 6.62 6.52 6.66 6.61 6.44 6.52 6.71 6.84 6.5 6.65 6.72 6.66 6.58 6.6 6.28
NAD+ metabolism%WikiPathways_20191210%WP3644%Homo sapiens 5.96 6.14 6.19 5.62 5.62 5.85 5.31 6.5 5.68 5.62 5.44 6.14 5.89 5.87 5.75 6.03 6.02 6.04 5.86 5.46 5.45 5.64 6.14 5.79 5.55 5.77 5.8 5.17 5.97 5.62 6.09 5.53 6.27 6.02 5.6 6.03 6.09 6.02 5.65
Prader-Willi and Angelman Syndrome%WikiPathways_20191210%WP3998%Homo sapiens 4.13 4.1 3.78 3.21 3.57 3.59 4.04 3.7 3.67 3.77 3.93 3.69 3.8 3.45 3.68 3.64 3.81 3.75 3.84 3.53 3.57 3.7 3.83 3.75 3.81 3.79 3.41 3.93 3.8 3.55 3.82 3.41 3.71 3.24 3.42 3.3 3.42 3.43 4.48
Structural Pathway of Interleukin 1 (IL-1)%WikiPathways_20191210%WP2637%Homo sapiens 6.38 6.16 6.44 6.8 6.41 6.57 6.16 6.25 6.49 6.27 6.18 5.96 6.25 6.23 6.27 6.18 6.17 6.15 5.88 6.33 6.57 6.44 6.33 6.37 6.29 6.23 6.52 6.3 6.21 5.82 6.3 6.41 6.34 6.41 6.3 6.3 6.3 6.69 6.21
Mitochondrial Gene Expression%WikiPathways_20191210%WP391%Homo sapiens 5.04 5.21 4.45 5.16 4.85 4.76 4.8 5.34 4.56 5.07 4.72 4.97 4.94 5.1 4.71 4.73 4.96 5.12 4.63 4.79 5.02 4.45 5.04 4.72 4.74 4.84 4.63 4.74 5.15 5.18 5.38 4.77 4.58 4.51 4.72 4.75 4.77 5.37 4.93
Canonical  and Non-canonical Notch signaling%WikiPathways_20191210%WP3845%Homo sapiens 5.97 5.63 6.31 6.77 6.06 6.6 6.37 6.52 6.16 6.04 5.99 6.05 5.72 6.21 6.04 5.91 6.03 5.81 6.13 6.53 6.5 6.23 6.3 6.46 6.35 6.41 6.31 6.54 5.8 6.08 6.56 6.45 6.12 6.46 6.3 6.07 6.48 6.2 5.74
Mesodermal Commitment Pathway%WikiPathways_20191210%WP2857%Homo sapiens 4.68 4.75 4.98 4.74 4.76 4.75 5.03 4.84 4.75 4.77 4.79 4.85 5.05 4.72 4.76 4.59 5 4.7 4.85 4.83 4.69 4.75 4.8 4.94 4.78 4.71 4.72 4.78 4.79 4.82 4.77 4.73 4.92 4.72 4.52 4.75 5.15 4.76 4.73
PPAR Alpha Pathway%WikiPathways_20191210%WP2878%Homo sapiens 5.03 5.14 5.11 5.04 4.98 5.02 5.47 5.43 5.09 5.41 5.21 5.26 5.46 5.23 5.27 5.06 5.18 4.95 5.13 5.27 5.34 5.14 5.1 5.04 5.08 5.24 5.28 5.31 5.19 5.21 5.04 5.33 5.13 5.17 5.26 5.21 5.24 5.07 4.81
Striated Muscle Contraction Pathway%WikiPathways_20191210%WP383%Homo sapiens 3.84 3.94 4.04 3.63 3.79 3.87 4.25 4.18 3.88 4.03 4.18 4.09 4.25 3.82 4.08 3.79 3.68 3.82 4.03 3.99 3.59 3.74 3.86 4.09 4.13 3.9 3.97 4.18 4.02 4.24 4.1 3.98 3.64 3.86 3.9 3.9 3.65 3.73 3.79
MAPK  and NFkB Signalling Pathways Inhibited by Yersinia YopJ%WikiPathways_20191210%WP3849%Homo sapiens 5.51 5.41 5.6 6.54 5.68 5.54 5.97 5.65 5.76 5.79 5.93 5.6 5.31 5.81 5.9 5.56 5.55 5.72 5.65 5.47 5.98 5.58 5.53 5.74 6.05 5.73 5.8 5.69 5.72 5.58 6.09 5.63 5.62 6.1 6.08 5.92 5.76 5.72 5.25
PPAR signaling pathway%WikiPathways_20191210%WP3942%Homo sapiens 4.61 4.98 4.93 4.93 4.89 4.98 4.96 5.26 4.87 5.07 5.04 4.81 5.01 4.77 4.76 4.68 4.72 4.87 5.13 4.79 4.83 4.65 5.09 5.01 5 5.1 4.92 5.02 5.08 4.92 4.98 4.69 5.12 4.68 4.6 4.76 4.97 5.09 4.49
Selenium Metabolism and Selenoproteins%WikiPathways_20191210%WP28%Homo sapiens 5.76 5.84 5.95 6.41 5.67 6.31 5.72 5.96 6.04 5.86 5.63 5.79 6.33 6.13 5.82 5.92 5.72 5.89 5.79 5.46 6.36 5.79 5.91 6.25 6.13 5.88 5.93 5.65 5.96 5.92 5.98 5.77 5.92 6.22 5.83 6.03 6.22 5.95 5.49
Vitamin A and Carotenoid Metabolism%WikiPathways_20191210%WP716%Homo sapiens 4.12 3.96 4.04 3.89 3.9 3.99 4.04 3.8 3.77 3.9 4.01 4.12 3.86 4.15 3.89 4.25 4.21 3.95 4.25 4.17 3.61 4.21 3.97 4.12 3.91 4.17 3.86 3.61 4.09 3.88 3.91 4.17 3.88 4.2 4.15 3.77 4.15 3.67 4.21
PDGF Pathway%WikiPathways_20191210%WP2526%Homo sapiens 6.7 7.1 7.06 7.25 6.9 7.09 6.9 6.64 6.64 7.03 6.73 6.84 7.07 7.07 6.94 6.81 6.81 7.2 6.96 6.82 7.5 6.78 7.11 7.12 6.64 6.7 7.3 6.74 6.71 7.02 7.15 6.87 7.1 6.97 7.14 7.2 7.14 7.36 6.65
Angiogenesis%WikiPathways_20191210%WP1539%Homo sapiens 5.99 6.17 6.25 6.73 6.11 6.18 5.86 6.18 6.1 6.28 5.91 6.08 6.77 6.58 6.45 6.11 6.04 6.07 6.29 6.35 6.38 6.05 6 6.42 6.32 6.37 6.5 6.2 6.31 6.48 6.13 6.4 6.49 6.47 6.51 6.48 6.51 6.17 6.04
EDA Signalling in Hair Follicle Development%WikiPathways_20191210%WP3930%Homo sapiens 3.28 3.65 2.87 2.57 3.14 2.66 3.05 3.06 2.81 2.91 2.9 2.87 3.51 2.86 2.82 2.79 2.86 3.23 2.87 2.86 2.73 2.84 2.79 2.94 2.9 2.75 2.75 2.96 2.85 2.9 4 2.77 3.46 2.73 3.14 2.99 3.57 2.61 3.29
Regulation of toll-like receptor signaling pathway%WikiPathways_20191210%WP1449%Homo sapiens 4.31 4.61 4.55 5.22 4.37 4.6 4.68 4.89 4.49 4.82 4.82 4.42 4.52 4.62 4.99 4.35 4.37 4.67 4.55 4.56 4.84 4.47 4.59 4.67 5.07 4.48 4.89 4.9 4.41 4.41 4.66 4.55 4.53 4.67 4.88 4.87 4.44 4.73 4.13
IL17 signaling pathway%WikiPathways_20191210%WP2112%Homo sapiens 5.6 5.63 5.6 6.68 5.65 5.61 5.81 5.88 5.83 5.93 5.82 5.6 5.75 6.21 5.86 5.67 5.77 5.79 5.72 5.48 5.96 5.68 5.44 5.77 5.8 5.91 6.2 5.82 5.7 5.68 6.14 6.05 6.02 6.17 6.03 5.97 6.14 6.03 5.68
TLR4 Signaling and Tolerance%WikiPathways_20191210%WP3851%Homo sapiens 4.72 5.19 5.01 5.89 5.14 5.18 5.23 5.3 5.55 5.38 4.27 5.12 5.22 5.5 5.17 5.3 4.69 5.36 4.66 4.71 5.58 5.15 4.91 5 5.4 5.38 5.44 4.85 4.63 4.9 5.08 5.15 5.08 5.8 5.52 5.5 5.27 5.13 4.73
Oncostatin M Signaling Pathway%WikiPathways_20191210%WP2374%Homo sapiens 5.91 5.93 6.1 6.7 6.33 6.1 5.98 6.21 5.93 6 6.01 5.97 6.03 6.25 6.3 5.65 5.88 5.94 5.91 6.14 6.74 6.59 5.94 6.21 6.41 6.27 6.04 5.98 5.86 5.95 6 6.25 5.94 6.56 6.37 6.1 6.19 6.53 5.74
ncRNAs involved in Wnt signaling in hepatocellular carcinoma%WikiPathways_20191210%WP4336%Homo sapiens 4.46 4.37 4.52 4.93 4.58 4.31 4.55 4.5 4.59 4.41 4.67 4.41 4.48 4.43 4.64 4.55 4.29 4.48 4.8 4.63 4.75 4.68 4.64 4.42 4.39 4.34 4.62 4.73 4.2 4.56 4.73 4.66 4.94 4.6 4.46 4.62 4.71 4.53 4.36
ERK Pathway in Huntington's Disease%WikiPathways_20191210%WP3853%Homo sapiens 5.81 5.24 6.55 6.28 6.47 5.74 5.45 5.74 6.49 6.24 5.93 6.33 5.79 5.78 6.33 6.54 6.07 5.98 5.9 6.54 6.19 5.77 6.35 6.25 4.64 6.35 6.13 5.96 6.17 5.95 5.75 6.69 6.45 5.81 6.38 6.86 6.7 6.48 5.47
miRNA targets in ECM and membrane receptors%WikiPathways_20191210%WP2911%Homo sapiens 4.42 4.72 4.81 5.3 4.34 4.81 4.55 4.53 4.35 4.47 4.8 4.83 5.12 5.85 4.61 4.81 4.33 4.82 4.87 4.89 5.51 4.4 4.58 4.45 5.28 4.49 4.85 4.36 4.48 4.79 4.86 5.42 4.62 5.77 4.67 5.2 4.63 4.74 4.47
Regulation of Microtubule Cytoskeleton%WikiPathways_20191210%WP2038%Homo sapiens 6.66 6.94 6.31 6.8 7.17 7.09 6.74 6.84 7.18 7.28 7.01 7.16 6.95 6.81 6.83 7.06 6.91 7.09 6.36 6.49 6.8 6.94 6.62 6.9 6.99 7.19 6.68 6.71 7.03 6.52 6.84 6.42 7.17 6.88 6.73 6.69 6.96 6.96 6.9
Pregnane X Receptor pathway%WikiPathways_20191210%WP2876%Homo sapiens 4.79 5.06 5.24 4.88 5 5.13 5.18 5.36 4.88 5.04 5.11 5.05 5.14 5.01 4.97 5.04 5.07 4.99 5.29 5.29 4.9 4.97 4.94 5.04 4.76 5 5.13 5.15 5.04 5.22 5.15 5.18 4.94 4.83 5.16 5.21 5.22 4.94 5.01
Non-genomic actions of 1,25 dihydroxyvitamin D3%WikiPathways_20191210%WP4341%Homo sapiens 5.09 5.19 5.1 5.93 5.33 5.22 5.17 5.42 5.13 5.12 5.59 5.18 5.15 5.16 5.55 5.31 5.11 5.61 5.13 5.56 5.86 5.27 5.12 5.2 5.74 5.09 5.31 5.44 5.05 5.25 5.11 5.19 5.05 5.1 5.54 5.49 5.09 5.63 5
Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling%WikiPathways_20191210%WP3850%Homo sapiens 4.82 5.19 5.28 5.3 5.14 5.34 5.02 5.48 5.11 5.49 4.92 5.19 5.22 5.19 5.1 5.19 4.69 5.36 4.89 5.36 5.02 5.15 4.95 5.39 5.37 5.11 5.43 4.89 5.25 5.16 5.33 5.19 5.08 5.02 4.93 5.43 5.37 5.29 4.98
Amino Acid metabolism%WikiPathways_20191210%WP3925%Homo sapiens 7.11 7.12 6.84 6.81 6.84 7.07 6.39 6.73 6.87 6.91 6.38 6.9 6.73 6.99 6.55 6.92 7.07 7.02 6.72 6.44 7 6.95 6.88 6.5 6.87 6.9 6.77 6.38 6.88 6.62 6.7 6.76 7.2 6.84 6.78 6.59 6.81 6.62 6.93
Notch Signaling%WikiPathways_20191210%WP268%Homo sapiens 6.34 6.25 6.68 6.82 6.32 6.91 6.67 6.67 6.49 6.49 6.31 6.47 6.44 6.54 6.51 6.39 6.28 6.23 6.59 6.77 6.63 6.44 6.55 6.78 6.44 6.48 6.79 6.6 6.53 6.56 6.72 6.91 6.55 6.56 6.78 6.79 6.67 6.52 6.12
Nanoparticle-mediated activation of receptor signaling%WikiPathways_20191210%WP2643%Homo sapiens 6.12 6.13 6.78 6.66 6.74 6.69 6.21 5.87 6.69 6.74 6.04 6.19 6.31 6.95 6.32 6.73 6.24 6.07 6.08 6.74 6.77 6.34 6.61 6.89 6.57 6.58 6.92 6.28 6.23 6.5 6.3 6.57 7.07 6.63 7.14 7.22 7.02 6.66 5.86
Toll-like Receptor Signaling related to MyD88%WikiPathways_20191210%WP3858%Homo sapiens 3.83 4.42 3.95 6.01 3.67 4.59 4.37 5.1 4.11 4.63 4.58 3.8 4.37 4.52 4.79 4.32 3.9 4.81 4.22 4.46 5.27 3.96 4.37 4.31 5.09 4.11 5.35 4.87 4.03 3.89 5.03 4.29 4.29 4.59 5.12 4.87 4.43 5.26 3.63
4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression%WikiPathways_20191210%WP3879%Homo sapiens 6.79 6.96 7.14 7.3 7.29 7.12 6.77 6.84 7.36 7.36 6.68 7.13 7.33 7.51 7.27 6.96 7.05 7.21 6.89 6.9 7.21 7.42 7 7.19 7.05 7.19 7.44 7.02 7.05 7.37 7.26 6.79 7.22 7.49 7.32 7.47 7.1 7.03 6.7
Ectoderm Differentiation%WikiPathways_20191210%WP2858%Homo sapiens 5.17 5.45 5.38 5.51 5.29 5.44 5.25 5.24 5.04 5.46 5.19 5.04 5.1 5.27 5.3 5.13 5.29 5.52 5.42 5.34 5.56 5.34 5.33 5.22 5.51 5.24 5.47 5.12 4.99 5.3 5.33 5.04 5.39 5.4 5.34 5.41 5.39 5.52 5.08
Physiological and Pathological Hypertrophy  of the Heart%WikiPathways_20191210%WP1528%Homo sapiens 6.29 6.35 6.55 7.31 6.37 6.92 6.21 6.43 6.3 6.47 6.34 6.19 6.52 6.59 6.88 6.58 6.25 6.29 6.65 6.5 6.83 6.49 6.71 6.26 6.46 6.16 6.45 6.7 6.07 6.52 6.29 6.57 6.18 7.08 7.03 6.67 6.46 7.09 6.36
Integrin-mediated Cell Adhesion%WikiPathways_20191210%WP185%Homo sapiens 6.06 6.12 6.4 6.55 6.14 6.55 6.1 6.12 6.3 6.25 6.29 6.15 6.1 6.13 6.55 6.2 5.97 6.38 6.38 6.38 6.48 6.13 6.4 6.3 6.51 6.13 6.35 6.44 6.2 6.05 6.33 6.45 6.17 6.61 6.64 6.35 6.36 6.31 5.84
Preimplantation Embryo%WikiPathways_20191210%WP3527%Homo sapiens 3.98 4.13 4.02 4.19 4.53 3.9 4.34 4.32 4.26 4.02 4.37 4.11 4.28 4.59 4.34 4 4.27 4.23 4.26 4.49 3.92 4.21 4.54 4.77 4.04 4.31 3.98 4.11 4.06 4.31 4.53 4.34 4.21 4.21 4.4 4.28 4.4 4.5 3.93
Dopaminergic Neurogenesis%WikiPathways_20191210%WP2855%Homo sapiens 4.84 5.36 5.33 5.47 5.05 5.48 4.44 4.42 3.71 5.13 4.65 3.74 3.96 4.43 5.17 5.31 4.62 5.51 5.27 4.74 5.7 5.32 5.4 4.46 5.02 4.43 4.85 4.49 4.22 4.01 4.97 4.68 5.7 4.59 5.25 4.93 5.09 4.7 4.63
Human Complement System%WikiPathways_20191210%WP2806%Homo sapiens 4.04 4.58 4.51 5.24 4.33 4.56 4.5 4.85 4.51 4.94 4.7 4.63 4.52 4.67 4.7 4.44 4.12 4.48 4.69 4.66 4.46 4.51 4.58 4.47 5.3 4.37 5.33 4.81 4.63 4.2 5.03 4.65 4.49 4.82 4.82 5.01 4.42 5.13 4
Mammary gland development pathway - Puberty (Stage 2 of 4)%WikiPathways_20191210%WP2814%Homo sapiens 5.03 5.41 5.48 4.74 5.29 5.49 5.23 5.51 4.94 5.78 5.34 5.42 5.41 5.34 5.59 5.25 5.18 4.97 5.43 5.42 5.49 5.59 5.41 5.07 5.03 5.38 5.48 5.49 5.2 5.05 4.89 5.37 5.06 5.26 5.4 5.37 5.17 5.73 4.82
Novel intracellular components of RIG-I-like receptor (RLR) pathway%WikiPathways_20191210%WP3865%Homo sapiens 5.26 5.33 5.13 5.66 5.34 5.26 5.16 5.43 5.53 5.55 5.04 5.25 5.18 5.6 5.81 5.38 5.49 5.72 5.27 5.46 5.65 5.48 5.24 5.16 5.56 5.43 5.76 5.32 5.08 5.21 5.07 5.46 5.22 5.81 5.64 5.79 5.38 5.42 4.97
Monoamine GPCRs%WikiPathways_20191210%WP58%Homo sapiens 3.07 3.06 3.08 2.8 2.95 2.96 3.33 3.07 2.95 3.13 3.19 3.09 3.21 2.96 2.99 2.9 3.01 2.94 3.16 3.06 2.76 2.9 3.05 3.09 3.05 2.95 2.78 3.14 3.02 3.19 3.07 3.03 2.93 2.88 2.97 3.02 2.97 2.82 3.01
Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway%WikiPathways_20191210%WP3670%Homo sapiens 6.18 6.28 6.03 5.96 6.17 6.4 5.96 6.08 6.64 5.83 5.89 6.57 6.08 6.53 6.05 5.94 6.04 6.45 5.84 5.64 6.36 6.17 5.8 6.22 6.36 6.47 6.21 5.94 6.3 6.41 6.45 6.48 6.41 6.75 6.45 6.23 6.17 6.12 6.65
Metapathway biotransformation Phase I and II%WikiPathways_20191210%WP702%Homo sapiens 3.75 3.86 4 3.74 3.61 3.79 4.02 3.99 3.72 3.91 3.96 3.93 4.01 3.82 3.88 3.85 3.72 3.71 3.98 3.89 3.59 3.73 3.8 3.75 4.1 3.85 3.83 3.92 3.98 3.88 3.91 3.91 3.72 3.8 4.01 3.84 3.76 3.71 3.59
Cell-type Dependent Selectivity of CCK2R Signaling%WikiPathways_20191210%WP3679%Homo sapiens 4.9 4.44 5 4.12 4.66 4.97 3.73 4.04 4.26 4.28 3.79 4.31 3.92 3.83 4.31 5.2 4.66 4.66 4.85 4.47 4.63 4.91 4.48 4.04 4.43 4.55 4.31 3.75 4.73 3.99 3.84 4.35 4.85 3.83 4.49 4.45 4.61 4.73 4.54
Energy Metabolism%WikiPathways_20191210%WP1541%Homo sapiens 5.24 5.23 5.39 5.62 5.23 5.52 5.53 5.52 5.47 5.56 5.46 5.3 5.42 5.24 5.11 5.27 5.07 5.21 5.22 5.34 5.44 5.38 5.56 5.63 5.22 5.55 5.51 5.51 5.35 5.39 5.55 5.34 5.52 5.04 5.38 5.69 5.64 5.56 5.27
Endoderm Differentiation%WikiPathways_20191210%WP2853%Homo sapiens 5.12 5.25 5.28 5.52 5.23 5.11 5.19 5.34 5.07 5.28 5.2 4.98 5.33 5.15 5.27 5.19 5.13 5.28 5.23 5.08 5.2 5.25 5.38 5.27 5.07 5.1 5.29 5.13 4.92 5.09 5.27 5.14 5.41 5.13 5.28 5.3 5.42 5.38 5.01
Glycerophospholipid Biosynthetic Pathway%WikiPathways_20191210%WP2533%Homo sapiens 6.02 6.17 6.19 6.35 5.9 6.15 5.99 6.28 6.1 6.07 6.17 5.9 5.9 6.24 6.26 6.04 6.15 6.1 6.3 5.99 6.28 5.96 6.33 5.79 6.36 6.03 6.27 5.96 6.01 6.17 6.22 6.23 6.33 6.42 6.22 6.28 6.33 6.28 6.27
Hematopoietic Stem Cell Gene Regulation by GABP alpha/beta Complex%WikiPathways_20191210%WP3657%Homo sapiens 5.41 4.85 5.5 6.02 5.31 5.35 5.87 5.9 4.9 5.19 5.55 5.27 5.67 5.57 5.85 5.35 5.32 5.18 5.52 5.49 5.93 5.55 5.4 5.66 5.81 5.31 5.55 6.13 5.76 5.3 5.57 5.53 5.63 5.62 5.84 5.86 5.8 5.94 5.23
MAPK Cascade%WikiPathways_20191210%WP422%Homo sapiens 6.22 6.05 6.25 6.62 6.14 6.38 6.16 6.09 6.04 6.42 6.08 6.05 6.34 6.21 6.55 6.44 6.11 5.94 6.43 6.14 6.35 5.92 6.19 6.1 6.1 6.02 6.45 6.52 5.85 6.38 5.98 6.41 6 6.47 6.54 6.43 6.41 6.46 6.35
Glycogen Synthesis and Degradation%WikiPathways_20191210%WP500%Homo sapiens 7.36 6.95 6.98 7.12 7.76 6.95 6.56 6.95 6.88 6.65 6.46 7.2 6.81 6.45 6.73 7.52 7.54 6.98 6.69 7.1 7.48 7.44 6.78 6.6 6.82 6.96 6.92 6.65 6.96 6.61 6.73 6.73 7.39 6.58 6.71 6.88 7.13 7.14 7.28
Fatty Acid Beta Oxidation%WikiPathways_20191210%WP143%Homo sapiens 6.4 6.57 7.16 7.05 6.49 6.65 6.75 6.86 6.6 6.74 6.96 6.76 6.85 6.57 6.62 6.73 6.21 6.83 6.66 7.3 6.74 6.31 6.96 6.72 6.97 6.88 6.63 6.66 6.76 6.43 7.04 6.74 6.67 6.78 6.73 7.3 6.5 6.53 6.22
MAPK Signaling Pathway%WikiPathways_20191210%WP382%Homo sapiens 5.41 5.46 5.5 5.73 5.63 5.81 5.42 5.39 5.4 5.54 5.54 5.43 5.29 5.64 5.63 5.44 5.31 5.46 5.57 5.46 5.79 5.54 5.54 5.54 5.37 5.52 5.66 5.36 5.43 5.34 5.78 5.48 5.56 5.76 5.73 5.73 5.54 5.73 5.33
DNA IR-Double Strand Breaks (DSBs) and cellular response via ATM%WikiPathways_20191210%WP3959%Homo sapiens 4.75 4.74 5.03 4.94 4.63 4.83 5.16 5.11 4.79 4.95 4.96 4.74 5.26 4.97 4.97 4.86 4.58 4.81 4.95 4.78 4.94 4.81 4.91 4.99 5.19 4.83 5.01 5.18 4.92 5.29 5.13 4.91 4.72 5.01 4.84 5.11 4.87 5.13 4.67
Osteoblast Signaling%WikiPathways_20191210%WP322%Homo sapiens 4.44 4.37 4.45 4.22 4.39 4.09 4.55 4.54 4.97 4.69 4.59 4.4 4.78 4.64 4.47 4.32 4.36 4.54 4.28 4.43 4.32 4.4 4.53 4.31 5.07 4.57 4.63 4.64 4.55 5.13 4.79 4.65 4.3 4.99 4.45 4.37 4.09 4.43 4.32
Prolactin Signaling Pathway%WikiPathways_20191210%WP2037%Homo sapiens 5.52 5.76 5.89 6.38 5.89 5.99 5.83 5.74 5.66 5.9 5.68 5.66 5.83 6.25 6.14 5.72 5.83 5.88 5.69 6.03 6.1 6.08 5.94 5.71 6.24 5.59 6.02 5.88 5.64 6 5.89 6.1 5.94 6.41 6.06 6.1 5.81 6.07 5.6
Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway%WikiPathways_20191210%WP4577%Homo sapiens 6.76 6.78 6.7 6.69 6.83 6.97 6.51 6.48 6.84 6.61 6.71 6.52 6.43 6.98 6.73 6.75 6.49 6.87 6.76 6.66 6.71 6.81 6.61 6.75 6.65 6.81 6.65 6.67 6.56 6.47 6.72 6.55 6.93 6.87 6.71 6.65 6.84 6.74 6.68
Osteopontin Signaling%WikiPathways_20191210%WP1434%Homo sapiens 5.61 5.72 6.13 6.98 5.81 6.28 6.14 6.39 6.64 5.93 6.18 5.68 6.66 6.41 6 5.9 6.03 5.79 5.79 6.38 6.72 5.75 6.33 6.37 6.91 6.26 6.5 6.3 6.25 5.82 6.94 6.59 6.27 6.98 6.3 6.18 6.6 6.39 5.74
Cori Cycle%WikiPathways_20191210%WP1946%Homo sapiens 9.46 9.43 8.7 8.14 9.17 8.95 7.86 7.58 9.12 8.02 8.04 9 7.91 8.74 8.71 8.98 9.06 9.5 8.43 8.69 8.92 9.29 8.73 8.02 8.32 8.92 8.48 7.87 8.64 8.15 7.98 8.18 9.05 8.56 8.54 8.12 8.64 8.07 9.33
Circadian rhythm related genes%WikiPathways_20191210%WP3594%Homo sapiens 5.18 5.2 5.24 5.51 5.29 5.57 5.13 5.3 4.94 5.3 5.09 4.96 5.11 5.09 5.12 5.08 5.26 5.31 5.24 5.06 5.43 5.39 5.27 5.37 5.22 5.15 5.29 5.24 5.03 4.91 5.39 5.26 5.4 5.02 5.37 5.4 5.49 5.37 5.25
G13 Signaling Pathway%WikiPathways_20191210%WP524%Homo sapiens 6.81 7 6.85 7.18 7.46 6.83 7 6.35 6.88 6.62 6.55 6.85 6.55 6.95 6.56 7.04 6.98 7.08 6.82 6.91 6.88 7.35 6.67 7.13 6.71 6.85 6.8 6.67 6.75 6.7 7.22 6.64 7.3 6.83 6.82 6.8 6.99 6.96 6.79
Cholesterol Biosynthesis Pathway%WikiPathways_20191210%WP197%Homo sapiens 8.18 7.24 7.36 7.15 7.8 7.62 7.04 7.13 8.25 7.06 7.04 8.22 7.47 7.03 6.75 7.14 7.31 7.24 7.08 6.94 7.23 7.22 7.44 6.84 7.13 7.93 7.21 6.67 7.48 6.96 6.72 6.49 6.91 6.39 6.57 6.82 6.97 7.16 8.03
Follicle Stimulating Hormone (FSH) signaling pathway%WikiPathways_20191210%WP2035%Homo sapiens 5.86 5.61 6.01 6.56 5.97 5.73 5.73 5.74 5.8 5.76 5.53 5.61 5.53 5.72 6.02 5.68 5.93 5.85 5.68 6 6.49 5.92 5.82 5.75 5.99 5.91 6.03 5.84 5.47 5.7 5.93 5.8 5.84 6.27 5.96 5.99 6 6.16 5.85
Heart Development%WikiPathways_20191210%WP1591%Homo sapiens 4.53 4.56 4.9 4.77 4.23 4.52 5.02 4.46 4.64 4.67 4.34 4.8 5 4.58 4.64 4.43 4.63 4.36 4.34 4.68 4.22 4.35 4.38 4.56 4.72 4.52 4.53 4.47 4.8 4.79 4.48 4.41 4.5 4.83 4.51 4.64 4.61 4.38 3.92
Irinotecan Pathway%WikiPathways_20191210%WP229%Homo sapiens 4.42 4.9 4.38 5.13 5.02 4.94 5 4.89 4.58 4.49 5.15 4.39 5.39 4.76 4.69 5.41 4.36 5.12 5.01 4.69 4.84 5.25 4.64 4.87 5.36 5.01 4.8 5.42 4.68 4.58 4.76 4.89 4.76 4.64 4.6 4.25 5.31 5.33 4.61
Fluoropyrimidine Activity%WikiPathways_20191210%WP1601%Homo sapiens 4.41 4.82 4.46 4.81 4.42 4.81 4.49 4.87 4.61 4.53 4.76 4.65 4.79 4.62 4.64 4.56 4.49 4.53 4.68 4.48 4.78 4.43 4.62 4.65 4.47 4.85 4.8 4.82 4.65 4.53 4.76 4.82 4.32 4.48 4.48 4.58 4.4 4.77 4.38
Pathogenic Escherichia coli infection%WikiPathways_20191210%WP2272%Homo sapiens 7.72 7.76 8.08 8.56 8.02 8.25 7.92 8.26 8.1 8.52 7.97 8.1 8.08 8.16 8.28 8.08 8.02 8.02 8.13 8.06 8.52 7.96 7.97 7.85 8.41 8.05 8.59 8.43 7.87 8.17 8.35 8.06 8.15 8.28 8.49 8.09 8.17 8.42 7.86
Serotonin and anxiety-related events%WikiPathways_20191210%WP3944%Homo sapiens 4.45 4.78 4.72 4.5 5.14 5.72 4.3 3.87 4.29 4.68 4.2 4.37 4.37 4.31 4.98 4.15 4.77 4.93 4.93 4.01 4.61 5.44 4.68 4.13 4.58 4.84 4.71 4.51 4.42 4.16 4.42 4.23 4.69 4.74 4.67 4.67 4.7 4.91 4.22
Aryl Hydrocarbon Receptor Pathway%WikiPathways_20191210%WP2873%Homo sapiens 4.79 4.83 4.92 5.62 5.1 5.56 5.03 5.29 4.78 5.19 5.03 4.77 4.9 4.88 5.4 5.19 5.13 4.8 5.07 4.91 6.1 5.47 4.92 4.97 5 4.87 5.31 5.11 4.68 4.86 5.21 5.02 4.67 4.9 5.84 5.34 4.87 5.63 4.82
PDGFR-beta pathway%WikiPathways_20191210%WP3972%Homo sapiens 6.82 7.1 7.06 7.31 6.9 7.18 6.9 6.86 6.61 6.76 6.7 6.93 6.98 6.98 7.18 6.81 6.96 7.2 6.99 6.87 7.42 6.98 7.11 6.99 7.15 6.75 7.36 6.88 7.02 6.96 6.9 6.84 7.05 7.08 7.24 7.19 7.11 7.36 7.03
Folate Metabolism%WikiPathways_20191210%WP176%Homo sapiens 4.43 4.4 4.57 4.92 4.55 4.49 4.51 4.54 4.42 4.54 4.51 4.64 4.46 4.56 4.49 4.47 4.3 4.43 4.52 4.46 4.56 4.81 4.64 4.6 4.55 4.41 4.48 4.42 4.45 4.3 4.57 4.55 4.33 4.68 4.51 4.54 4.42 4.38 4.4
Photodynamic therapy-induced unfolded protein response%WikiPathways_20191210%WP3613%Homo sapiens 6.01 5.84 6.05 6.99 6.16 6.4 6.44 6.23 6.27 6.57 6.28 6.21 6.05 7.07 6.57 6.07 6.07 6.24 6.18 6.01 6.78 6.05 6.18 6.32 6.18 6.12 6.46 6.49 5.97 5.98 6.81 5.99 6.25 6.95 6.49 6.15 6.27 6.87 6.12
Senescence and Autophagy in Cancer%WikiPathways_20191210%WP615%Homo sapiens 5.51 5.74 5.75 6.38 5.62 5.94 5.83 5.88 5.49 5.64 5.53 5.51 5.5 5.73 5.76 5.56 5.52 5.49 5.61 5.84 6.07 5.79 5.76 5.68 6.1 5.48 5.77 5.7 5.58 5.7 5.93 5.66 5.66 6.05 5.78 5.92 6.06 6.05 5.47
Kennedy pathway from Sphingolipids%WikiPathways_20191210%WP3933%Homo sapiens 5.29 5.56 5.24 5.44 5.61 5.61 5.75 5.39 5.7 5.44 5.36 5.04 5.64 5.4 5.43 5.37 5.2 5.7 5.52 5.27 5.55 5.37 5.42 5.53 5.39 5.41 5.8 5.15 5.19 5.64 5.46 5.06 5.51 5.75 5.5 5.54 5.37 5.32 5.39
Dopamine metabolism%WikiPathways_20191210%WP2436%Homo sapiens 9.13 9.07 8.66 8.06 8.83 8.8 8.08 8.15 8.53 9.05 8.17 9.31 8.79 9.15 8.91 9.06 8.52 8.94 8.67 8.27 9.16 8.94 8.82 8.72 8.87 8.68 9.02 8.19 9.02 9.28 8.28 8.07 9.49 8.8 8.82 8.75 9.01 8.82 8.52
Endometrial cancer%WikiPathways_20191210%WP4155%Homo sapiens 6.46 6.66 6.78 6.85 6.84 6.8 6.59 6.5 6.54 7.01 6.42 6.47 6.54 6.92 6.9 6.77 6.4 6.6 6.57 6.82 6.8 6.81 7.08 6.6 6.62 6.52 7.07 6.46 6.58 6.76 6.71 6.66 6.59 6.9 7.08 7.15 6.9 7.02 6.24
BMP Signaling Pathway in Eyelid Development%WikiPathways_20191210%WP3927%Homo sapiens 5.09 5.19 4.75 5.55 4.98 4.71 5.46 5.24 5.93 4.94 4.4 5.1 4.85 5.15 5.13 5.25 5.27 5.18 4.89 4.95 5.44 4.78 5.54 5.62 5.06 5.23 5.53 5.09 4.84 5.05 5.59 4.6 5.33 4.96 5.28 5.26 5.79 5.43 5.24
MicroRNAs in cardiomyocyte hypertrophy%WikiPathways_20191210%WP1544%Homo sapiens 5.34 5.25 5.31 5.91 5.41 5.45 5.28 5.34 5.4 5.5 5.41 5.32 5.43 5.58 5.79 5.41 5.35 5.57 5.45 5.47 5.63 5.5 5.56 5.64 5.41 5.54 5.64 5.55 5.45 5.31 5.76 5.86 5.42 5.74 5.73 5.57 5.48 5.59 5.26
G1 to S cell cycle control%WikiPathways_20191210%WP45%Homo sapiens 5.01 5 4.84 5.07 4.83 4.74 4.89 4.82 4.86 4.75 4.93 4.85 4.94 4.72 4.81 4.73 5 4.88 5.02 4.8 4.86 4.99 4.97 4.67 4.69 4.89 4.74 5.05 4.86 4.66 4.88 4.88 4.8 4.64 4.69 4.75 4.65 4.86 4.94
Integrated Cancer Pathway%WikiPathways_20191210%WP1971%Homo sapiens 5.03 5.16 5.3 5.65 5.02 5.34 5.31 5.41 4.99 5.47 5.48 5.05 5.41 5.24 5.48 5.22 4.98 5.02 5.36 5.32 5.47 5.19 5.32 5.2 5.51 5.01 5.56 5.54 5.24 5.19 5.4 5.25 5.13 5.24 5.32 5.28 5.21 5.71 4.87
GPCRs, Other%WikiPathways_20191210%WP117%Homo sapiens 3.25 3.16 3.3 3.14 3.06 3.07 3.39 3.22 3.04 3.13 3.35 3.19 3.41 3.12 3.13 3.14 3.16 3.2 3.36 3.26 3 3.14 3.31 3.18 3.41 3.12 3.08 3.22 3.32 3.21 3.2 3.27 3.08 3.09 3.12 3.11 3.08 2.99 3.2
AMP-activated Protein Kinase (AMPK) Signaling%WikiPathways_20191210%WP1403%Homo sapiens 5.46 5.36 5.52 5.84 5.35 5.67 5.16 5.4 5.35 5.3 5.3 5.19 5.23 5.43 5.62 5.62 5.54 5.6 5.15 5.8 5.76 5.53 5.76 5.47 5.64 5.38 5.86 5.62 5.25 5.48 5.74 5.77 5.72 6.09 5.54 5.67 5.66 6.01 5.27
Tamoxifen metabolism%WikiPathways_20191210%WP691%Homo sapiens 3.35 3.44 3.51 3.23 3.25 3.34 3.56 3.53 3.5 3.48 3.7 3.56 3.67 3.37 3.5 3.4 3.21 3.35 3.53 3.45 3.24 3.26 3.44 3.54 3.48 3.43 3.41 3.61 3.57 3.49 3.5 3.45 3.28 3.34 3.37 3.44 3.22 3.28 3.17
T-Cell Receptor and Co-stimulatory Signaling%WikiPathways_20191210%WP2583%Homo sapiens 5.08 5.55 5.67 5.92 5.36 5.88 5.57 5.94 5.28 5.57 6.15 5.3 5.47 5.68 5.86 5.44 5.13 5.94 5.24 5.49 5.65 5.37 5.22 5.4 6.3 5.38 5.82 5.95 5.44 5.5 5.55 5.47 5.36 5.96 5.82 5.77 5.49 5.89 5.75
Target Of Rapamycin (TOR) Signaling%WikiPathways_20191210%WP1471%Homo sapiens 6.54 6.22 6.41 6.32 6.7 6.64 5.93 5.85 6.26 6.23 5.91 6.25 5.79 6.53 6.31 6.09 6.43 6.32 6.2 6.34 6.59 6.61 6.25 6.04 6.35 6.06 6.2 5.99 6.3 6.09 5.95 6.13 6.52 6.8 6.57 6.28 6.6 6.19 6.27
Prion disease pathway%WikiPathways_20191210%WP3995%Homo sapiens 6.22 6.94 6.92 6.88 6.67 6.72 6.53 6.77 6.73 6.76 6.73 7.11 6.92 7.07 6.9 6.92 6.26 7.08 6.96 6.99 6.72 6.7 7.17 6.81 6.92 6.87 7.05 6.56 6.81 7.06 6.9 6.89 7.04 6.94 7.14 7.38 7.51 7.14 6.92
Signaling Pathways in Glioblastoma%WikiPathways_20191210%WP2261%Homo sapiens 5.86 5.88 6 6.28 6.12 6.09 6 6.13 6.23 5.99 6.07 5.86 6.07 5.93 6.16 5.89 5.91 6.06 5.9 6.23 6.09 6.08 5.93 6.22 6.19 6.23 6.18 6.27 5.89 5.84 6.13 6.19 5.96 6.17 6.09 6.19 6.2 6.17 5.87
Proteasome Degradation%WikiPathways_20191210%WP183%Homo sapiens 8.58 8.71 8.14 8.65 8.53 8.47 8.07 8.48 8.7 8.44 8.12 8.29 8.34 8.36 8.46 8.34 8.37 8.79 8.07 7.83 8.68 8.47 8.17 8.08 8.53 8.48 8.27 8.19 8.27 8.35 8.23 7.83 8.38 8.29 8.06 7.96 8.1 8.29 8.63
Inflammatory Response Pathway%WikiPathways_20191210%WP453%Homo sapiens 3.33 3.62 3.87 3.62 3.47 3.72 4.12 3.94 3.71 3.8 3.92 3.8 3.92 3.69 3.83 3.56 3.36 3.58 3.75 3.81 3.78 3.59 3.75 3.87 3.91 3.73 3.84 3.89 3.78 3.87 3.79 3.73 3.46 3.63 3.68 3.84 3.49 3.92 3.42
Association Between Physico-Chemical Features and Toxicity Associated Pathways%WikiPathways_20191210%WP3680%Homo sapiens 6.09 6.14 6.62 6.49 6.72 6.75 6 6.09 6.46 6.48 5.87 6.16 6.16 6.65 6.45 6.29 6.36 6.36 6.09 6.33 6.53 6.61 6.57 6.72 6.34 6.43 6.67 6.28 6.26 6.58 6.06 6.39 6.74 6.47 6.5 6.77 6.52 6.49 6.19
GPCRs, Class B Secretin-like%WikiPathways_20191210%WP334%Homo sapiens 3.02 2.96 3.18 3.04 3.06 2.78 3.09 3.14 2.98 3.08 2.9 3.19 2.91 3.12 3.19 2.93 2.99 2.97 3.27 3.18 2.96 3 3.25 2.92 2.99 3.03 3.11 2.89 2.85 2.9 3.18 3.06 3.09 2.82 3.16 3.04 3.1 2.91 2.92
IL-9 Signaling Pathway%WikiPathways_20191210%WP22%Homo sapiens 6.96 7.25 7.11 7.55 7.34 7.09 6.7 6.86 7.09 7.64 6.84 6.96 7.07 6.98 7.52 7.13 7.45 7.22 7.14 6.87 7.71 7.1 7.11 6.99 6.92 7.13 7.51 6.74 7.22 7.02 7.15 6.84 7.1 7.13 7.51 7.19 7.11 7.49 7.1
Oxidative Stress%WikiPathways_20191210%WP408%Homo sapiens 5.05 5.18 4.93 6.39 5.48 5.96 5.18 5.62 5.5 5.45 5.8 5.46 5.42 6.01 5.52 5.16 4.9 5.38 4.82 4.88 6.34 5.49 4.92 5 5.5 5.42 5.86 5.85 5.22 5.47 5.36 5.21 5.16 6.23 5.68 5.62 5.31 5.6 4.98
Endochondral Ossification%WikiPathways_20191210%WP474%Homo sapiens 5.04 5.03 5.27 5.57 5.34 5.79 5.02 5.17 5.11 5.25 5.22 5.22 5.19 5.67 5.23 5.46 5.36 5.47 5.68 5.64 5.8 5.52 5.07 5.43 5.58 5.55 5.76 5.33 5.39 5.73 5.42 5.81 5.33 5.81 5.85 6.01 5.72 5.53 4.99
Complement and Coagulation Cascades%WikiPathways_20191210%WP558%Homo sapiens 3.45 3.55 3.61 3.73 3.32 3.49 3.84 3.82 3.5 3.65 3.7 3.59 3.89 3.53 3.81 3.41 3.42 3.34 3.58 3.65 3.42 3.44 3.6 3.73 3.68 3.51 3.75 3.87 3.71 3.74 3.7 3.56 3.3 3.45 3.77 3.5 3.36 3.5 3.37
Cell Cycle%WikiPathways_20191210%WP179%Homo sapiens 5.45 5.33 5.39 5.54 5.3 5.45 5.13 5.46 5.34 5.25 5.56 5.37 5.47 5.35 5.41 5.3 5.29 5.4 5.32 5.41 5.51 5.46 5.42 5.38 5.46 5.33 5.51 5.51 5.2 5.22 5.6 5.54 5.34 5.44 5.42 5.35 5.39 5.55 5.25
Endothelin Pathways%WikiPathways_20191210%WP2197%Homo sapiens 4.83 4.69 5.64 6.7 5.15 5.57 5.2 4.92 5.17 5.38 5.17 5 5.21 5.1 5.44 4.86 4.93 4.71 4.87 5.44 6.34 5.18 5.27 5.39 5.24 5.44 5.51 5.34 5.13 4.81 5.23 5.58 5.19 5.2 5.79 5.27 5.25 6.19 4.65
Matrix Metalloproteinases%WikiPathways_20191210%WP129%Homo sapiens 3.24 3.3 3.56 3.1 3.23 3.29 3.49 3.37 3.35 3.29 3.35 3.5 3.29 3.26 3.29 3.45 3.43 3.34 3.5 3.25 3.07 3.37 3.48 3.35 3.51 3.36 3.22 3.32 3.39 3.48 3.31 3.39 3.46 3.43 3.23 3.37 3.29 3.24 3.29
Oxidation by Cytochrome P450%WikiPathways_20191210%WP43%Homo sapiens 3.33 3.44 3.51 3.19 3.21 3.22 3.47 3.53 3.39 3.48 3.57 3.4 3.44 3.32 3.5 3.47 3.16 3.35 3.46 3.43 3.04 3.26 3.44 3.54 3.48 3.43 3.41 3.47 3.52 3.37 3.5 3.45 3.24 3.39 3.37 3.44 3.18 3.25 3.15
Apoptosis%WikiPathways_20191210%WP254%Homo sapiens 4.4 4.71 4.96 5.51 4.5 4.76 4.92 5.02 4.74 5.16 4.83 4.7 4.75 4.76 4.84 4.86 4.59 4.92 4.76 4.98 5.33 4.65 4.79 4.81 5.23 4.81 5.15 4.83 4.7 4.78 4.88 5 4.8 5.21 4.94 5.25 4.89 5.04 4.69
Common Pathways Underlying Drug Addiction%WikiPathways_20191210%WP2636%Homo sapiens 7.19 7.45 7.15 7.1 7.4 7.39 6.99 7.07 7.55 7.33 6.84 7.52 7.24 7.24 7.13 7.26 7.39 7.33 6.93 6.72 7.2 7.4 7.13 7.08 6.83 7.38 6.86 7.24 7.27 6.95 7.06 7.07 7.2 7.41 6.97 7.1 7.11 7.19 7.22
IL-6 signaling pathway%WikiPathways_20191210%WP364%Homo sapiens 6.25 6.44 6.35 6.83 6.68 6.85 6.2 6.52 6.54 6.72 6.38 6.38 6.09 6.78 6.49 6.2 6.39 6.63 6.01 6.28 6.75 6.57 6.4 6.88 6.91 6.52 6.83 6.71 6.37 6.41 6.57 6.41 6.59 6.88 6.67 6.32 6.48 7.07 5.99
Nuclear Receptors%WikiPathways_20191210%WP170%Homo sapiens 4.27 4.43 4.48 4.02 4.22 4.07 4.81 4.44 4.23 4.57 4.67 4.48 4.33 4.38 4.47 4.5 4.07 4.18 4.46 4.74 3.87 4.08 4.38 4.57 4.3 4.44 4.35 4.31 4.32 4.51 4.44 4.5 4.1 4.15 4.23 4.21 4.19 3.91 4.19
Type II diabetes mellitus%WikiPathways_20191210%WP1584%Homo sapiens 4.87 4.76 4.74 4.71 4.69 4.81 4.6 5.01 4.52 4.55 4.36 4.4 4.7 4.57 4.6 4.56 4.7 4.61 4.7 4.64 4.67 4.76 4.68 4.73 4.53 4.5 4.68 4.78 4.64 4.84 4.8 4.59 4.67 4.52 4.67 4.61 4.57 4.45 4.66
p38 MAPK Signaling Pathway%WikiPathways_20191210%WP400%Homo sapiens 6.45 6.19 6.4 6.71 6.44 6.34 6.3 6.25 6.57 6.21 6.37 6.36 6.08 6.17 6.32 6.26 6.27 6.57 6.13 6.21 6.62 6.4 6.18 6.61 5.85 6.5 6.33 6.4 6.33 6.13 6.14 6.24 6.53 6.05 6.34 6.23 6.54 6.51 6.2
Iron metabolism in placenta%WikiPathways_20191210%WP2007%Homo sapiens 5.96 6.45 6.52 7.57 6.72 7.04 5.86 6.91 6.15 6.83 6.41 6.29 5.94 6.45 7.11 6.24 5.68 6.46 6.71 6.98 7.49 6.49 6.88 5.84 6.48 6.51 7.3 6.49 5.9 5.96 6.96 6.73 6.46 6.84 7.18 7.09 6 7.28 6.07
Aryl Hydrocarbon Receptor Netpath%WikiPathways_20191210%WP2586%Homo sapiens 5.59 6.08 6.17 6.6 6.12 6.85 5.83 6.11 5.75 6.39 6.1 5.8 5.95 6.31 6.48 5.67 5.84 6.35 5.82 6 6.44 5.89 6.23 6.21 6.21 6.12 6.57 5.84 5.9 5.87 5.8 6.41 6.38 6.08 6.29 6.22 6.26 6.52 5.21
TNF alpha Signaling Pathway%WikiPathways_20191210%WP231%Homo sapiens 5.82 5.75 6.13 6.63 5.99 6.22 5.84 6.19 5.97 6.12 5.85 5.63 5.84 6.25 6.26 5.89 5.92 5.93 5.72 5.62 6.31 6.03 5.69 5.98 6.35 5.91 6.45 6.3 5.94 5.82 6.18 6.06 5.95 6.34 6.3 6.2 6.15 6.24 5.72
Nucleotide Metabolism%WikiPathways_20191210%WP404%Homo sapiens 6.98 7.4 7.22 7.55 7.18 7.38 6.64 6.98 7.29 6.93 6.89 6.98 6.78 6.95 7.27 7.04 6.99 7.3 7.04 6.57 7.24 7.1 7.07 6.69 6.86 6.96 6.87 7.04 6.96 6.53 7.47 6.47 7 7.03 7.05 6.62 7.18 6.87 7
Apoptosis Modulation and Signaling%WikiPathways_20191210%WP1772%Homo sapiens 5.19 5.26 5.33 5.78 5.09 5.33 5.24 5.48 5.36 5.41 5.42 5.33 5.22 5.43 5.61 5.03 4.94 5.28 5.23 5.4 5.42 5.14 5.27 5.29 5.55 5.19 5.44 5.19 5.09 5.21 5.57 5.27 5.08 5.73 5.54 5.44 5.24 5.5 5.07
Differentiation of white and brown adipocyte   %WikiPathways_20191210%WP2895%Homo sapiens 3.15 3.5 3.72 3.82 3.16 3.36 3.65 3.5 3.23 3.6 3.58 3.41 3.63 3.44 3.58 3.23 3.2 3.52 3.44 3.74 3.76 3.24 3.73 3.52 3.67 3.31 3.57 3.45 3.55 3.5 3.63 3.39 3.33 3.48 3.67 3.5 3.44 3.98 3.24
Drug Induction of Bile Acid Pathway%WikiPathways_20191210%WP2289%Homo sapiens 3.46 3.62 3.48 3.42 3.43 3.11 3.58 3.49 3.46 3.49 4.09 3.49 3.54 3.46 3.57 3.46 3.44 3.44 3.59 3.86 3.31 3.34 3.49 3.51 3.43 3.47 3.44 3.5 3.48 3.59 3.48 3.49 3.41 3.45 3.47 3.47 3.42 3.42 3.42
RANKL/RANK (Receptor activator of NFKB (ligand)) Signaling Pathway%WikiPathways_20191210%WP2018%Homo sapiens 5.22 5.31 5.16 6.07 5.3 5.35 5.23 5.3 4.97 5.38 5.42 5.25 5.22 5.7 5.77 5.4 5.34 5.41 5.24 5.14 5.58 5.41 5.23 4.99 5.33 5.28 5.7 5.19 5.18 5.17 5.08 5.15 5.08 5.8 5.77 5.72 5.44 5.65 5.17
Wnt Signaling%WikiPathways_20191210%WP428%Homo sapiens 4.81 5.02 5.04 5.08 4.98 4.71 4.9 4.83 4.95 4.99 4.79 4.98 4.93 4.82 4.85 5.06 4.98 4.79 4.99 5.08 4.94 5.02 4.96 5.16 4.87 5.09 4.88 4.93 5 4.79 5.04 5.01 4.96 5 4.88 5.1 4.96 4.84 5.01
Estrogen signaling pathway%WikiPathways_20191210%WP712%Homo sapiens 5.78 5.63 6.23 6.69 5.81 6.28 5.97 5.74 5.93 5.87 5.93 5.61 5.93 6.41 6 5.67 6 5.79 5.7 6.11 6.67 5.88 6 6.25 6.13 5.91 6.2 5.96 5.93 5.82 6.14 6.14 5.98 6.41 6.16 6.01 6.36 6.39 5.84
Fas Ligand (FasL) pathway and Stress induction of Heat Shock Proteins (HSP) regulation%WikiPathways_20191210%WP314%Homo sapiens 5.56 5.6 5.59 5.95 5.61 5.58 5.79 6.08 5.67 5.79 5.9 5.6 5.7 5.67 5.69 5.55 5.37 5.77 5.51 5.53 5.6 5.7 5.64 5.61 5.43 5.38 5.73 5.47 5.46 5.66 5.44 5.74 5.47 5.86 5.7 5.41 5.43 5.59 5.46
Hypertrophy Model%WikiPathways_20191210%WP516%Homo sapiens 4.45 4.89 5.34 5.79 4.81 5.59 5.59 5.79 4.56 6.1 5.34 4.99 5.13 6.04 5.07 4.9 4.53 5.06 5.72 4.79 5.02 5.14 4.54 5.8 6.32 4.74 5.88 5.52 5.34 4.87 5.31 4.93 4.32 5.77 5.56 5.73 4.74 5.07 4.53
Hedgehog Signaling Pathway Netpath%WikiPathways_20191210%WP47%Homo sapiens 4.55 4.41 4.49 4.43 4.51 4.19 4.62 4.41 4.39 4.56 4.43 4.54 5.09 5.05 4.57 4.58 4.47 4.33 4.52 4.73 4.33 4.58 4.46 4.64 4.42 4.52 4.6 4.47 4.53 4.86 4.84 4.86 4.72 4.95 4.84 4.62 4.59 4.24 4.39
Cannabinoid receptor signaling%WikiPathways_20191210%WP3869%Homo sapiens 5.45 5.25 5.71 5.74 5.34 6.08 5.67 5.55 5.33 5.81 5.54 5.53 5.15 5.51 5.51 5.41 5.34 5.66 5.84 5.57 5.72 5.27 6 5.53 5.9 5.47 6.02 5.69 5.42 5.48 5.74 6.14 5.32 5.69 5.82 5.7 5.33 5.82 5.18
Retinoblastoma Gene in Cancer%WikiPathways_20191210%WP2446%Homo sapiens 5.01 5.26 5.25 5.64 5.34 5.6 5.46 5.38 5.61 5.35 5.55 5.35 5.31 5.1 5.34 5.35 5.44 5.19 5.38 5.31 5.49 5.56 5.15 5.5 5.1 5.39 5.28 5.44 5.13 5.16 5.34 5.19 5.13 5.13 5.34 5.3 5.21 5.65 5.28
SREBF and miR33 in cholesterol and lipid homeostasis%WikiPathways_20191210%WP2011%Homo sapiens 5.81 5.65 5.7 5.73 6.26 6.19 5.63 5.5 5.89 5.7 5.4 6.03 5.56 5.41 5.54 5.53 5.54 5.72 5.7 5.58 5.74 6.15 5.8 5.64 5.68 5.79 5.68 5.54 6.02 5.61 5.78 5.62 5.84 5.39 5.43 5.99 5.87 5.64 5.56
ACE Inhibitor Pathway%WikiPathways_20191210%WP554%Homo sapiens 2.87 2.85 2.92 2.92 2.84 2.7 3.08 2.98 2.87 2.96 3.06 2.91 2.97 2.86 2.89 2.96 2.85 2.76 2.91 2.98 2.67 2.85 2.89 2.94 2.9 2.82 2.8 2.91 2.95 3.04 2.93 2.9 2.83 2.92 2.96 2.88 2.84 2.83 2.76
Cardiac Progenitor Differentiation%WikiPathways_20191210%WP2406%Homo sapiens 3.9 4.03 4.09 3.77 3.79 3.88 4.27 3.81 3.79 4.06 4.04 4.01 3.95 3.77 4.04 3.93 3.84 3.89 3.98 4.02 3.66 3.8 3.97 3.84 4.1 3.76 3.95 4.03 3.8 4.1 4.08 3.79 3.71 3.75 3.96 3.81 3.81 3.74 3.67
Pathways Affected in Adenoid Cystic Carcinoma%WikiPathways_20191210%WP3651%Homo sapiens 5.89 5.91 6.21 6.33 6 6.12 6.05 6.17 5.73 5.97 5.99 5.74 5.83 5.95 5.96 6.06 6 5.94 5.85 6.2 6.17 5.96 5.98 6.27 6.49 5.95 6.44 6.46 6.01 5.9 6.38 6.17 6.12 6.19 6.12 6.21 6.26 6.03 6.04
miRNA regulation of prostate cancer signaling pathways%WikiPathways_20191210%WP3981%Homo sapiens 6.09 6.36 6.53 6.83 6.59 6.8 6.78 6.44 6.48 6.86 6.42 6.46 6.56 6.76 6.49 6.54 6.06 6.35 6.53 6.52 6.3 6.7 6.45 6.41 6.53 6.47 6.51 6.56 6.5 6.88 6.72 6.59 6.42 6.92 6.69 6.49 6.51 6.99 6.25
Human Thyroid Stimulating Hormone (TSH) signaling pathway%WikiPathways_20191210%WP2032%Homo sapiens 6.66 6.57 6.73 6.87 6.71 7.09 6.64 6.75 6.66 7.13 6.59 6.64 6.81 6.74 6.98 6.76 6.48 6.91 6.73 6.81 7.02 6.72 6.78 6.89 6.83 6.57 7.02 6.75 6.63 6.84 6.88 6.6 6.76 6.92 6.81 6.82 6.89 6.94 6.42
Cardiac Hypertrophic Response%WikiPathways_20191210%WP2795%Homo sapiens 5.4 5.34 5.52 5.87 5.63 5.48 5.37 5.38 5.45 5.67 5.48 5.33 5.67 5.75 5.82 5.5 5.34 5.66 5.59 5.37 5.56 5.64 5.56 5.58 5.4 5.53 5.61 5.53 5.48 5.36 5.93 5.91 5.49 5.94 5.8 5.65 5.65 5.58 5.26
Canonical and Non-Canonical TGF-B signaling%WikiPathways_20191210%WP3874%Homo sapiens 4.45 4.28 4.56 5.44 5.11 4.69 5.08 5.1 5.12 5.02 5.45 4.99 5.19 5.43 5.26 5.25 4.63 5.25 4.37 4.72 5.33 5.13 4.66 5.01 5.25 5.01 5.78 5.19 4.9 5.04 5.63 5.49 5.19 5.84 5.18 5.63 5.26 5.72 4.93
EPO Receptor Signaling%WikiPathways_20191210%WP581%Homo sapiens 6.81 6.56 6.78 6.91 6.78 6.77 6.06 6.74 6.52 6.97 6.49 6.5 6.31 6.89 6.95 6.38 6.43 7.05 6.56 6.63 7.27 6.75 6.78 6.66 6.77 6.61 7.41 6.7 6.4 6.74 6.94 6.48 6.78 6.85 7.15 7.18 6.79 7.02 6.2
Apoptosis-related network due to altered Notch3 in ovarian cancer%WikiPathways_20191210%WP2864%Homo sapiens 6.36 6.38 6.51 6.97 6.77 7.04 6.34 6.71 6.74 6.83 6.51 6.65 6.73 6.77 6.51 6.37 6.4 6.56 6.51 6.74 6.83 6.74 6.5 6.8 6.66 6.58 6.88 6.57 6.47 6.5 6.78 6.67 6.44 6.86 6.63 7.15 6.67 7.08 6.19
Parkin-Ubiquitin Proteasomal System pathway%WikiPathways_20191210%WP2359%Homo sapiens 8.65 8.43 7.77 8.23 8.43 8.31 7.87 7.86 8.44 8.27 7.57 8.08 7.93 8.16 8.09 8.15 8.27 8.61 7.7 7.73 8.25 8.22 7.8 7.83 8.26 8.54 8.01 7.92 8.14 8.27 7.99 7.57 8 8.14 7.83 7.72 7.85 8.04 8.67
Brain-Derived Neurotrophic Factor (BDNF) signaling pathway%WikiPathways_20191210%WP2380%Homo sapiens 6.45 6.44 6.57 6.65 6.67 6.53 6.16 6.35 6.46 6.45 6.15 6.41 6.29 6.52 6.47 6.49 6.38 6.57 6.46 6.48 6.72 6.63 6.49 6.47 6.35 6.41 6.66 6.44 6.4 6.3 6.53 6.5 6.53 6.5 6.59 6.45 6.56 6.54 6.28
Triacylglyceride Synthesis%WikiPathways_20191210%WP325%Homo sapiens 4.95 5.2 4.88 4.94 5.41 5.59 5.24 5.14 5.11 5.34 5.19 5.11 5 4.99 4.89 4.99 4.99 5.06 4.7 5.01 4.86 5.2 4.65 5.13 4.34 5.01 4.97 5.32 5.03 5 5.1 5.32 4.89 5.13 4.95 5.01 4.78 5.31 4.9
Ebola Virus Pathway on Host%WikiPathways_20191210%WP4217%Homo sapiens 6.37 6.48 6.84 7.04 6.61 7.15 6.53 6.8 6.75 6.77 6.63 6.47 6.6 6.85 6.84 6.52 6.33 6.92 6.6 6.83 6.97 6.62 6.61 6.9 7.04 6.85 7.09 6.74 6.46 6.53 6.65 6.88 6.63 6.93 6.98 6.76 6.78 7.05 6.29
Osteoclast Signaling%WikiPathways_20191210%WP12%Homo sapiens 3.69 3.87 3.93 4.11 3.75 3.49 4.22 4.27 3.83 3.93 4.21 3.93 4.21 3.99 3.98 3.79 3.61 3.75 4.28 3.94 3.37 3.65 3.89 4.21 4.09 3.87 3.83 4.11 4 4.02 4 3.87 3.61 3.93 3.88 3.96 3.71 3.93 3.66
Microglia Pathogen Phagocytosis Pathway%WikiPathways_20191210%WP3937%Homo sapiens 4.89 5.6 5.61 6.61 4.97 5.91 5.08 6.14 5.07 5.82 6.45 4.71 4.68 5.21 5.85 5.43 5.14 5.98 5.09 5.09 6.87 5.47 5.51 5.1 6.73 5.21 6.18 6.64 5.15 4.76 6.14 5.67 5.56 5.64 6.3 5.71 5.3 6.62 5.02
Peptide GPCRs%WikiPathways_20191210%WP24%Homo sapiens 2.9 2.93 2.98 2.81 2.81 2.89 3.11 3.08 2.95 2.98 3.12 3.01 3.12 2.93 2.99 2.85 2.81 2.84 3 2.98 2.67 2.84 2.97 3.03 2.96 2.92 2.91 3.04 3 3.11 2.97 2.98 2.79 2.83 2.91 2.93 2.81 2.75 2.83
Nucleotide-binding Oligomerization Domain (NOD) pathway%WikiPathways_20191210%WP1433%Homo sapiens 4.16 4.33 4.85 5.79 4.36 4.22 4.64 4.79 4.3 5.18 4.56 4.58 4.65 4.24 4.92 4.72 4.14 4.45 4.7 4.4 5.37 4.5 4.49 4.62 4.29 4.35 5.25 4.98 4.72 4.36 4.8 4.88 4.11 4.52 5.44 4.53 4.11 5.14 4.11
Wnt Signaling in Kidney Disease%WikiPathways_20191210%WP4150%Homo sapiens 3.67 3.79 3.76 4.3 3.77 3.81 3.93 3.95 3.9 3.83 3.85 3.77 4.21 3.72 3.79 3.57 3.56 3.56 3.83 3.89 3.67 3.86 3.83 3.84 3.98 3.7 3.81 3.89 3.77 4.02 3.92 3.69 3.92 3.99 3.73 3.98 4.04 3.67 3.58
Androgen receptor signaling pathway%WikiPathways_20191210%WP138%Homo sapiens 6.46 6.54 6.85 7.06 6.77 7.01 6.55 6.61 6.63 6.87 6.42 6.38 6.75 6.76 6.56 6.72 6.43 6.67 6.76 6.7 6.85 6.73 6.67 6.62 6.59 6.68 6.72 6.65 6.44 6.56 6.81 6.84 6.69 6.88 7.04 6.84 6.69 6.72 6.37
LTF danger signal response pathway%WikiPathways_20191210%WP4478%Homo sapiens 3.3 3.35 3.37 3.22 3.28 3.26 3.56 3.34 3.26 3.6 3.49 3.33 3.4 3.52 3.64 3.3 3.35 3.33 3.37 3.33 4.01 3.41 3.32 3.31 3.25 3.3 3.51 3.34 3.33 3.35 3.42 3.34 3.2 3.83 3.42 3.34 3.23 3.22 3.23
Splicing factor NOVA regulated synaptic proteins%WikiPathways_20191210%WP4148%Homo sapiens 7.85 7.69 7.22 7.32 7.25 7.36 6.56 6.43 6.65 6.73 6.47 6.88 6.03 7 6.68 7.02 7.49 7.53 7.16 6.94 7.08 7.35 7.31 6.81 6.56 6.92 6.64 6.42 6.7 6.55 6.83 6.65 7.59 6.84 6.92 7.04 7.08 6.84 7.82
NAD+ biosynthetic pathways%WikiPathways_20191210%WP3645%Homo sapiens 5 5.35 5.38 5.59 5.28 5.65 5.5 6.3 5.56 5.57 5.78 5.46 5.65 5.57 5.43 5.38 5.13 5.38 5.3 5.44 5.3 5.36 5.45 5.56 5.75 5.56 5.87 5.46 5.58 5.54 6.01 5.73 5.51 5.93 5.52 5.85 5.52 5.63 5
Biogenic Amine Synthesis%WikiPathways_20191210%WP550%Homo sapiens 5.45 5.94 6.29 5.06 5.47 5.92 3.41 4.32 3.23 5.16 4.17 3.42 3.18 3.96 5.06 5.76 5.31 5.9 5.91 4.7 4.52 4.93 5.81 4.18 5.01 4.17 3.99 4.19 4.04 3.98 5.36 4.49 7.1 3.79 5.08 4.32 6.69 4.37 4.56
Hedgehog Signaling Pathway%WikiPathways_20191210%WP4249%Homo sapiens 5.56 5.52 5.26 5.85 5.72 5.72 5.74 5.93 5.26 5.62 5.62 5.55 5.7 5.66 5.49 5.53 5.65 5.51 5.5 5.7 5.58 5.69 5.56 5.53 5.25 5.44 5.75 5.64 5.31 5.05 5.53 5.37 5.52 5.62 5.48 5.82 5.66 5.58 5.47
Photodynamic therapy-induced HIF-1 survival signaling%WikiPathways_20191210%WP3614%Homo sapiens 4.96 4.76 6.1 6.33 5.47 6.31 5.77 5.47 6.27 5.41 5.45 6.08 5.45 5.14 6.26 5.19 5.36 4.94 5.07 6.07 6.16 5.41 6.3 6.05 6.1 6.14 6.06 5.74 5.8 5.04 6.11 5.83 6 6.02 6.03 5.46 5.84 6.08 4.98
Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling%WikiPathways_20191210%WP3612%Homo sapiens 5.88 5.87 6.06 6.38 6.2 6.36 5.69 5.62 5.73 5.84 5.5 5.57 6.24 6.35 6.25 5.78 5.91 5.91 5.69 5.84 6.34 6.3 6.07 5.39 5.99 5.68 6.09 5.65 5.65 6.07 5.93 5.81 5.86 6.28 6.07 5.95 5.9 6.33 5.83
Trans-sulfuration and one carbon metabolism%WikiPathways_20191210%WP2525%Homo sapiens 5.74 6.28 6.45 6.74 6.25 6.26 6.02 5.77 6.71 6.22 6.08 6.28 6.23 6.3 6.34 6.44 6.1 6.48 5.79 6.4 6.42 6.19 6.05 6.12 6.15 6.33 6.1 6.2 6.05 6.23 6.07 6.34 6.32 6.68 6.47 6.21 6.23 6.28 6.33
Cytokines and Inflammatory Response%WikiPathways_20191210%WP530%Homo sapiens 3.5 3.63 3.81 3.6 3.57 3.6 4.04 3.93 3.6 3.9 3.99 3.71 4 3.67 4.17 3.51 3.45 3.51 3.75 3.66 3.54 3.69 3.65 3.85 3.92 3.66 3.7 3.98 3.94 3.99 3.8 3.62 3.46 3.65 3.69 3.69 3.49 3.56 3.36
Homologous recombination%WikiPathways_20191210%WP186%Homo sapiens 4.62 4.57 4.82 4.85 4.45 4.72 5.09 5.06 4.71 4.6 4.98 4.45 5.01 4.83 4.81 4.57 4.32 4.6 4.66 4.61 4.57 4.51 4.82 4.44 4.57 4.84 4.79 4.82 4.5 4.67 4.86 5.21 4.62 4.87 5.15 5.12 4.69 4.55 4.41
Hypothesized Pathways in Pathogenesis of Cardiovascular Disease%WikiPathways_20191210%WP3668%Homo sapiens 4.98 4.94 5.9 5.87 4.97 5.41 5.08 5.26 5.33 4.97 5.42 5.02 5.33 5.15 5.67 5.26 5.21 5.53 4.99 4.94 5.9 5.43 5.69 5.09 5.17 5.1 6.02 4.93 5.22 5.05 5.32 4.95 5.5 5.62 5.81 5.26 5.65 5.74 4.99
Ethanol effects on histone modifications%WikiPathways_20191210%WP3996%Homo sapiens 5.66 5.51 5.38 5.81 6.03 5.77 6.12 5.77 6.1 5.57 5.98 5.67 5.62 5.91 5.55 6.14 6.11 5.77 5.67 5.51 5.88 6.24 5.61 5.62 5.98 6.07 5.84 6 5.68 5.88 6.02 5.93 5.4 5.27 5.85 5.8 5.68 5.8 6.13
ErbB Signaling Pathway%WikiPathways_20191210%WP673%Homo sapiens 5.93 5.95 6.25 6.47 6.58 6.17 6.34 6.44 6.43 6.45 6.4 6.28 6.1 6.53 6.44 6.32 6.07 6.11 6.14 6.45 6.48 6.59 6.24 6.46 6.52 6.36 6.35 6.28 6.24 6.45 6.16 6.5 6.45 6.67 6.57 6.48 6.49 6.46 6.04
Interleukin-11 Signaling Pathway%WikiPathways_20191210%WP2332%Homo sapiens 6.12 6.44 6.43 6.83 6.15 6.61 6.16 6.39 6.43 6.54 6.51 6.41 6.47 6.38 6.45 6.29 6.1 6.36 6.06 6.46 6.67 6.51 6.33 6.38 6.62 6.34 6.66 6.56 6.43 6.52 6.8 6.59 6.42 6.65 6.5 6.37 6.49 6.39 6
Fatty Acid Omega Oxidation%WikiPathways_20191210%WP206%Homo sapiens 3.84 3.8 4 3.59 3.6 3.49 4.01 4.1 3.61 3.61 4.1 3.9 4.15 3.62 3.64 3.66 3.85 3.68 3.98 4.12 3.41 3.75 3.77 3.82 3.62 3.69 3.54 3.83 3.71 3.74 3.79 3.87 3.6 3.58 3.84 3.7 3.77 3.38 3.99
Vitamin D Receptor Pathway%WikiPathways_20191210%WP2877%Homo sapiens 3.82 4.03 3.98 4.55 3.99 4.22 4.27 4.3 3.93 4.37 4.63 4.02 4.18 4 4.34 3.87 4.05 4.17 4.08 4.16 4.48 4.42 4.12 3.97 4.25 4.24 4.18 4.45 4.01 4 4.43 4.21 4.19 4.14 4.36 4.21 4.12 4.35 3.91
Focal Adhesion-PI3K-Akt-mTOR-signaling pathway%WikiPathways_20191210%WP3932%Homo sapiens 5.29 5.06 5.05 5.18 5.14 5.31 5.05 5.12 5.07 5.08 4.9 4.97 5.07 5.14 5.14 4.99 5.23 5.15 5.14 5.05 5.33 5.24 5.06 5.15 4.98 5.13 5.29 5.02 5.02 5.03 5.21 5.17 5.29 5.1 5.38 5.41 5.18 5.25 5.03
IL-4 Signaling Pathway%WikiPathways_20191210%WP395%Homo sapiens 5.59 5.71 5.94 6.54 5.73 6.09 5.98 5.71 5.64 5.88 5.76 5.81 5.64 6.23 6.07 5.75 5.71 6.06 5.7 5.89 6.33 5.77 5.65 6.06 6.4 5.98 6.19 5.86 5.94 5.8 6.08 6.12 5.97 6.23 6.24 6.14 6.05 6.25 5.65
Wnt Signaling Pathway (Netpath)%WikiPathways_20191210%WP363%Homo sapiens 6.32 5.75 5.98 6.65 6.59 6.3 5.96 6.04 5.77 6.27 5.93 5.53 5.67 6.07 6.27 6.2 6.27 5.96 5.91 6.27 6.51 6.54 5.94 5.86 5.67 6.03 6.19 6.16 5.6 5.81 6.1 6.27 6.58 6.33 6.5 6.3 6.3 6.4 6.15
IL-3 Signaling Pathway%WikiPathways_20191210%WP286%Homo sapiens 5.59 5.55 5.98 6.59 6.22 6.71 5.54 6.14 5.42 6.1 6.25 5.31 5.22 6.59 6.35 5.87 5.56 5.97 5.39 5.62 6.79 6.48 5.72 5.78 6.61 5.77 6.54 6.6 5.56 5.63 6.39 6.44 5.79 6.75 6.62 6.26 5.98 6.63 5.69
Cell Differentiation - Index expanded%WikiPathways_20191210%WP2023%Homo sapiens 3.06 3.56 3.23 2.95 3.03 3.08 3.44 3.21 3.06 3.2 3.43 3.16 3.43 3.06 3.36 3.03 3.04 3.02 3.21 3.11 2.86 3.04 3.1 3.27 3.24 3.07 3.06 3.26 3.28 3.28 3.29 3.1 3 2.97 3.08 3.31 3.03 2.95 3.06
Monoamine Transport%WikiPathways_20191210%WP727%Homo sapiens 4.67 4.58 4.9 4.88 4.81 5.6 4.77 4.6 4.55 4.59 4.56 4.65 4.29 4.56 4.82 4.85 4.93 4.51 4.71 4.81 5.76 5.14 4.87 4.7 5.21 5.32 4.56 4.44 4.61 4.5 4.99 4.96 4.49 4.61 5.01 4.57 4.78 4.39 4.52
T-Cell antigen Receptor (TCR)  Signaling Pathway%WikiPathways_20191210%WP69%Homo sapiens 4.75 5.05 5.04 5.82 5.24 4.86 5.04 4.95 4.93 5.29 5.45 4.82 4.92 5.21 5.19 5.11 4.92 5.2 5.07 4.92 5.6 5.36 4.93 4.98 4.91 5.04 5.39 5.21 4.86 4.65 5.24 5 5.09 5.17 5.48 5.36 5.07 5.46 4.81
One carbon metabolism and related pathways%WikiPathways_20191210%WP3940%Homo sapiens 5.57 5.25 5.3 5.3 5.48 5.72 5.32 5.48 5.55 5.49 5.27 5.07 4.89 5.33 5.26 5.61 5.36 5.64 5.42 5.24 5.71 5.28 5.35 5.34 5.4 5.5 5 5.57 5.25 5.11 5.34 5.11 5.42 5.51 5.18 5.46 5.21 5.72 5.31
Small Ligand GPCRs%WikiPathways_20191210%WP247%Homo sapiens 3.3 3.36 3.48 3.4 3.18 3.46 3.62 3.45 3.3 3.44 3.5 3.58 3.68 3.3 3.39 3.21 3.26 3.42 3.45 3.45 3.21 3.35 3.35 3.48 3.49 3.38 3.31 3.53 3.67 3.56 3.42 3.34 3.39 3.18 3.3 3.33 3.39 3.15 3.17
VEGFA-VEGFR2 Signaling%WikiPathways_20191210%WP3888%Homo sapiens 6.57 6.67 6.91 7.06 6.82 7.19 6.69 6.8 6.81 6.92 6.66 6.63 6.6 6.93 6.9 6.72 6.65 6.79 6.76 6.96 7.1 6.87 6.8 6.9 6.91 6.87 7.02 6.79 6.67 6.65 6.8 6.77 6.88 7.02 6.94 6.98 6.89 7.02 6.56
Ganglio Sphingolipid Metabolism%WikiPathways_20191210%WP1423%Homo sapiens 4.87 4.44 4.02 3.83 4.14 3.99 4.29 3.88 3.88 3.97 4.13 4.1 4.2 3.86 3.96 3.96 3.93 4.67 4.34 4.18 3.61 4.2 4.17 4.1 4.27 3.87 3.83 4.28 4.1 4.1 4.01 3.93 3.84 3.63 3.73 3.91 3.85 3.46 4.69
LncRNA involvement in canonical Wnt signaling and colorectal cancer%WikiPathways_20191210%WP4258%Homo sapiens 4.59 4.53 4.63 4.96 4.72 4.56 4.71 4.54 4.61 4.74 4.78 4.74 4.62 4.64 4.74 4.6 4.76 4.62 4.8 4.64 4.84 4.73 4.62 4.79 4.73 4.61 4.72 4.74 4.73 4.57 4.9 4.69 4.95 4.97 4.41 4.76 4.72 4.75 4.51
Pancreatic adenocarcinoma pathway%WikiPathways_20191210%WP4263%Homo sapiens 5.92 5.88 6.4 6.74 6.57 6.53 6.15 6.36 6.45 6.44 6.15 6.26 6.02 6.45 6.45 6.15 6.05 6.26 5.97 6.44 6.66 6.61 6.36 6.4 6.69 6.35 6.58 6.38 6.27 6.31 6.72 6.53 6.44 6.65 6.68 6.5 6.5 6.52 6.06
Cells and Molecules involved in local acute inflammatory response %WikiPathways_20191210%WP4493%Homo sapiens 3.71 3.71 3.78 4.14 4.25 3.88 4.17 3.82 3.51 3.99 3.93 3.74 4.12 3.95 3.84 3.65 3.84 4.19 3.87 3.85 4.01 4.52 3.75 3.92 3.94 3.69 3.7 3.98 3.74 3.74 3.79 3.74 3.45 4.11 3.72 3.73 3.6 3.78 3.48
Ciliary landscape%WikiPathways_20191210%WP4352%Homo sapiens 6.68 6.68 6.73 6.78 6.77 6.97 6.64 6.82 6.95 6.78 6.54 6.77 6.74 6.69 6.56 6.8 6.72 7 6.65 6.6 6.71 6.71 6.78 6.63 6.8 6.85 6.76 6.56 6.73 6.75 6.64 6.66 6.86 6.87 6.7 6.63 6.71 6.77 6.78
Extracellular vesicles in the crosstalk of cardiac cells%WikiPathways_20191210%WP4300%Homo sapiens 5.52 6.01 6.33 5.89 5.71 6.53 5.9 6.09 6.36 6.89 6.2 5.27 5.72 6.41 6.33 5.84 6.07 6.1 5.9 6.78 6.14 5.77 6.22 6.3 5.62 6.4 6.68 6.39 5.72 6.05 5.75 6.27 6.03 5.83 6.09 6.69 6.93 6.71 5.72
PI3K-Akt Signaling Pathway%WikiPathways_20191210%WP4172%Homo sapiens 4.48 4.58 4.64 4.75 4.55 4.81 4.73 4.91 4.86 4.76 4.6 4.47 4.56 4.73 4.6 4.53 4.69 4.63 4.66 4.71 4.92 4.64 4.68 4.72 4.59 4.72 4.9 4.76 4.63 4.57 4.8 4.71 4.72 4.82 4.76 4.88 4.71 5.04 4.57
Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells%WikiPathways_20191210%WP4301%Homo sapiens 6.93 7.08 7.4 6.82 7.37 7.49 7.01 6.99 7.18 7.41 6.82 7.36 6.6 7.32 7.25 7.45 7.09 6.95 7.04 7.06 7.47 7.38 7.26 7.28 7.05 7.51 7.3 7 7.32 7.12 6.83 7.06 7.54 7.21 7.51 7.51 7.32 7.09 7.25
Non-small cell lung cancer%WikiPathways_20191210%WP4255%Homo sapiens 5.51 5.46 5.93 5.98 6.07 5.87 5.31 5.76 5.64 5.78 5.41 5.47 5.78 5.92 5.82 5.98 5.73 5.78 5.78 6.3 5.95 5.7 5.92 5.81 5.85 5.52 5.99 5.53 5.39 5.51 5.93 6.21 5.74 5.97 5.96 5.94 5.8 6.13 5.44
Breast cancer pathway%WikiPathways_20191210%WP4262%Homo sapiens 4.81 4.92 4.94 4.94 4.81 4.78 4.9 5.04 4.84 4.94 4.82 4.58 4.88 4.79 5.09 4.72 4.69 4.9 4.99 4.88 5.09 5.03 4.9 5.02 4.86 4.84 5.1 4.94 4.89 4.83 4.87 5.05 4.95 4.96 4.94 5.06 4.96 4.91 4.67
Metabolic reprogramming in colon cancer%WikiPathways_20191210%WP4290%Homo sapiens 7.76 7.75 7.93 7.86 8.08 8.08 7.38 7.54 8.14 7.85 7.4 8.07 7.56 7.86 7.85 7.86 7.74 7.82 7.64 7.35 8.04 8.04 7.69 7.69 7.49 7.96 7.66 7.45 7.82 7.49 7.53 7.6 7.97 7.7 7.81 7.74 7.6 7.66 7.98
Methionine metabolism leading to Sulphur Amino Acids and related disorders%WikiPathways_20191210%WP4292%Homo sapiens 5.25 4.58 5.05 5.18 5.64 6.07 5.9 5.35 5.55 5.36 5.39 5.64 5.73 5.33 5.36 5.67 5.2 5.75 5.12 5.34 5.84 5.28 5.76 5.44 5.77 5.54 5.48 5.39 5.43 4.6 5.85 5.03 5.64 5.02 5.14 5.34 4.8 5.98 5.2
Fibrin Complement Receptor 3 Signaling Pathway%WikiPathways_20191210%WP4136%Homo sapiens 4.2 4.91 4.65 5.17 4.55 4.5 4.04 4.84 4.68 4.74 4.94 3.8 4.1 4.44 4.9 4.28 4.69 4.8 4.53 4.21 4.74 4.85 4.59 4.3 4.25 3.94 4.9 4.9 3.86 3.89 4.62 4.14 4.33 4.6 5.27 4.92 4.46 4.7 4.07
Resistin as a regulator of inflammation%WikiPathways_20191210%WP4481%Homo sapiens 5.5 5.63 5.87 6.61 5.36 5.97 5.67 5.69 5.66 5.77 5.59 5.6 5.74 5.79 5.86 5.67 5.77 5.79 5.7 5.83 5.96 5.72 5.91 5.72 6.22 5.69 6.02 5.82 5.7 5.48 6.14 6.06 5.74 6.04 5.88 5.97 6.03 6.07 5.74
Thermogenesis%WikiPathways_20191210%WP4321%Homo sapiens 5.74 5.52 5.73 5.96 5.89 5.87 5.72 5.53 5.94 5.84 5.64 5.57 5.7 5.91 5.54 5.67 5.79 5.72 5.82 5.69 5.88 5.63 5.76 5.63 5.69 5.68 6 5.66 5.51 5.69 5.8 5.78 5.78 5.89 5.82 5.82 5.79 5.84 5.85
Metabolic pathway of LDL, HDL and TG, including diseases%WikiPathways_20191210%WP4522%Homo sapiens 3.4 3.6 3.7 4.16 3.49 4.7 3.67 3.56 3.54 3.56 3.95 3.4 3.63 4.17 3.56 3.54 3.5 3.95 3.86 3.65 3.84 3.5 3.66 3.91 3.51 3.54 4.39 3.62 3.56 3.61 3.55 4.14 3.24 4.83 3.56 3.55 3.49 3.5 3.49
The human immune response to tuberculosis%WikiPathways_20191210%WP4197%Homo sapiens 5.62 6.6 6.1 6.47 6.03 6.1 6.36 6.31 5.81 5.63 6.23 5.97 6.11 5.9 6.14 5.59 5.7 6.73 5.67 5.98 6.23 5.91 5.94 6.21 6.37 6.02 6.03 6.97 6.08 5.95 6.09 6.24 5.84 5.69 6.19 5.95 6.08 6.11 5.42
The alternative pathway of fetal androgen synthesis%WikiPathways_20191210%WP4524%Homo sapiens 3.17 3.39 3.38 3.08 3.16 3.32 3.64 3.7 3.62 3.45 3.7 3.5 3.86 3.53 3.62 3.28 3.23 3.16 3.49 3.4 3.17 3.08 3.56 3.69 3.47 3.45 3.41 3.77 3.47 3.54 3.46 3.57 3.02 3.31 3.7 3.37 3.23 3.23 3.81
MET in type 1 papillary renal cell carcinoma%WikiPathways_20191210%WP4205%Homo sapiens 6.65 6.8 6.78 7.06 7.29 6.85 6.75 6.61 6.89 7.11 6.5 6.69 6.67 6.92 7.06 6.77 6.77 6.76 6.73 6.82 7.14 7.1 6.59 7 6.92 6.73 7.09 6.57 6.96 6.81 7.15 6.6 6.59 6.96 7.19 7.14 6.69 7.2 7.03
Hereditary leiomyomatosis and renal cell carcinoma pathway%WikiPathways_20191210%WP4206%Homo sapiens 7.33 7.5 7.54 7.35 7.68 7.9 7.66 7.64 7.93 7.57 7.08 8.04 7.88 7.68 7.53 7.41 7.57 7.61 7.28 7.28 7.42 7.49 7.66 7.78 7.54 7.77 7.66 7.15 7.69 7.37 7.9 7.52 7.59 7.31 7.43 7.78 7.63 7.24 7.47
Tryptophan catabolism leading to NAD+ production%WikiPathways_20191210%WP4210%Homo sapiens 3.38 3.51 3.61 3.44 3.39 3.6 3.43 3.54 3.66 3.57 3.61 3.51 3.38 3.53 3.55 3.45 3.53 3.44 3.61 3.75 3.31 3.45 3.51 3.67 3.53 3.49 3.46 3.56 3.65 3.71 3.54 3.52 3.34 3.36 3.51 3.69 3.3 3.26 3.42
Transcriptional cascade regulating adipogenesis%WikiPathways_20191210%WP4211%Homo sapiens 5.3 5.32 6.18 5.33 5.14 5.54 5.42 5.06 5.37 5.5 5.56 5.44 5.15 5.37 5.31 4.78 5.23 4.87 6 5.38 4.89 5.04 5.37 6.69 5.43 6.02 5.1 5.42 5.48 5.33 5.23 5.32 4.92 5.27 4.95 5.06 5.58 5.24 5.04
Oxysterols derived from cholesterol%WikiPathways_20191210%WP4545%Homo sapiens 4 4.16 4.15 4.02 4.23 4.16 3.84 3.79 4.01 4.2 4.19 4.16 4.21 4.15 4.18 4.01 3.77 4.09 4.17 4.2 3.96 4.13 4.17 4.17 4.17 3.99 4.14 3.86 4.15 4.29 4.15 4.21 3.65 3.88 4.14 4.16 3.86 3.93 3.89
MTHFR deficiency%WikiPathways_20191210%WP4288%Homo sapiens 5.61 4.79 4.79 4.6 5.48 5.23 4.8 4.45 4.78 4.66 4.65 4.75 4.51 4.7 4.78 5.45 4.99 4.63 4.52 4.74 5 5.24 4.52 4.48 4.47 4.74 4.4 4.46 4.78 4.8 4.45 4.99 4.88 4.76 5.18 4.74 4.87 4.71 5.31
The effect of progerin on the involved genes in Hutchinson-Gilford Progeria Syndrome%WikiPathways_20191210%WP4320%Homo sapiens 6.67 6.57 6.85 7.38 6.94 7.53 6.56 7.01 6.73 6.8 6.5 6.53 6.45 6.51 7.04 6.78 6.83 6.67 6.57 6.49 7.42 6.7 6.82 6.95 6.88 6.96 7.19 6.9 6.77 6.43 7.25 6.98 6.98 6.68 6.89 6.75 6.8 6.77 6.55
Chromosomal and microsatellite instability in colorectal cancer %WikiPathways_20191210%WP4216%Homo sapiens 5.88 5.98 6.19 6.58 6.24 6.35 5.93 6.38 5.94 6.32 6.1 5.97 6.13 6.34 6.23 6.03 5.86 6.13 6.07 6.29 6.42 6.48 5.97 6.14 6.53 5.88 6.44 6.45 5.97 6.15 6.54 6.39 6.14 6.37 6.47 6.29 6.24 6.43 5.88
Rett syndrome causing genes%WikiPathways_20191210%WP4312%Homo sapiens 5.82 5.93 6.12 5.93 6.16 6.07 6.05 5.94 5.99 6.08 5.72 5.95 5.51 6.12 6.07 6.35 5.85 6.09 6.17 6.08 6.09 6.51 6.12 5.91 6.07 6.16 6.13 5.98 6.17 5.87 6.04 6.21 6.51 6.06 5.96 6.41 6.36 6.33 6.14
Genotoxicity pathway%WikiPathways_20191210%WP4286%Homo sapiens 4.96 4.98 4.99 5.36 4.96 5.29 5.03 4.99 4.95 5.09 4.93 4.88 5.16 5.01 5.1 4.91 4.83 4.99 4.89 5.07 5.17 5.08 4.97 4.91 4.92 4.93 4.99 5.3 4.98 5.04 5.16 5.18 5.29 5.07 5.16 5.06 4.85 5.04 4.95
NRF2-ARE regulation%WikiPathways_20191210%WP4357%Homo sapiens 7.31 6.99 7.62 8.05 7.14 7.79 6.71 7.72 7.45 7.98 7.15 7.22 7.9 7.68 7.57 7.31 7.19 7.32 6.96 7.57 8.01 7.17 7.36 7.34 7.27 7.33 8.16 7.1 7.29 7.55 7.5 7.71 7.52 7.63 7.53 7.91 7.68 7.67 7.13
Lipid Metabolism Pathway%WikiPathways_20191210%WP3965%Homo sapiens 7.42 7.36 7.03 6.83 7.23 6.93 6.59 6.3 6.99 6.72 6.73 7.37 6.18 6.81 7.15 7.18 7.37 7.36 6.81 6.99 7.23 7.31 7.16 6.58 6.51 6.92 6.66 6.57 6.65 6.52 6.73 6.82 7.53 6.88 7.01 7.02 6.93 6.81 7.38
Phosphodiesterases in neuronal function%WikiPathways_20191210%WP4222%Homo sapiens 3.98 4.22 4.38 4.13 4.38 4.53 4.48 4.38 4.32 4.03 4.15 4.56 4.45 4.4 4.27 4.32 4.12 4.16 4.28 4.52 3.77 4.46 4.51 4.45 4.23 4.52 4.22 4.05 4.65 4.39 4.65 4.51 4.07 4.15 4.26 4.36 4.29 4.45 4.35
Ras Signaling%WikiPathways_20191210%WP4223%Homo sapiens 5.95 5.97 6.23 6.48 6.05 6.22 6.24 6.17 6.36 6.19 6.12 6.14 6.13 6.44 6.29 6.04 6.04 6.06 6.06 6.38 6.27 6.02 5.92 6.28 6.44 6.32 6.41 6.24 6.23 6.26 6.18 6.4 6.18 6.5 6.25 6.32 6.29 6.27 5.97
Pyrimidine metabolism and related diseases%WikiPathways_20191210%WP4225%Homo sapiens 4.69 4.87 4.7 4.92 4.72 4.54 4.87 4.87 4.88 4.7 4.79 4.85 4.79 4.62 4.92 4.76 4.7 4.91 4.9 4.81 4.86 4.86 4.83 4.76 4.9 4.97 4.73 4.98 4.75 4.3 4.9 4.76 4.82 4.57 4.92 4.71 4.74 4.78 4.67
Purine metabolism%WikiPathways_20191210%WP4224%Homo sapiens 6.12 6.38 6.54 7.03 6.16 5.95 5.81 6.2 5.97 6.66 6.05 6.09 5.86 5.97 6.47 5.68 5.92 6.17 5.85 6.13 6.35 5.82 6.05 5.72 5.83 6.17 6.46 6.22 5.65 5.65 6.22 6.04 5.89 5.72 6.26 5.81 6.01 6.25 6.12
Ferroptosis%WikiPathways_20191210%WP4313%Homo sapiens 7.16 7.3 6.92 8.17 7.39 7.15 6.54 6.66 7.38 7.5 7.06 7 7.33 7.38 7.37 6.91 7.07 6.99 6.83 7.06 7.85 7.14 7.31 6.94 6.88 7.22 7.64 7.12 7.04 7.05 7.32 7 7.09 7.33 7.18 7.13 7.22 7.38 7.35
Epithelial to mesenchymal transition in colorectal cancer%WikiPathways_20191210%WP4239%Homo sapiens 4.44 4.39 4.52 4.74 4.71 4.33 4.53 4.38 4.46 4.41 4.37 4.36 4.48 4.44 4.51 4.71 4.42 4.67 4.53 4.45 4.79 4.43 4.61 4.5 4.43 4.52 4.72 4.74 4.73 4.53 4.62 4.48 4.71 4.6 4.47 4.65 4.71 4.76 4.47
Type 2 papillary renal cell carcinoma%WikiPathways_20191210%WP4241%Homo sapiens 6.09 6.11 6.26 6.35 6.29 6.84 6.53 6.33 6.32 6.21 6.87 6.5 6.4 6.19 6.26 6.22 6.18 6.35 6.03 6.37 6.45 6.53 6.22 6.36 6.64 6.4 6.53 6.87 6.31 6.29 6.78 6.68 6.23 6.48 6.44 6.91 6.18 6.15 6.35
Regulation of sister chromatid separation at the metaphase-anaphase transition%WikiPathways_20191210%WP4240%Homo sapiens 4.92 4.85 5.29 4.65 5.09 4.92 4.72 4.28 5.38 5 4.86 5.17 4.1 4.85 4.76 4.79 4.89 5.31 4.81 4.65 5.11 5.19 5.05 5.03 5.14 4.98 4.35 5.01 5.06 4.48 5.36 5.19 5.39 5.12 4.9 4.9 4.38 4.5 5.11
Vitamin D in inflammatory diseases%WikiPathways_20191210%WP4482%Homo sapiens 5.62 5.46 5.76 6.66 5.72 5.57 5.74 5.85 5.6 5.79 5.79 5.57 6.03 5.81 5.9 5.47 5.67 5.78 5.64 5.74 6.07 5.74 5.63 5.74 6.03 5.53 5.82 5.69 5.56 5.78 6.02 5.83 5.59 6.1 5.92 5.92 5.79 6.09 5.4
Oligodendrocyte Specification and differentiation(including remyelination), leading to Myelin Components for CNS%WikiPathways_20191210%WP4304%Homo sapiens 4.92 5.47 5.39 6.46 5.68 6.21 4.86 6.56 5.03 5.94 4.69 5.52 5.46 5.39 5.75 5.29 4.64 5.36 5.45 5.45 5.99 5.94 5.47 5.63 6.32 5.59 5.66 4.67 5.67 5.46 5.33 5.71 5.22 5.37 5.81 6.2 5.36 6.26 5.33
Viral Acute Myocarditis%WikiPathways_20191210%WP4298%Homo sapiens 4.71 5.08 4.99 5.87 4.79 5.2 5.09 5.4 4.9 5.26 5.46 4.84 4.87 5.16 5.46 4.95 4.99 5.16 4.97 4.91 5.37 4.98 4.97 4.99 5.25 4.93 5.65 5.83 4.94 4.8 5.41 5.25 5.06 5.12 5.54 5.35 5.22 5.44 4.73
Disorders of Folate Metabolism and Transport%WikiPathways_20191210%WP4259%Homo sapiens 5.75 5.71 5.66 6.51 5.94 5.98 5.79 5.77 6.47 5.77 5.98 5.82 5.95 5.69 5.84 6.29 5.87 5.8 5.77 5.49 6.13 5.96 5.7 5.87 6 5.9 5.69 6.11 5.65 5.62 5.82 6.16 5.43 5.49 6 5.86 5.77 5.99 5.96
Omega-9 FA synthesis%WikiPathways_20191210%WP4724%Homo sapiens 7.44 7.75 7.38 7.85 8.37 8.56 7.81 7.37 8.51 7.44 7.95 8.45 8.36 7.8 7.57 8.34 8.18 7.95 6.83 7.52 8.22 8.3 7.19 8.22 7.19 8.16 7.64 8.35 8.3 7.42 8.13 8.19 7.93 8.2 7.59 7.66 7.64 7.54 7.63
Mitochondrial complex I assembly model OXPHOS system%WikiPathways_20191210%WP4324%Homo sapiens 9.21 9.23 8.77 8.85 9.05 8.75 8.39 8.64 9.11 8.86 8.4 9.27 8.66 8.45 8.49 8.98 8.85 8.99 8.71 8.29 8.8 8.9 8.7 8.51 8.86 8.94 8.62 8.41 8.92 8.68 8.67 8.38 8.64 8.52 8.23 8.32 8.55 8.68 9.16
Sphingolipid Metabolism (integrated pathway)%WikiPathways_20191210%WP4726%Homo sapiens 7.58 7.08 6.87 7.09 7.61 7.14 7.4 6.83 7.23 7.02 6.71 7.15 6.89 7.37 6.83 7.41 7.49 7.51 6.59 6.83 7.08 7.72 6.95 7.02 6.72 7.26 7.06 6.68 7.04 7.07 7.39 6.55 7.58 7.47 6.92 6.91 7.26 6.89 7.83
Overview of interferons-mediated signaling pathway%WikiPathways_20191210%WP4558%Homo sapiens 3.11 3.22 3.2 3.02 3.1 3.04 3.5 3.24 3.12 3.21 3.36 3.19 3.42 3.14 3.19 3.08 3.1 3.05 3.26 3.29 3.01 3.08 3.22 3.27 3.24 3.16 3.12 3.32 3.28 3.48 3.3 3.18 3.03 3.02 3.17 3.17 3.03 2.98 3.08
Interactions between immune cells and microRNAs in tumor microenvironment%WikiPathways_20191210%WP4559%Homo sapiens 3.4 3.75 4.04 3.75 3.69 3.75 4.21 3.9 3.82 4.06 3.94 3.85 3.88 3.81 3.95 3.75 3.39 3.78 3.78 3.95 4.29 3.78 3.9 3.85 3.91 3.76 3.93 4.29 3.87 4.05 4.1 3.9 3.81 3.82 4.05 4 3.73 3.88 3.51
22q11.2 Deletion Syndrome%WikiPathways_20191210%WP4657%Homo sapiens 5.09 5.26 5.27 5.09 5.4 5.59 5.33 4.96 4.95 5.2 5.11 5.32 5.05 5.23 5.28 5.36 5.21 5.4 5.57 5.59 4.87 5.27 5.49 5.03 5.32 4.89 5.21 5.02 5.05 5.38 5.59 5.67 5.33 5.42 5.41 5.27 5.38 5.08 5.4
Neural Crest Cell Migration in Cancer%WikiPathways_20191210%WP4565%Homo sapiens 5.73 5.77 5.83 6.58 6.14 6.44 5.87 5.75 5.76 6.01 5.81 5.73 5.81 5.91 5.88 5.94 6 5.74 5.92 5.82 6.78 6.44 5.94 5.75 6.07 5.86 6.2 5.76 5.68 5.86 5.98 6.31 5.98 5.96 5.93 5.96 6.36 6.07 6.22
Omega-3/Omega-6 FA synthesis%WikiPathways_20191210%WP4723%Homo sapiens 6.38 6.41 6.57 6.21 6.48 6.14 6.17 6.13 6.04 6.54 5.89 6.58 6.49 6.44 6.49 6.81 6.39 6.09 6.5 6.47 6.45 6.41 6.33 6.25 5.9 5.8 6.43 5.73 6.45 6.65 6.03 6.76 6.34 6.15 6.48 6.83 6.58 6.29 6.21
Cysteine and methionine catabolism%WikiPathways_20191210%WP4504%Homo sapiens 5.87 6.14 6.36 6.51 6.12 6.55 6.11 5.74 6.64 6.18 6.18 6.69 6.33 6.43 6.26 6.38 6.04 6.1 5.72 6.41 6.18 6.29 6.03 6.16 6.45 6.64 6.23 6.24 6.55 6.45 6.04 6.35 6.4 6.45 6.48 6.44 6.45 6.22 5.89
Cell migration and invasion through p75NTR%WikiPathways_20191210%WP4561%Homo sapiens 5.75 5.62 6.15 5.57 5.94 6.05 5.3 5.91 5.75 6.15 5.24 5.55 5.64 5.89 5.96 5.91 5.43 5.9 5.94 6.03 5.52 5.79 6 5.82 5.47 5.72 6.15 5.3 5.36 5.37 5.99 5.42 5.98 5.92 5.81 6.36 6.41 5.48 5.41
Control of immune tolerance by vasoactive intestinal peptide%WikiPathways_20191210%WP4484%Homo sapiens 2.91 2.98 3.06 2.8 2.87 2.72 3.36 3.03 2.88 3.07 3.3 3.06 3.05 2.94 3.01 2.84 2.78 2.84 3.05 3.28 2.87 2.89 2.98 3.18 3.04 2.96 2.94 3.22 3.52 3.29 3.09 2.96 2.74 2.87 2.93 2.96 2.85 2.86 2.66
Relationship between inflammation, COX-2 and EGFR%WikiPathways_20191210%WP4483%Homo sapiens 4.82 5.02 5.05 5.22 4.89 5.4 4.91 5.2 5.03 5.02 4.94 4.54 4.95 5 5.67 4.76 5.13 5.09 4.93 4.96 5.38 4.88 4.92 4.92 4.62 5.03 5.45 5.06 4.91 5.17 4.85 5.02 4.94 4.96 5.27 5.16 5.21 5 5.03
IL-10 Anti-inflammatory Signaling Pathway %WikiPathways_20191210%WP4495%Homo sapiens 3.61 4.11 4.38 5.77 4.28 4.37 3.8 5.11 4.14 5.1 4.97 3.92 4.24 5.38 5.22 3.87 3.79 4.43 4.09 4.34 5.83 4.37 4.47 4.31 5.57 4.05 5.73 5.59 4.1 4.55 4.66 4.51 3.98 5.6 5.65 5.21 4.15 5.24 3.31
Selective expression of chemokine receptors during T-cell polarization%WikiPathways_20191210%WP4494%Homo sapiens 3.23 2.98 3.06 3.04 3.25 2.88 3.36 3.15 2.98 3.18 3.3 3.06 3.05 3.24 3.01 3.36 3.17 2.92 3.05 3.28 2.87 3.17 2.98 3.18 3.57 3.61 2.94 3.22 3.52 3.29 3.09 3.47 3.4 2.88 2.93 2.96 2.85 2.95 2.8
Neural Crest Cell Migration during Development%WikiPathways_20191210%WP4564%Homo sapiens 5.67 5.56 5.72 5.6 5.6 6.02 5.23 5.34 5.64 5.44 5.39 5.55 5.64 5.85 5.73 5.64 5.69 5.65 5.87 5.65 5.75 5.72 5.75 5.6 5.58 5.72 5.74 5.66 5.45 5.59 5.87 5.86 5.77 5.81 5.89 5.78 5.88 5.82 5.88
FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma%WikiPathways_20191210%WP4553%Homo sapiens 6.35 6.46 7 7.62 6.44 7.1 6.59 6.97 6.75 6.81 6.76 6.77 6.73 6.61 6.94 6.33 6.09 6.69 6.81 6.7 6.81 6.3 6.75 7 6.77 6.34 7.09 6.91 6.47 6.44 6.93 6.54 6.66 7 6.73 7 6.99 7.32 6.77
Hepatitis B infection%WikiPathways_20191210%WP4666%Homo sapiens 5.23 5.15 5.13 5.83 5.27 5.33 5.35 5.25 5.13 5.19 5.47 5.15 5.18 5.32 5.28 5.31 5.16 5.24 5.18 5.24 5.71 5.27 5.2 5.06 5.37 5.27 5.51 5.45 5.04 5.28 5.39 5.31 5.35 5.61 5.53 5.59 5.4 5.62 5.08
Bile Acids synthesis and enterohepatic circulation %WikiPathways_20191210%WP4389%Homo sapiens 3.7 3.96 3.95 3.84 3.89 3.84 4.09 3.83 3.97 4 3.91 3.94 3.54 4.2 4 3.25 3.65 3.83 3.76 4.14 3.85 3.94 3.86 3.95 3.96 3.84 3.94 3.62 3.68 3.66 4.01 3.68 3.71 3.82 3.88 4.03 3.88 3.91 3.82
Signal transduction through IL1R%WikiPathways_20191210%WP4496%Homo sapiens 4.82 5.02 4.96 5.54 5.19 5.09 5.16 5.1 4.94 5.24 5.47 5.04 5.12 5.42 5.26 5.1 4.78 5.29 4.9 4.83 5.71 5.21 4.92 4.97 5.37 5.33 5.39 5.06 5.02 4.96 5.06 5.11 5.05 5.52 5.49 5.28 5.36 5.42 4.8
Fragile X Syndrome %WikiPathways_20191210%WP4549%Homo sapiens 6.76 6.74 6.72 6.52 6.8 6.87 6.48 6.5 6.71 6.69 6.4 6.48 6.31 6.64 6.64 6.7 6.7 6.82 6.78 6.54 6.73 6.88 6.7 6.75 6.54 6.69 6.68 6.58 6.55 6.41 6.65 6.63 7.06 6.82 6.64 6.68 6.95 6.71 6.67
Translation inhibitors in chronically activated PDGFRA cells%WikiPathways_20191210%WP4566%Homo sapiens 6.65 6.72 6.55 6.92 7.04 6.65 6.69 6.59 7.03 6.75 6.84 6.41 6.57 6.88 6.83 6.65 6.85 6.66 6.54 6.54 7.02 6.91 6.83 6.91 6.7 6.98 6.94 6.74 6.55 6.62 6.83 6.57 6.94 6.83 6.92 6.88 6.84 6.94 7.33
Nonalcoholic fatty liver disease%WikiPathways_20191210%WP4396%Homo sapiens 7.52 7.48 7.45 7.65 7.72 7.72 7.34 7.41 7.53 7.5 7.15 7.56 7.17 7.46 7.4 7.44 7.37 7.45 7.25 7.33 7.44 7.53 7.4 7.32 7.47 7.5 7.36 7.25 7.45 7.43 7.52 7.33 7.4 7.44 7.39 7.47 7.34 7.57 7.68
Platelet-mediated interactions with vascular and circulating cells%WikiPathways_20191210%WP4462%Homo sapiens 3.96 4.14 4.55 6.42 4.61 4.87 4.73 5.18 4.23 5.07 4.77 4.11 4.31 4.73 5.04 4.49 4.17 5.14 4.03 4.55 5.94 4.84 4.64 4.18 5.23 4.41 5.31 5.27 4.75 4.25 5.15 4.71 4.33 4.69 5.44 5.12 4.43 5.55 3.54
MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement%WikiPathways_20191210%WP4560%Homo sapiens 6.11 6.54 6.73 7.43 6.13 7.53 6.29 6.74 6.32 6.81 6.55 6.16 6.51 6.61 7.14 6.42 6.35 6.86 6.9 6.97 7.34 6.58 6.78 6.68 6.56 6.62 7.3 6.51 6.18 6.24 6.11 6.71 6.47 6.96 7.44 6.77 6.75 7.03 6.15
Melanoma%WikiPathways_20191210%WP4685%Homo sapiens 5.91 6.01 6.03 6.4 6.41 6.26 5.9 5.92 5.98 6.43 6 6.14 5.95 6.41 6.35 6.06 6 6.31 5.91 6.35 6.48 6.44 6 6.25 6.1 6.27 6.45 6.19 5.77 5.8 6.35 5.99 6.31 6.29 6.38 6.28 6.49 6.48 5.96
Glycosylation and related congenital defects%WikiPathways_20191210%WP4521%Homo sapiens 4.77 4.67 4.49 5.2 5.03 5.11 4.54 4.63 4.97 4.47 4.8 4.84 4.67 4.81 4.6 4.75 5.25 5.14 4.85 4.76 5.26 5.14 4.87 4.46 4.5 4.5 4.9 4.46 4.53 4.57 4.59 4.73 5.32 4.72 4.59 4.56 4.84 5.11 5.05
Classical pathway of steroidogenesis, including diseases%WikiPathways_20191210%WP4523%Homo sapiens 3.09 3.02 3.06 2.94 2.95 2.96 3.2 3.05 3.01 3.06 3.14 3.04 3.13 3.02 3.05 2.96 2.99 2.97 3.09 3.15 2.91 3.06 3 3.09 3.01 3.02 2.95 3.07 3.05 3.09 3.05 3.04 2.93 2.98 3.01 3.03 3 2.94 3
Computational Model of Aerobic Glycolysis%WikiPathways_20191210%WP4629%Homo sapiens 11.13 10.64 9.92 9.8 10.86 10.29 8.92 9.07 10.51 9.43 9.33 10.53 9.62 10.55 10.06 10.45 10.68 10.45 10.04 9.57 10.48 10.76 10.26 9.52 9.87 10.32 9.83 9.31 10.18 9.82 9.67 9.63 10.64 10.41 10.46 10.01 10.33 9.86 11
Hippo-Yap signaling pathway%WikiPathways_20191210%WP4537%Homo sapiens 5.06 5.55 5.12 5.5 5.51 5.5 5.3 5.15 5.39 5.36 5.3 5.18 6.05 5.04 5.45 5.2 5.47 5.48 5.24 5.09 5.6 5.36 5.11 5.67 5.73 5.58 5.89 5.63 5.68 5.4 5.53 5.38 5.49 5.2 5.76 5.63 5.58 5.67 5.29
Synaptic signaling pathways associated with autism spectrum disorder%WikiPathways_20191210%WP4539%Homo sapiens 5.36 5.11 5.16 5.27 5.4 5.62 4.87 4.94 5.21 5.05 4.97 5.23 5.1 5.03 5.25 5.34 5.44 5.24 5.01 5.01 5.68 5.41 5 5.24 4.97 5.31 5.18 5.27 5.28 5.25 5.33 5.32 5.43 5.46 5.26 5.2 5.32 5.47 5.36
Hippo-Merlin Signaling Dysregulation%WikiPathways_20191210%WP4541%Homo sapiens 5.44 5.41 5.65 5.78 5.55 6.05 5.39 5.46 5.43 5.63 5.7 5.47 5.42 5.49 5.69 5.51 5.5 5.47 5.77 5.69 5.81 5.56 5.58 5.71 5.61 5.75 5.62 5.63 5.42 5.51 5.81 5.48 5.49 5.43 5.79 5.68 5.63 5.94 5.45
Regulatory circuits of the STAT3 signaling pathway%WikiPathways_20191210%WP4538%Homo sapiens 3.88 4.15 4.26 4.29 4.08 4.2 4.23 4.24 4.02 4.18 4.12 4.08 4.19 4.22 4.18 4.24 4.16 4.07 4.25 4.17 4.29 3.99 4.19 4.25 4.11 4.15 4.21 4.28 4.06 4.28 4.09 4.26 4.24 4.24 4.3 4.37 3.96 4.01 4.01
Transcription co-factors SKI and SKIL protein partners%WikiPathways_20191210%WP4533%Homo sapiens 4.73 5.05 5.08 5.5 4.7 4.98 5.3 5.15 5 5.36 5.19 5.11 5.43 5.03 5.11 4.72 4.99 5 4.72 5.09 4.95 4.99 5.07 5.12 5.25 4.78 5.23 5.28 5.12 5.75 5.13 5.6 4.75 5.07 5.34 5.12 5.02 5.73 4.54
Genes related to primary cilium development (based on CRISPR)%WikiPathways_20191210%WP4536%Homo sapiens 4.93 5.1 5.37 5.25 4.94 5.33 5.16 5.1 5.18 4.89 4.96 5.26 5.25 4.91 5.13 5.06 5.03 5.06 5.18 5.13 5.08 4.88 5.16 5.07 4.93 5.05 5.09 5.21 5.46 4.98 5.03 5.01 5.18 4.86 4.86 4.95 5.1 5.21 5.15
Intraflagellar transport proteins binding to dynein%WikiPathways_20191210%WP4532%Homo sapiens 6.85 6.99 6.89 7.15 6.91 6.98 6.76 6.79 6.94 6.82 6.58 7.04 6.78 6.68 6.78 7.03 6.83 7.24 6.95 6.46 7.07 6.99 6.89 6.76 6.72 6.95 6.68 6.66 6.9 6.77 6.81 6.63 7.33 6.75 6.59 6.34 6.99 6.98 6.57
Envelope proteins and their potential roles in EDMD physiopathology%WikiPathways_20191210%WP4535%Homo sapiens 6.72 6.44 6.83 7.09 6.76 6.68 6.24 6.55 6.95 6.56 6.19 7.01 6.75 6.49 6.34 6.59 6.21 6.57 6.51 6.82 6.81 6.39 6.95 6.41 6.35 6.83 7.01 6.8 6.8 6.38 6.78 6.64 6.82 6.65 6.65 7.19 6.89 6.58 6.89
Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms%WikiPathways_20191210%WP4534%Homo sapiens 5.27 5.33 5.33 5.51 5.26 6.25 5.39 5.52 5.47 5.45 5.36 5.47 5.98 5.13 5.35 5.35 5.34 5.32 5.44 5.64 6.05 5.34 5.34 5.74 6.04 5.77 5.93 5.63 5.7 5.62 5.7 5.49 5.5 5.28 5.55 5.68 5.79 5.7 5.36
Pathways Regulating Hippo Signaling%WikiPathways_20191210%WP4540%Homo sapiens 5.5 5.47 5.8 6 5.57 5.53 5.44 5.59 5.51 5.71 5.78 5.51 5.46 5.59 5.69 5.6 5.51 5.66 5.94 6.05 5.85 5.69 5.65 5.76 5.68 5.76 5.77 5.64 5.56 5.55 5.84 5.9 5.61 5.65 5.87 5.9 6.04 5.84 5.29
Small cell lung cancer%WikiPathways_20191210%WP4658%Homo sapiens 4.82 4.77 4.93 5.56 4.95 5.19 4.83 5.21 4.92 4.98 4.82 4.85 4.87 4.88 4.89 4.76 4.96 5.03 4.91 4.74 5.42 5.04 4.84 4.96 5.17 4.96 5.29 5.09 4.76 4.84 5.07 5.09 4.95 5 4.85 5.13 5.14 5.32 4.71
Joubert Syndrome%WikiPathways_20191210%WP4656%Homo sapiens 5.25 5.33 5.49 5.2 4.97 5.13 5.35 5.44 5.05 5.27 5.38 5.23 5.53 5.26 5.37 5.27 5.1 5.38 5.28 5.15 5.43 5.25 5.29 5.46 5.01 5.17 5.36 5.37 5.35 5.05 5.31 5.3 5.23 5.5 5.32 5.04 5.18 5.32 5.33
Cytosolic DNA-sensing pathway%WikiPathways_20191210%WP4655%Homo sapiens 4.31 4.6 4.58 4.93 4.43 4.4 4.53 4.66 4.46 4.49 4.68 4.56 4.44 4.56 4.85 4.49 4.31 4.62 4.57 4.48 4.73 4.44 4.49 4.52 4.75 4.51 4.59 4.61 4.4 4.43 4.71 4.43 4.18 4.69 4.96 4.47 4.37 4.67 4.21
Cancer immunotherapy by CTLA4 blockade%WikiPathways_20191210%WP4582%Homo sapiens 5.13 5.3 5.54 6.12 4.97 5.82 4.8 5.43 5.07 5.03 5.7 4.6 4.57 4.94 5.76 5.1 5.22 5.83 4.91 5.01 5.88 5.37 4.96 5.31 6.63 5.53 6.05 5.97 5.25 5.01 5.62 5.77 5.89 5.59 5.7 5.65 5.79 6.14 5.36
Biomarkers for pyrimidine metabolism disorders%WikiPathways_20191210%WP4584%Homo sapiens 4.41 4.87 4.7 4.92 4.45 5.05 4.87 4.88 4.79 4.7 5.03 4.85 5.05 4.62 4.97 4.56 4.7 4.53 4.9 4.86 4.86 4.47 4.83 4.76 5 4.97 4.86 5.02 4.77 4.25 4.9 4.82 4.82 4.57 4.92 4.71 4.64 4.89 4.38
Biomarkers for urea cycle disorders%WikiPathways_20191210%WP4583%Homo sapiens 5.82 5.19 4.56 4.25 4.93 4.54 4.64 3.56 5.51 3.86 4.63 5.39 4.66 4.53 4.45 4.82 4.96 5.09 5.04 4.54 4.39 4.97 5.09 4.4 4.11 4.85 3.85 3.49 4.69 4.3 4.54 4.63 4.67 4.29 4.57 4.33 4.74 4.43 5.77
Cancer immunotherapy by PD-1 blockade%WikiPathways_20191210%WP4585%Homo sapiens 3.44 3.53 3.73 3.49 3.65 3.36 3.51 3.58 3.3 3.49 4.19 3.52 4.03 3.5 3.57 3.5 3.54 3.72 3.78 3.91 3.44 3.49 3.53 3.45 3.52 3.5 3.37 4.15 3.52 3.55 3.51 3.77 3.44 3.75 3.51 3.51 3.56 3.44 3.8
Pathways of nucleic acid metabolism and innate immune sensing%WikiPathways_20191210%WP4705%Homo sapiens 4.31 6.07 4.68 5.09 4.74 4.67 5.92 5.79 4.96 5.4 6.13 5.33 5.39 5.31 5.27 5.32 4.62 6.18 4.68 5.51 5.58 4.48 5.24 5.23 4.99 4.63 6.2 6.49 5.78 5.54 4.75 5.45 5.36 5.73 5.72 6.01 5.86 5.37 4.47
Major receptors targeted by epinephrine and norepinephrine%WikiPathways_20191210%WP4589%Homo sapiens 4.67 5.21 5.53 5.53 4.64 5.52 4.72 5.03 4.63 5.42 4.92 4.65 4.9 5.06 5.04 5.38 4.62 5.2 5.49 5.28 5.07 4.63 5.24 4.94 5.43 4.63 5.48 4.8 5.2 4.73 5.21 5.29 4.83 5.48 5.24 5.47 5.22 4.82 4.93
Urea cycle and associated pathways%WikiPathways_20191210%WP4595%Homo sapiens 6.62 6.85 6.88 6.28 6.79 6.52 6.33 6.57 6.36 6.16 6.44 6.65 6.62 6.59 6.61 6.65 6.89 6.78 6.37 6.43 6.68 6.61 6.29 6.34 6.61 6.43 6.36 6.31 6.83 6.64 6.51 7.19 6.34 6.55 6.96 6.23 6.52 6.44 6.24
Eicosanoid metabolism via Cyclo Oxygenases (COX)%WikiPathways_20191210%WP4719%Homo sapiens 4.36 4.62 4.63 4.43 4.37 4.6 4.49 4.66 4.37 4.63 4.83 4.63 4.72 4.47 4.64 4.47 4.55 4.47 4.66 4.62 4.43 4.45 4.65 4.66 4.65 4.6 5.08 4.72 4.45 4.8 4.63 4.69 4.31 4.43 4.59 4.54 4.25 4.47 4.28
Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways)%WikiPathways_20191210%WP4718%Homo sapiens 6.95 6.75 6.81 6.98 6.86 7.46 6.77 6.43 7.27 6.61 6.77 6.86 6.52 6.56 6.55 6.87 6.88 6.79 6.51 6.58 6.83 7.05 6.54 6.57 6.82 7.06 6.67 6.77 6.85 6.46 6.85 6.53 6.8 6.62 6.55 6.87 6.72 6.69 6.76
Genes involved in male infertility%WikiPathways_20191210%WP4673%Homo sapiens 4.14 4.28 4.43 4.32 4.2 4.14 4.51 4.4 4.43 4.4 4.5 4.29 4.56 4.33 4.46 4.23 4.4 4.15 4.38 4.35 4.18 4.17 4.34 4.32 4.28 4.26 4.39 4.47 4.38 4.24 4.44 4.51 4.02 4.35 4.33 4.28 4.14 4.37 4.24
Head and Neck Squamous Cell Carcinoma%WikiPathways_20191210%WP4674%Homo sapiens 5.9 5.75 6.04 6.53 6.45 6.39 5.97 6.06 6.29 6.48 6.21 6.17 6.01 6.55 6.37 6.06 6 6.03 5.91 6.4 6.48 6.25 6.06 6.45 6.31 6.35 6.53 6.22 6 6.15 6.64 6.58 6.44 6.49 6.67 6.47 6.59 6.36 5.92
Eicosanoid metabolism via Lipo Oxygenases (LOX)%WikiPathways_20191210%WP4721%Homo sapiens 4.21 4.24 4.27 4.1 4.16 4.05 4.4 4.29 4.14 4.33 4.57 4.27 4.14 4.19 4.42 4.09 4.19 4.04 4.3 4.4 4.08 4.19 4.4 4.46 4.27 4.14 4.17 4.49 4.24 4.17 4.1 4.36 4.1 4.1 4.19 4.2 4.05 3.95 4.16
Sphingolipid Metabolism (general overview)%WikiPathways_20191210%WP4725%Homo sapiens 7.58 7.08 6.87 7.09 7.61 7.14 7.4 6.83 7.23 7.02 6.71 7.15 6.89 7.37 6.83 7.41 7.49 7.51 6.59 6.83 7.08 7.72 6.95 7.02 6.72 7.26 7.06 6.68 7.04 7.07 7.39 6.55 7.58 7.47 6.92 6.91 7.26 6.89 7.83
Nephrotic syndrome%WikiPathways_20191210%WP4758%Homo sapiens 4.2 4.54 4.71 4.47 4.14 4.87 4.75 4.52 4.47 4.61 4.38 4.28 4.52 4.6 4.71 4.49 4.39 4.53 4.7 4.68 4.28 4.4 4.53 4.61 4.84 4.29 4.62 4.45 4.24 4.18 4.72 4.47 4.43 4.66 4.59 4.6 4.34 4.5 4.25
Gastrin Signaling Pathway%WikiPathways_20191210%WP4659%Homo sapiens 5.81 5.95 6.24 6.64 6.36 6.28 6.03 6.17 6.13 6.35 6.11 5.86 5.95 6.53 6.3 6.06 6.03 6.08 6.03 6.38 6.67 6.44 6.12 6.41 6.38 6.27 6.42 6.19 5.94 6.28 6.28 6.43 6.09 6.44 6.45 6.32 6.49 6.39 5.97
